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The complex interplay between virus and host is an often overlooked key determinant 
to the outcome of infection. Host factors are instrumental in supporting the entire virus 
lifecycle, where a majority have been implicated in the virus replication, especially for 
the formation of replication organelles. Simultaneously, the innate immune response 
confers a rapid non-specific defence against invading flaviviruses, where interferon 
(IFNs) and subsequently interferon stimulated genes (ISGs) are upregulated to directly 
inhibit virus replication and induction of an antiviral state within a cellular population. 
Although numerous host factors have been identified and characterised to be critical 
for the flaviviridae lifecycle through the usage of both RNAi and CRISPR genome-wide 
screens, limitations with RNAi technology combined with modifications of screening 
methodology may allow elucidation of novel host factors for virus infection. This thesis 
aims to identify and characterise novel host factors which positively and negatively 
influence the flaviviridae lifecycle, using in part genome wide CRISPR knockout (KO) 
technology.  
 
Hepatitis C Virus (HCV) is a medically important member of the flaviviridae family and 
thus chosen as a model virus to search for pan-flaviviridae novel host factors. The first 
aim explores the generation of multiple HCV sub-genomic (SGR) cell lines with 
mCherry, GFP and thymidine kinase (TK) reporter genes and their compatibility with 
our chosen screening platform, the GeCKO LentiCRISPRv2 library. Proof of concept 
experiments with the LentiCRISPRv2 system were performed via simplistic KO of 
EGFP or Cluster of Differentiation 81 (CD81), demonstrating the effectiveness of 
CRISPR in targeting both exogenous and endogenous genes. Furthermore, issues 
which surface upon attempting the genome-wide CRISPR screen with the HCV SGR 
are addressed and future directions proposed.  
 
The second aim repurposes the optimised GeCKO LentiCRISPRv2 library with an 
altered screening methodology to identify novel host factors important for ZIKV 
infection which may also be important for cell survival. Our top hits include previously 
identified host factors from the endoplasmic reticulum membrane protein complex 
(EMC) complex in addition to novel host factors Bcl-2-associated X protein 2 (BAX2) 
and Receptor for Activated C Kinase 1 (RACK1). We show that RACK1 is an important 
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pro-viral host factor for both mosquito and tick-borne flaviviruses. Furthermore, it plays 
a critical role in the construction of replication organelles early in the virus lifecycle. 
Furthermore, flavivirus non-structural protein 1 (NS1) which is important for the 
biogenesis of vesicle packets (VPs) is able to interact with RACK1 within the ER lumen. 
Collectively this aim reinforces the utility of CRISPR/Cas9 genome-wide KO screens 
in the identification of viral host dependency factors and identifies RACK1 as a scaffold 
protein for the recruitment of viral NS proteins that are essential to the biogenesis of 
the replication complex.    
 
The third aim investigates the cellular innate immune response to Zika Virus (ZIKV) 
infection. We show that biologically relevant transformed and primary cells infected 
with ZIKV have abrogated upregulation of IFN-b and associated ISGs. In addition, we 
have identified that ZIKV attenuates the RIG-I-like Receptors (RLR) signalling pathway, 
required for the efficient induction of ISGs. Expression of the highly characterised 
multifunctional ISG viperin inhibits the ZIKV lifecycle and this observation is 
complemented by the usage of ZIKV infected viperin-/- mouse embryonic fibroblasts 
(MEFs). Finally, we show that the C-terminus of viperin is critical for ZIKV antiviral 
activity, an observation which is supported in future publications by collaborators.  
 
Collectively, this thesis not only enhances our understanding of the flavivirus lifecycle 
and their complex relationship with the host but also may guide towards the 
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aa  Amino acids 
ADE Antibody-dependent enhancement 
ATP  Adenosine triphosphate 
bp Base pair(s) 
BSA  Bovine serum albumin 
C Cytosine 
CARD caspase recruitment and activation domains 
cccDNA Covalently closed circular DNA 
CD81 Cluster of Differentiation 81 
cDNA Complementary deoxyribonucleic acid 
cGAS Cyclic-GMP-AMP synthase 
cGAMP 2’3’-cyclic GMP-AMP 
CHC  Chronic hepatitis C 
CLDN Claudin 
CMV Cytomegalovirus  
CPE Cytopathic effect 
CRISPR Clustered Regularly Interspaced Short 
Palindromic Repeats 
crRNA CRISPR targeting RNA 
CTD C-terminal domain 
CypA Cyclophilin A 
CZS Congenital ZIKV syndrome 
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DAPI  4’, 6-Diamidino-2-pheylinodole 
dATP Deoxyadenosine triphosphate 
dCas9 Dead Cas9 
DC-SIGN Dendritic cell-specific intercellular adhesion 
molecule-3-Grabbing non-integrin 
dCTP Deoxycytosine tripshosphate 
ddhCTP 3’-deoxy-3’,4’-didehydro-CTP 
DENV Dengue Virus 
DF Dengue Fever 
dGTP Deoxyguanosine triphosphate 
dH2O  Deionised water 
DHF Dengue Hemorrhagic Fever 
DMEM Dulbecco’s Modified Eagle Medium with 
HEPES 
DMSO  Dimethyl sulfoxide 
DMV  Double-membrane vesicle 
DNA Deoxyribonucleic acid 
dNTP Deoxynucleotide triphosphate 
DSB Double strand break 
dsRNA  Double stranded RNA 
DSS Dengue Shock Syndrome 
DTT  Dithiothreitol  
dTTP Deoxythymidine triphosphate 
E Envelope 
EBV Epstein-Barr Virus 
ECMV  Encephalomyocarditis virus 
EDTA  Ethylenediamine tetraacetic acid 
elF  E74-like factor 
ER  Endoplasmic reticulum 
FACS  Fluorescence-activated cell sorting 
FASN Fatty acid synthase 
FCS  Foetal calf serum 
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GBS Guillan-Barré syndrome 
GBF1 Golgi brefeldin A-resistant guanine nucleotide 
exchange factor 1 
GeCKO Genome-scale CRISPR knock-out 
GFP  Green fluorescent protein 
gRNA Genomic RNA 
HCC  Hepatocellular carcinoma 
HCEC Human primary corneal epithelial cells 
HCV  Hepatitis C virus 
HCVcc  Cell-culture propagated hepatitis C virus 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid 
HIV  Human immunodeficiency virus 
hr Hour(s) 
HRP  Horse radish peroxidase 
Huh  Human hepatoma 
IFI6 IFN-inducible protein 6 
IFITM IFN-inducible transmembrane 
IFN Interferon 
IFN-g Interferon gamma 
IFN-α  Interferon alpha  
IFN-β Interferon beta 
IFN-λ Interferon lambda 
IFNAR Interferon-alpha/beta receptor 
Ig Immunoglobulin(s) 
IKKe Ikb kinase-e 
IL Interleukin 
IRES  Internal ribosome entry site 
IRF Interferon regulatory factor 
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KFDV Kyasanur Forest disease virus 
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LD  Lipid droplet 
LDL-R Low-density lipoprotein receptor 
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LGTV Langat virus 
LIV Louping ill virus 
Luc  Luciferase 
M Mole 
mA Milliampere(s) 
MAVS Mitochondrial antiviral-signaling protein 
MCS  multiple cloning site 
MDA5 Melanoma differentiation associated factor 5 
MEM Minimum Essential Medium 
mg Milligram(s) 
MHC Major Histocompatibility Complex 
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MMV  Multi-membrane vesicle 
MOI  Multiplicity of infection 
mRNA Messenger ribonucleic acid 
MTase Methyltransferase 
MuV Mumps Virus 
MW  Molecular weight 
Mx1 MX Dynamin Like GTPase 1 
N/A Not applicable 
NANBH  Non-A, non-B hepatitis 
NF-kB Nuclear factor kappa-light-chain-enhancer of 
activated B cells 
ng Nanogram(s) 
NHEJ Non-homologous end joining 
nM Nanomolar 
NS  Non-structural 
nt (s) Nucleotide (s) 
OAS 2'-5'-Oligoadenylate Synthetase 
OCLN  Occludin 
OHFV Omsk hemorrhagic fever virus 
ORF  Open reading frame 
OSBP Oxysterol-binding protein  
OST Oligosaccharyltransferase 
PAM Protospacer adjacent motif 
PAMPS Pathogen associated molecular patterns 
PBMCs Peripheral blood mononuclear cells 
PBS  Phosphate buffered saline 
PCR  Polymerase chain reaction 
pDCs Plasmacytoid dendritic cells 
PEG  Polyethylene glycol 
pg Picograms 
pH Negative logarithm of hydrogen ion activity 
PI4KA  Phosphatidylinositol 4-kinase III alpha 
PI4P  Phosphatidylinositol 4-phosphate 
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pmol Picomolar 
POWV Powassan virus 
prM Pre-membrane 
PRRs Pattern recognition receptors 
Rab Ras-associated binding 
RC  Replication complex 
RdRp  RNA-dependent RNA polymerase 
RIG-I Retinoic acid-induced gene-I 
RISC RNA-induced silencing complex 
RLR  RIG-I like receptors 
RNA  Ribonucleic acid 
RNAi RNA interference 
RNase Ribonuclease 
rpm  Revolutions per minute 
RT  Reverse transcriptase or Room Temperature 
RT-PCR  Reverse transcriptase polymerase chain 
reaction 
SDS Sodium dodecyl sulfate 
SDS-PAGE  Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis 
sec Second(s) 
SGR Sub-genomic replicon 
sgRNA Single guide RNA 
shRNA Short hairpin RNA 
siRNA Short interfering RNA 
SLA Stem-loop A 
SLB Stem-loop B 
SMV  Single-membrane vesicle 
sNS1 Secreted NS1 
SOC  Super optimal broth with catabolite repression 
SRB1  Scavenger receptor class B1 
ss Single stranded 
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T Thymidine 
TAE  Tris, acetic acid, EDTA (TAE) buffer 
TALEN Transcription activator-like effector nuclease 
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TBEV  Tick-borne encephalitis virus 
TBFV Tick-borne flaviviruses 
TBK1 TANK-binding kinase 1 
TEMED N,N,N’,N’-tetramethylethylenediamine 
TIM T-cell Ig mucin 
TLR Toll-like receptor 
TNF-a Tumor necrosis factor alpha 
tracRNA Trans-acting RNA 
TRIF TIR-domain-containing adapter-inducing 
interferon-β 
TRIM Tripartite motif 
TYK2 Tyrosine kinase 2 
U/µl Unit(s) per microliter 
UTR Untranslated region 
UV  Ultraviolet 
V  Volt(s) 
v/v  Volume per volume 
VAPA  Vesicle-associated membrane protein-
associated protein A 
Viperin Virus inhibitory endoplasmic reticulum 
associated interferon inducible protein 
VLDL  Very low density lipoprotein 
VP Vesicle packet 
w/v Weight per volume 
WNV West Nile Virus 
WHO  World Health Organization 
WT  Wild-type 
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Chapter 1 - Introduction 
1.1  The Flaviviridae family 
The flaviviridae family consists of a group of enveloped viruses with a positive sense 
RNA genome.  Viruses in this family are grouped, according to similarities in their 
genome structure and canonical lifecycle of replication, into multiple genera. The two 
most prominent are the hepacivirus and flaviviruses. Viruses from these genera, such 
as Hepatitis C virus (HCV) and Dengue virus (DENV) and Zika virus (ZIKV) 
respectively, are classified as major human pathogens that inflict a worldwide burden 
on society. As obligate intracellular parasites, viruses have evolved multiple strategies 
to manipulate infected cells to support their own replication. However, research 
indicates that the subtle differences in how these viruses manipulate the cell allows 
them each to flourish in their unique niches. 
1.2  Discovery and Epidemiology 
The flaviviridae family consists of four genera; Flavivirus, Hepacivirus, Pegivirus and 
Pestivirus (Fig. 1.1). The Flavivirus genus is named after the Yellow Fever virus (YFV), 
where the Latin word for “yellow” is flavus, describing yellowing of the skin as a visible 
symptom of liver damage caused by virus infection. This genus is composed of over 
80 viruses of which several with high medical importance will be discussed below 
(Kuno et al. 1998; King et al. 2012). 
YFV has had a huge impact historically, with epidemics recorded in the 18th and 19th 
century in North and Central America and Europe, likely introduced via ships 
originating from Africa (Cathey and Marr 2014). Flaviviruses were originally 
categorised into the Togaviridae family which include Chikungunya virus, Rubella virus 
and Ross River virus based on early serological assessment but in 1984 they were re-
classified into the flaviviridae family when research made it apparent that these viruses 
differ to other Togaviridae significantly in both virion structure and virus lifecycle.  
The earliest official Dengue virus (DENV) infection was recorded in 1779 in Java, 
Indonesia by David Bylon after centuries of etiological confusion between the former 
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Figure 1.1: Phylogeny of the flaviviridae family based on genetic analysis of the 
NS5 (NS5B) RdRp 
The flaviviridae family is composed of 4 genera; flaviviruses, hepaciviruses, 





and Chikungunya virus due to their similarities in pathogenesis in causing arthritis in 
patients (Halstead 2015). DENV is currently endemic in at least 100 countries located 
within the Asia-Pacific, African and American regions, where annually approximately 
one million infected individuals display symptoms of dengue fever or dengue 
haemorrhagic fever and approximately 5% succumb to infection (Fig. 1.2). In contrast, 
ZIKV was first identified in 1947 in a sentinel rhesus macaque in Uganda with little 
impact on public health systems until 2005, where the first outbreak outside of Africa 
and Asia occurred on Yap state in the Federated states of Micronesia, resulting in 
approximately 72% of the population infected (Musso et al. 2014). Another outbreak 
in 2013 in French Polynesia identified a possible link between ZIKV and Guillan-Barré 
syndrome (GBS) where an increase in severe neurological manifestations were 
reported (Musso et al. 2014). Global attention to ZIKV increased dramatically in 2015, 
when spread of the ZIKV infection skyrocketed to upwards of 1.3 million cases in Brazil 
following increased population movement due to the 2015 FIFA world cup and 2016 
Rio Olympic games. To date, at least 87 countries and territories have recorded 
evidence of mosquito-borne transmission of ZIKV (WHO). 
Transmission of the above flaviviruses is highly dependent on the activity and 
geographic distribution of arthropod vectors (Fig. 1.2). Rapid urbanisation, increased 
international travel and ongoing climate change are all factors that increase the range 
of the Aedes (DENV/ZIKV) and Culex (West Nile Virus (WNV) and Japanese 
Encephalitis Virus (JEV)) species of mosquitoes which in turn greatly expands the 
areas these viruses are now endemic (Daep et al. 2014). 
Unlike flaviviruses, HCV was classified as non-A and non-B hepatitis virus (NANBH) 
until 1989 when the viral genome was isolated from NANBH patient serum (Choo et 
al. 1989). 170 million people are now infected worldwide with HCV, with 500,000 
patients succumbing to HCV-related liver disease each year (Fig. 1.3) (Thomas 2013; 
Messina et al. 2015). In Australia, it is estimated that 264,000 are infected with HCV 
and it is the most common cause of clinically significant liver disease as a result of 
virus induced liver cirrhosis and hepatocellular carcinoma (HCC) (Razali et al. 2009). 
However, in contrast to the above mentioned flaviviruses, we now have efficacious 
therapeutics for HCV that is further discussed below.  
1.3  Transmission 
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Figure 1.2: Global distribution of flavivirus infection. 
Worldwide distribution of flaviviruses varies in geographical area, dependent on the 
habitual area of the mosquito vector. West Nile Virus, Zika Virus and Dengue virus are 
distributed worldwide whereas Japanese Encephalitis Virus and Yellow Fever are 
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Members of the flaviviridae family are split into two groups when considering 
transmission of virions from one host to another: arthropod dependent or arthropod 
independent transmission.  
1.3.1  Arthropod dependent transmission 
Arthropod-dependant flaviviruses are generally categorised into two groups defined 
by the arthropods that carry them, mosquito-borne and tick-borne.  
1.3.1.1  Mosquito-borne transmission 
Historically, the link between the role of mosquitos in transmitting agents that result in 
flavivirus disease, such as  yellow fever was first  reported in 1881, while in Cuba in 
1900  Major Walter Reed deduced that yellow fever was a filterable agent responsible 
for the outbreak of yellow fever (Brès 1986; Clements and Harbach 2017). Since then, 
multiple viruses within the flaviviridae family, especially in the flavivirus genus have 
been found to utilise the mosquito as the primary arthropod for transmission. The 
mosquito (namely Aedes aegypti and Aedes albopictus) is able to transmit virions via 
a blood meal of an infected host. In the case of flaviviruses, the natural reservoir (host) 
is often wild birds and domesticated animals, where infection of the former results in 
negligible pathogenesis despite high viremic load. The consensus is that high viremic 
load is critical for efficiency of transmission for not only flaviviruses, but other viruses 
as well. This is the main reason why humans are often a dead end for most flaviviruses, 
as transmission from one human to another is inefficient due to low viremia during 
infection. One exception to this rule is Dengue virus, where high viremia in humans 
means they can act as a reservoir for epidemics to spread. Vector control of 
mosquitoes is utilised in developing countries to prevent flavivirus transmission. This 
primarily involves the usage of insecticide treated nets and sprays. Mosquitoes have 
however adapted to develop resistance to insecticides and also changes in feeding 
schedules (Liu 2015). To bypass the need for insecticides trials involving the 
introduction of the bacteria Wolbachia into Aedes aegypti to not only control population 
levels of flavivirus carrying mosquitoes but also directly block virus transmission are 
ongoing (Ford et al. 2019). As a naturally existing gram-negative bacterium, 
Wolbachia is harmless to humans but transmitted vertically in mosquitoes. Infection 
distorts sex ratio phenotypes of progeny mosquitoes through a number of mechanisms, 
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including feminisation of genetic males, parthenogenetic induction, the killing of male 
progeny from infected females and cytoplasmic incompatibility (Werren et al. 2008). 
In addition, aedes aegypti mosquitoes harbouring Wolbachia are highly resistant to 
infection of circulating ZIKV strains and therefore also prevent viral transmission 
(Dutra et al. 2016). Although innovative vector control strategies utilising Wolbachia 
shows great promise to supress transmission of flaviviruses, antivirals and vaccines 
will still be required to control virus infection. 
1.3.1.2  Tick-borne transmission 
Although ticks carry multiple pathogens including bacteria, protozoa and viruses, the 
tick-borne flaviviruses (TBFV) are considered major pathogens worldwide. Ioxdidae 
(hard ticks) and Argasidae (soft ticks) are the main families of ticks that transmit 
flaviviruses. Unlike mosquitoes where multiple species such as Aedes aegypti have a 
global distribution in transmitting flaviviruses, TBFV are transmitted by ticks which 
reside in specific geographical locations (Grabowski and Hill 2017). Currently, there 
are seven mammalian TBFV of known or putative (implicit) medical importance; 
Kyasanur Forest disease virus (KFDV), Karshi virus, Langat virus (LGTV), Louping ill 
virus (LIV), Omsk hemorrhagic fever virus (OHFV), Powassan virus (POWV) and Tick 
borne encephalitis virus (TBEV) (Kemenesi and Bányai 2019). TBEV and LIV are 
endemic in both Europe and Asia whereas OHFV, LGTV, KFDV and Karshi virus are 
present only in the latter. POWV is the only known member of the TBFV family 
endemic across North America, where transmission rates have been increasing 
annually and the fatality rate of virus induced encephalitis exceeds 30% in some cases 
(Hinten et al. 2008; Hermance and Thangamani 2017). Other TBFVs that cause 
meningitis and encephalitis in humans include, TBEV, LIV, LGTV and Karshi virus 
while OFHV and KFDV induce haemorrhagic fever in infected patients (Kemenesi and 
Bányai 2019).  
1.3.2  Arthropod independent transmission 
The main vector-independent virus in the flaviviridae family is the hepacivirus Hepatitis 
C virus (HCV). This virus is transmitted via entry of contaminated infected blood 
directly into blood stream. Blood transfusion was the main mode of infection until 1992, 
when improvements in blood screening technology eliminated HCV contamination in 
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donor blood. However, in developing countries inappropriate medical procedures 
combined with inadequate blood screening technology means this type of 
transmission remains prevalent. In developed countries  HCV is now predominately 
transmitted by intravenous drug use (IVDU) particularly through  sharing virus-
contaminated needles and syringes (Ng et al. 2015). Other modes for transmission of 
HCV include tattooing, piercing, sexual intercourse or vertical transmission from 
mother to baby during pregnancy (S. L. Thomas et al. 1998; Fauteux-Daniel et al. 
2017). Although flaviviruses were thought to be only transmitted by mosquitoes, there 
is evidence that DENV can be vertically transmitted, although this is a rare event most 
likely due to the short duration of viremia (Yin et al. 2016). In addition, during the 
outbreak of ZIKV in the Americas in 2015, it was found ZIKV can be readily transmitted 
vertically due to the virus’s ability to infect the reproductive organs of both sexes and 
cross the placental barrier during pregnancy, resulting in congenital Zika syndrome in 
the foetus (Chan et al. 2016; Krauer et al. 2017). 
1.4  Pathogenesis 
Due to the diverse nature of members of the flaviviridae family, pathogenesis of 
disease differs significantly. As members of the flaviviridae family do not integrate their 
genome into host cell genetic material, clinical outcomes of infection are mediated 
either directly through viral factors or indirectly through interaction with the immune 
response of the infected individual. 
Our understanding of the intricacies of flavivirus pathogenesis is still limited in part due 
to the lack of a suitable models of disease progression. Immuno-compromised mice 
that cannot respond to type I IFN (IFNAR-/-) are widely used as an animal model for 
DENV, WNV and ZIKV infection, as they support replication of clinical isolates (Wong 
and Qiu 2018). However, the clinical symptoms arising in these mouse models do not 
mirror those seen in humans. Although non-human primates do not present clinical 
disease, the onset of viremia and the production of humoral immune responses 
against flaviviruses is similar to that seen in humans indicating non-human primates 
can be utilised for vaccine testing (Estes et al. 2018).  
Flaviviruses can be categorised into two groups defined by the clinical outcomes the 
infection produces, one being vascular leakage and haemorrhage (DENV and YFV) 
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and the other encephalitis (JEV and WNV). Flaviviruses such as DENV, JEV, WNV 
and ZIKV all induce cytopathic effects (CPE) on the infected cell type during replication. 
However, the mechanism by which CPE is induced by each flavivirus is unique. Most 
infections (up to 80%) by flaviviruses are asymptomatic or result in mild flu-like 
symptoms, however failure to clear flavivirus infection in an individual may progress to 
more severe clinical outcomes.  
Although is still not possible to predict which individuals will progress to severe clinical 
disease post infection, epidemiological studies have shown that there are several risks 
factors including age (younger for DENV and JEV/older for WNV), high body mass 
index, viral strain, gender, genetic variation in genes involved in innate immune 
response (MHC class I/TNF-a) and receptors for viral entry (DC-SIGN), environmental 
conditions, such as mosquito spread and temperature, and previous exposure to 
flavivirus infection (Daep et al. 2014). Although HCV, DENV and ZIKV are all viruses 
within the flaviviridae family and thus have similar replication strategies, each cause 
unique pathological disease during virus infection which will be discussed below. 
1.4.1  Dengue Virus  
The numerous symptoms which are collectively referred to as Dengue Fever (DF) 
have been identified by various observations of both natural and experimental origins 
since the 1920s. These symptoms often occur after an incubation period of 3-15 days 
with the first of these including the onset of fever, chills and breakbone headaches. 
Young children can often present with respiratory symptoms as well as maculopapular 
rash of the trunks and/or limbs. Although young children often experience less severe 
disease from primary DENV infection compared to adults, they are more susceptible 
to severe outcomes from secondary infection in endemic areas via antibody 
dependent enhancement (ADE). Other symptoms which arise from Dengue Fever 
include nausea and vomiting, lymphadenopathy, leukopenia and insufficient 
coagulation complications (Fig. 1.4) (Chuang et al. 2013). Viremia duration ranges 
from 1-7 days post infection and is often absent approximately the same time the fever 
dissipates. 
Dengue Haemorrhagic Fever (DHF) is primarily physiologically distinguished from 
Dengue Fever by the leakage of plasma, termed vascular leakage, and is often the 
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Figure 1.4: Clinical symptoms of Dengue (DENV) and Zika (ZIKV) Virus infection. 
Symptoms for DENV and ZIKV infections are similar in the acute phase, resulting in 
headaches, rash, myalgia and arthralgia. However, patients with DENV infection can 
progress to Dengue Haemorrhagic Fever (DHF), resulting in organ haemorrhage and 
vascular leakage. Pregnant women infected with ZIKV can vertically transmit the virus 








determinant of severity of disease (Fig. 1.4) (Chuansumrit and Chaiyaratana 2014).  
There are four grades of disease for patients diagnosed with DHF as outlined by the 
World Health Organisation. Grade I is classified as high fever accompanied by 
symptoms which resemble DF, whereas Grade II includes spontaneous haemorrhagic 
manifestations which results in positive tourniquet tests, measuring both capillary 
fragility and thrombocytopenia (Chuansumrit and Chaiyaratana 2014). Grade III and 
IV are classified as Dengue Shock Syndrome (DSS) where the condition of patients 
deteriorates rapidly, resulting in circulatory failure brought on low blood pressure and 
characterised by rapid weak pulse with, cold skin and restlessness (Chuansumrit and 
Chaiyaratana 2014).  
There is also the potential complication of ADE upon DENV re-infection. Pre-existing 
antibodies that develop against one serotype of DENV bind to a DENV virion of a 
different serotype and aid viral entry in a subsequent infection. The antibody-virion 
complex that forms is able to bind Fcg receptors present on the cell surface of 
macrophages, promoting fusion and entry of viral particles as well as enhancing DENV 
infection (Flipse et al. 2016). In addition, an extensive cross-reactive antibody 
response is observed between DENV and ZIKV due to the high similarity of the 
envelope protein of both viruses (Priyamvada et al. 2016). Thus, antibodies from a 
previous DENV infection have been shown to confer either protective (cross-
neutralisation) or inhibitory ADE effects on a sequential ZIKV infection (Dejnirattisai et 
al. 2016; Paul et al. 2016; Robbiani et al. 2017; Pantoja et al. 2017). 
1.4.2  Zika Virus  
Patients infected with ZIKV present with febrile disease consisting of flu-like symptoms 
in about 20% of individuals and most fully recover within days. These symptoms are 
similar to that of DENV but may include arthralgia, rash and cardiovascular 
complications (Fig. 1.4). However, a rare subset of patients may develop Guillain-
Barré Syndrome (GBS), an autoimmune condition where the patient’s immune 
response attacks the peripheral nerve myelin proteins. These patients can die from 
complications arising from blood infections and paralysis of muscles critical for 
breathing (Krauer et al. 2017). The link between ZIKV infection and its ability to cause 
microcephaly in infants born to ZIKV infected mothers only became evident as the 
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2015 epidemic in Brazil progressed. ZIKV infected infants may develop Congenital 
ZIKV Syndrome (CZS), which encompasses a unique spectrum of congenital defects 
including microcephaly, ocular abnormalities, delays in neurological development and 
arthrogryposis (Fig. 1.4) (Del Campo et al. 2017). In addition, neurodevelopment 
abnormalities were observed in children without ZIKV induced CZS at birth and thus 
further follow up on infants with in utero exposure is required to assess the impacts of 
congenital infection on adulthood (Mulkey et al. 2020). To date, this is the only 
flavivirus that can cross the placental barrier and infect the developing foetus, 
furthermore the mechanisms by which ZIKV is able to cross the placental barrier and 
induce CZS remain poorly understood.  
1.4.3  Hepatitis C Virus  
Due to cell specificity of infection, pathogenesis of HCV is limited mainly to the liver. 
As HCV is a non-cytopathic virus, liver disease as a result of infection occurs slowly 
and is primarily driven by both innate and adaptive immune responses to HCV infected 
hepatocytes, leading to immune-mediated cytolysis. Although hepatocytes are the 
main target during HCV infection, HCV RNA has been reported in other cell types 
including macrophages, monocytes and dendritic cells (Liu et al. 2019). However, this 
is somewhat controversial and its relevance in the clinical outcome during infection is 
unknown. Acute HCV infection is asymptomatic in most individuals, where 20% will 
successfully clear the virus while the remaining 80% of patients develop a chronic 
lifelong infection due to ineffective host antiviral responses. Twenty % of patients who 
develop chronic HCV infection will progress to liver cirrhosis within 25-30 years, where 
long term hepatic inflammation results in extensive scarring of liver tissue (Fig. 1.5) 
(Conde et al. 2017; Lingala & Ghany 2015). Two percent of individuals with liver 
cirrhosis progress to HCC. Co-factors that drive progression to chronic liver disease 
include alcohol consumption and co-infection with other viruses including HIV and 
HBV.  
1.5  Treatment 
Current treatments for the majority of flaviviruses are limited to supportive care, which 
include analgesics, fluid replacements and bedrest. There are no effective specific 
therapies for disease caused by the flaviviruses, despite highly successful drug 
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Figure 1.5: Clinical progression of HCV infection. 
Following initial infection with HCV, ~55-85% of patients will develop chronic HCV 
infection where 20-30% go on to develop cirrhosis. Patients with HCV-induced 
cirrhosis have a 1-4% risk per year of developing hepatocellular carcinoma (HCC) or 











discoveries in treating the hepacivirus HCV where the cure rate is now upwards of 
95%. There are several reasons for the failure thus far to produce antivirals to treat 
flavivirus infections (Grebely et al. 2018). Flaviviruses have been previously regarded 
as neglected pathogens, due to prevalent spread in developing tropical countries with 
high variability in symptoms during infection. In addition, there are efficient vaccines 
to combat a subset of flaviviruses, including YFV, JEV and TBEV. More recently, 
significant progress has been made in the development of antivirals for flaviviruses, 
including repurposing drugs with known antiviral activity to non-flaviviruses to 
screening compound libraries to identify molecules which disrupt virus replication 
(Botta et al. 2018; Eyre et al. 2020). Antivirals targeting both the structural and non-
structural proteins are currently undergoing clinical trials, with significant focus on NS3 
and NS5 due to their essential roles in virus replication and the success of direct acting 
antivirals that target the proteases and polymerases of other viruses, including HIV 
and HCV. However, challenges still remain during development and testing of 
candidate antivirals due to limited efficacy in vivo and the need to target multiple 
genotypes of certain flaviviruses such as DENV to prevent ADE by a single drug 
candidate. In addition, the differentiation of patients who may progress to severe 
dengue fever from the thousands of patients with febrile illness during an outbreak 
combined with a reduced window of opportunity for treatment with patients upon late 
presentation to the clinic complicates the challenges involved in the implementation of 
effective antivirals for flavivirus infection.  
The first vaccine produced for flaviviruses, YFV-17D was developed in 1937 through 
176 passages in chicken embryo tissue to produce a live attenuated stain which lost 
its neurotropic phenotype (Theiler and Smith 1937). Since then, YFV-17D has been 
utilised to produce chimeric live attenuated vaccines to target both the pre-membrane 
and envelope proteins, the major antigen of the virion, of other flaviviruses with varying 
results. IMOJEV, a vaccine in which the JEV pre-membrane and envelope proteins 
replaced the endogenous YFV pre-membrane and envelope proteins has high efficacy 
with regards to JEV infection and was approved for use in Australia in 2010 (Feroldi 
et al. 2012).  Development of vaccines which target DENV has been inherently difficult 
due to the need to protect against all four serotypes, as cross protection is poor 
between serotypes of DENV and the risk of development of DHF, due to ADE, is 15-
80x higher following secondary infection. The only approved vaccines are tetravalent 
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by the replacement of prM/E proteins from each of the four serotypes into the YFV-
17D backbone. Clinical trials demonstrated strong neutralising antibody responses 
against all serotypes despite variances in serotypes (DENV3=78.4%, DENV2=35%) 
with genetically and phenotypically stable and non-hepatropic properties (Guy et al. 
2015). However, the efficacy in children was dependent on age, with a reported 
efficacy of 33.7% in children aged 2-5 years old. In addition, manufacturer of 
Dengvaxia, Sanofi, discovered that vaccination actually resulted in increased risk of 
developing severe DF/DHF post DENV infection compared to naïve infection. This 
ultimately resulted in a permanent ban of Dengvaxia by the department of health in 
the Philippines after approximately 600 people died after receiving the vaccination, 
although the link hasn’t been medically confirmed (Fatima and Syed 2018).  
1.6  Lifecycle 
Despite differences in transmission, cell tropism and pathogenesis, there is a 
conserved lifecycle for viruses within the flaviviridae family with distinct differences 
and is outlined below (Fig. 1.6 & 1.7) 
1.6.1  Flaviviridae binding and entry: 
Viruses from the flaviviridae family are grouped according to their similar viral lifecycles 
and replication strategies despite differences in cell tropism, transmission and 
pathogenesis. 
Due to the broad cell tropism of flaviviruses, DENV and ZIKV interact with myriad of 
receptors in a cell-candidate manner to allow for entry into permissive cells. Despite 
identification of multiple receptors for both DENV and ZIKV, the key receptors required 
exclusively for entry remains a contentious issue. Common receptors extensively 
characterised important for entry of both DENV and ZIKV include mannose specific C-
type lectins DC-SIGN and phosphatidyl serines receptors families TIM and TAM 
(Tassaneetrithep et al. 2003; Meertens et al. 2012; Hamel et al. 2015). Not only are 
these receptors important for viral attachment and internalisation, some also play a 
role in priming an optimal environment for viral replication to occur via triggering of 
internal signalling cascades which prevent apoptosis, induction of autophagy, 
downregulation of innate immune signalling or enhance binding of viral particles 
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Figure 1.6: Schematic representation of the HCV lifecycle. 
The HCV lifecycle consists of multiple phases, where the (a) virus attaches on a cell 
and internalised, (b) viral uncoating, (c) IRES mediated translation and polypeptide 
processing which (d) results in the establishment of HCV replication and replication 
complex formation. The virus is (e) packaged into progeny virions to be (f) released 












Figure 1.7: Schematic representation of the flavivirus lifecycle. 
The flavivirus lifecycle consists of multiple phases, where the (a) virus attaches on a 
cell and internalised, (b) membrane fusion and release of the viral RNA genome, (c) 
cap-mediated translation and polypeptide processing which (d) results in the 
establishment of flavivirus replication and replication complex formation. The virus is 
(e) packaged into progeny virions to (f) mature during golgi transport and (g) released 










(Lee et al. 2005; Best 2013; Aid et al. 2017; Dejarnac et al. 2018; Chu et al. 2019). 
HCV enters the host hepatocytes via receptor mediated endocytosis by a highly 
orchestrated process involving several cellular receptors (CD81, scavenger receptor 
class B type 1 (SRB1), claudin-1 and occludin), attachment molecules (apolipoprotein 
E) and HCV glycoprotein E1 and E2 (Fig. 1.8) (Cerikan et al. 2020).  
1.6.2  Flaviviridae internalisation and viral genomic RNA (gRNA) release: 
There are several routes of entry for DENV and to a certain extent ZIKV. The canonical 
route of entry requires flavivirus virions to form complexes with receptors and/or co-
receptors followed by fusion of the cell membrane and direct release of the 
nucleocapsid without the formation of vesicles (Hase et al. 1989). The ectodomains of 
the viral envelope protein play a critical role during this stage of the virus lifecycle. 
Clathrin-mediated endocytosis is the primary accepted model for entry of DENV, 
where DENV virion/receptor complexes are internalised within a pre-existing clathrin-
coated pit where the virion particle is delivered to Rab5-positive early endosomes (van 
der Schaar et al. 2008). Maturation of the early endosomes via the accumulation of 
Rab7 and loss of Rab5 in addition to acidification signals the beginning of the fusion 
between endosomal and viral membranes (Acosta et al. 2012). Insertion of the 
dissociated envelope homodimers into the endosomal membrane results in formation 
of DENV envelope trimers. A fusion pore is constructed by conformational changes 
induced by the DENV envelope trimers, resulting in the release of the DENV viral 
nucleocapsid. Uncoating of the viral genome requires ubiquitination, where the capsid 
protein is degraded in a proteasome mediated manner (Byk et al. 2016). How the 
flavivirus nucleoprotein folds and renders itself susceptible to ribosomal translation 
remains speculative due to the lack of a solved flaviviral capsid-RNA crystal structure. 
Similar to flaviviruses, HCV virions are transported with Rab5a positive early 
endosomes where acidification induce virus uncoating and allowing release of the viral 
gRNA into the cytosol for translation (Coller et al. 2009; Farquhar et al. 2012).  
1.6.3  Flaviviridae viral gRNA translation: 
The flavivirus gRNA contains all the genetic information required to initiate and 
facilitate virus replication, is released into the host cell cytoplasm. Through a multi-
coordinated effort between the viral gRNA flanking 5’ and 3’ untranslated regions (UTR) 
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Figure 1.8: Entry and attachment of HCV virions.  
HCV infects hepatocytes via clathrin mediated endocytosis, mediated by a highly 
orchestrated process which involves multiple host receptors including low-density 
lipoprotein receptor (LDL-R), glycosaminoglycans (GAGs), tetraspanin (CD81), 
scavenger receptor class B type 1 (SR-B1), claudin-1 (CLDN1) and occludin (OCLN) 












and host cellular proteins, the RNA is circularised to achieve efficient canonical cap-
dependent translation of the gRNA on the surface of the ER (Holden and Harris 2004; 
Chiu et al. 2005). DENV gRNA can also be cap-independent translated, leading to 
establishment of replication and the production of virus progeny (Edgil et al. 2006). It 
is thought that cap-independent translation is regulated through the 5’ and 3’ UTR, 
however the mechanism by which translation of the gRNA is achieved is unclear, 
especially due to the lack of IRES which is present in other viruses in the flaviviridae 
family such as HCV. The HCV internal ribosome entry site (IRES) present within the 
5’ UTR is a highly structured RNA element, which can directly recruit the 40S 
ribosomal subunit to the start AUG codon without scanning (Otto and Puglisi 2004). 
Recruitment of additional ribosomal subunits ultimately results in the formation of the 
60S IRES-preinitiation complex and the commencement of translation and elongation 
(Kieft et al. 2001; Fraser et al. 2009).   
 1.6.4  Flaviviridae polyprotein processing: 
Translation of both HCV and flavivirus viral gRNA results in the production of a 
transmembrane polyprotein that is highly associated with the endoplasmic reticulum 
(ER). The polyprotein is subsequently cleaved by host proteases such as signal 
peptidases, allowing the release of the structural proteins (capsid, pre-membrane and 
envelope for flaviviruses and core, E1 and E2 for HCV) from the rest of the polypeptide 
(Fig. 1.9 & 1.10) (Markoff 1989). Cleavage by viral proteases (NS2B-3 in flaviviruses 
and NS2/3 and NS3-4A in HCV) allow release of all the remaining NS proteins (Fig. 
1.9 & 1.10) (Preugschat et al. 1990; Khumthong et al. 2002). Introduction of constraints 
within the efficiency of viral protein processing is a tool both flaviviruses and HCV 
utilise to regulate lifecycle kinetics and/or the expression levels of viral proteins (Stocks 
and Lobigs 1998; Carrère-Kremer et al. 2004; Welbourn et al. 2005).  
1.6.5  Flaviviridae replication complex formation and viral gRNA generation: 
Spatiotemporal regulation of virus replication and encapsulation is required in order to 
allow for efficient completion of the virus lifecycle. Thus, compartmentalisation of each 
process is achieved through the remodelling of ER membranes to allow the 
construction of a micro-environment favourable to virus replication, commonly called 
the replication complex or replication organelles for both flaviviruses and HCV. 
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Figure 1.9: HCV genome organisation and polypeptide processing. 
HCV is a 9.6kb positive-strand RNA genome with 5’ and 3’ UTRs important for 
translation and replication of the viral RNA. Translation and processing by viral and 
host proteases of the polypeptide yields the structural proteins (core, envelope 
glycoproteins E1 and E2), transmembrane protein p7 and non-structural proteins 















Figure 1.10: Flavivirus genome organisation and polypeptide processing. 
Flaviviruses consist of a ~11kb positive-strand RNA genome that encodes one large 
open reading frame flanked by 5’ and and 3’ UTRs, critical for viral genome translation 
and replication. Translation and processing by viral and host proteases of the 
polypeptide yields the structural proteins (capsid (C), pre-membrane (prM) and 
envelope (E)) and non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, 2K-NS4B 














Formation of the replication complex in flaviviruses is a co-ordinated process involving 
all non-structural proteins and numerous host factors (Mackenzie et al. 1998; Uchil 
and Satchidanandam 2003; Gillespie et al. 2010; Muller and Young 2013). Within the 
flavivirus replication complex, electron microscopy coupled with immunogold labelling 
has identified dsRNA (the replication intermediate) as well as non-structural proteins 
within ~90nm wide vesicles, which are grouped together within vesicle packets (VP), 
a sub-structure within the replication complex and is thought to be the primary location 
of active virus replication (Fig. 1.11) (Welsch et al. 2009; Chatel-Chaix and 
Bartenschlager 2014). In contrast to this, HCV induces formation of the membranous 
web, which includes ~150nm wide ER membrane derived double membrane vesicles 
(DMV) during the peak level of viral replication, and is primarily driven by NS5A with 
secondary roles played other HCV NS proteins, especially NS4B (Fig.  1.11) (Paul et 
al. 2011; Romero-Brey et al. 2012). Host cell lipids are present within the membranous 
web (Alvisi et al. 2011) and multiple membrane vesicles (MMV) are also found at latter 
stages of HCV infection (Fig.  1.11) (Chatel-Chaix and Bartenschlager 2014). In 
addition, virus replication within the VP or DMV allows for protection of the viral 
genome and its dsRNA replication intermediates from the hosts defensive cytosolic 
nucleases and pathogen sensors, that would degrade gRNA and trigger an innate 
immune response respectively. Further research into flaviviridae-driven biogenesis of 
replication complexes and the host factors required has been directed by the 
construction of plasmid viral constructs that generate membranous webs (HCV) or 
VPs (DENV/ZIKV) indistinguishable from natural infection. For example, HCV 
membranous web formation can be generated solely by expression of HCV NS3-5B 
controlled by the T7 promoter (Tai and Salloum 2011) while both the flavivirus NS1-
NS5 proteins and RNA elements within the 3’UTR contribute to VPs biogenesis for 
both DENV and ZIKV (Cerikan et al. 2020).  
Amplification of viral RNA occurs within the replication complex, where a pool of viral 
RNAs is generated for either, translation of the polyprotein to form additional 
replication complexes, or assembly of genome into new virus progeny. This is possible 
via the RNA dependent RNA polymerase (RdRp) activity of the flavivirus NS5 protein 
in concert with other NS proteins, where binding to the secondary structures within the 
5’UTR known as stem loop A (SLA) result in the production of a complementary  
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Figure 1.11: Replication complex morphology of DENV and HCV.  
DENV induce remodelling of endoplasmic reticulum (ER) membranes to produce 
vesicle packets (VP) and convoluted membranes (CM), which is the location of active 
viral replication. In contrast, although HCV also re-arranges ER membranes to form 
replication complexes, double membrane vesicles (DMV) are present at the peak of 
viral replication, where multi membrane vesicles (MMV) are observed at later stages 













intermediate negative sense RNA (Lodeiro et al. 2009). The NS5B protein of HCV is 
the RdRp required for de novo synthesis of complementary intermediate negative 
sense RNA (Lohmann et al. 1997). This intermediate template is then utilised to 
generate additional copies of the positive sense stranded RNA to be translated or 
associated with capsid (flavivirus) or core (HCV) to be assembled into virus progeny. 
1.6.6  Flaviviridae assembly and release: 
Assembly of the virion is tightly coupled with replication and thus occurs adjacent to 
the replication complex for both flaviviruses and HCV. This is a highly orchestrated 
process involving the binding of only the negatively charged viral RNA to the basic 
capsid protein, likely through a non-specific mechanism despite the risk of cellular 
mRNA or viral intermediates contaminating the new viral progeny. Co-ordination of 
packaging and assembly of the virion is mediated by the NS proteins including NS1 
and NS2A in flaviviruses (Scaturro et al. 2015; Xie et al. 2019b). Although the precise 
roles of assembly for each NS proteins is unclear, there is evidence that NS proteins 
may shuttle RNA from replication complexes into new particles through direct binding 
of the viral genomic RNA. This potentially provides temporal and spatial control of viral 
replication dynamics, allowing the switch from active RNA replication to a later stage 
of the viral lifecycle. In contrast, HCV assembly is closely associated with lipids, where 
the matured core protein translocates from the ER membrane to the surface of lipid 
droplets and interactions with NS5A result in the recruitment of replication complexes 
to this site  (Miyanari et al. 2007; Masaki et al. 2008; Counihan et al. 2011). 
After packaging of nascent viral genomes with core (HCV) or capsid (flavivirus) 
proteins, viral nucleocapsids bud into the ER lumen. Although the entry stages of 
flaviviridae are similar through the usage of pH and subsequent fusion of the viral and 
endosomal membranes, divergent secretory pathways exist for both HCV and 
flaviviruses where the former protects envelope proteins from pH through the 
construction of the p7 ion channel and the latter allows for additional processing and 
maturation of prM by host protease furin during passage through the golgi network 
(Wengler 1989; Steinmann et al. 2007; Atoom et al. 2014). Infectious viral particles 
are released from the cell through exocytosis, enabling the virus lifecycle to repeat.  
1.7  Flaviviridae genome and proteins 
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The flaviviridae family are classified according to their positive sense single stranded 
RNA genomes that can range from 9.6kb (HCV) to 12kb (flaviviruses) in size. The 
genome consists of single open reading frame (ORF) flanked by highly structured non-
coding 5’ and 3’ untranslated regions (UTR) (Fig 1.9 & 1.10). The flavivirus 5’UTR of 
approximately 100bp in size is highly conserved which contains a m7GpppAmpN1 cap, 
which allows for translation of the polyprotein by host translational machinery in 
addition to providing protection from cellular exonucleases. Downstream of the 
m7GpppAmpN1 cap are the SLA and SLB regions, important for flavivirus virus 
replication through recruitment and initiation of RNA synthesis via NS5 (Lodeiro et al. 
2009). In contrast, the 3’UTR is more variable but still contains highly structured 
regions. It is likely that interactions between the highly structured 5’UTR and the 3’UTR 
are critical to allow for circularisation of the RNA genome required to promote initiation 
of viral synthesis of the complementary negative sense RNA (Khromykh et al. 2001; 
Alvarez et al. 2005). In comparison, the HCV 5’UTR contains four highly structured 
domains in addition to the internal ribosomal entry site (IRES), a highly structured RNA 
complex which can directly initiate cap-independent translation through high affinity 
recruitment and binding to the host 40S ribosomal subunit and translation initiation 
factor eIF3 (Otto and Puglisi 2004; Pérard et al. 2009). The HCV 3’UTR is essential 
for viral replication, consisting of a variable region, a long poly (U/UC) stretch and a 
highly conserved X region (Niepmann 2013). The 3’UTR is thought to facilitate efficient 
translation of the polyprotein through retention of the 40S ribosomal subunit post 
translation termination (Bai et al. 2013).  
Following polyprotein translation of the HCV genome and processing by cellular and 
viral proteases, 10 viral proteins are produced: three structural proteins (core, 
envelope glycoproteins E1 and E2) and seven non-structural proteins (p7, NS2, NS3, 
NS4A, NS4B, NS5A and NS5B) (Fig. 1.9). In comparison, the flavivirus polyprotein 
following processing allows release of three structural proteins (capsid, pre-membrane 
and envelope) and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, 
NS4B and NS5) (Fig. 1.10). The structural proteins are instrumental to the formation 
of the virion while the non-structural proteins are critical in the establishment of viral 
replication and immune evasion. Crosstalk between the structural and non-structural 
proteins is crucial in many stages within the virus lifecycle to allow for spatiotemporal 
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regulation, particularly during assembly of viral progeny. A brief summary of the 
functions of these proteins is provided below.    
1.7.1  Flavivirus Structural Proteins  
The flavivirus capsid is a highly basic protein, composed of four main alpha helices 
(α1 to α4) (Jones et al. 2003). Forming homodimers with asymmetric charge 
distribution, the top hydrophobic layer pre-α1 is thought to interact with lipid droplets 
and bind to membranes at sites of virus assembly (Martins et al. 2012; Faustino et al. 
2019). The bottom layer formed by α4 is positively charged and interacts with the viral 
RNA to form the nucleocapsid, the core of the mature virion particle (Shang et al. 
2018). Although classically defined as a structural protein, the flavivirus capsid protein 
has additional roles outside the virus assembly process including entry into the 
nucleus to possibly regulate gene expression to favour a virus replication environment 
(Colpitts et al. 2011).  
Precursor membrane (prM) is a ~20kDa protein which is critical for assembly of virion 
particles. Interaction of the envelope (E) protein with prM within the ER allows 
formation of prM-E complexes which form the key component of the immature virion 
(Li et al. 2008). During transportation of the immature virion through the trans-golgi 
network, maturation of prM is achieved through cleavage by furin or furin-like protease 
into the M protein (~9kDa) and release of the pr peptide which facilitates 
rearrangement of the E protein into homodimers (Murray et al. 1993; Zhang et al. 
2003). prM is also critical for protection of the E protein to prevent premature fusion 
with membranes during passage through the low pH environment of the golgi network, 
allowing for release of functional viral progeny via exocytosis (Oliveira et al. 2017).  
Envelope (E) protein is the primary component of the virion and is critical for multiple 
stages in the viral lifecycle including binding host cell receptors and internalisation 
during viral entry, virion assembly and release of the mature virus particle from the 
host cell. The flavivirus E monomer (53-60kDa dependent on glycosylation status) is 
composed of three main domains I, II and III (EDI, EDII and EDIII) and two 
transmembrane domains. Located at the N-terminus, EDI is the structural central 
domain linking EDII and EDIII and is responsible for the flexibility in the orientation of 
the E protein due to conformation changes in the virus assembly process (Zhang et 
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al. 2004). The fusion peptide is located within the EDII domain and is critical for virus 
mediated endosomal membrane fusion during viral entry (Allison et al. 2001). The 
EDIII participates in attachment of virions to host cells through binding to 
glycosaminoglycan (Watterson et al. 2012). 
1.7.2  Flavivirus Non-structural Proteins  
Flavivirus NS1 is a highly glycosylated protein with the molecular range of 46-55kDa, 
which can exist in various glycosolated states dependent on the stage of the viral 
lifecycle. The NS1 monomer is composed of the β-roll, wing and a β-sheet is 
translocated to the ER lumen post translation and cleaved from NS2A (Akey et al. 
2015; Watterson et al. 2016). Conformational change within the NS1 monomer results 
in self-dimerisation, where the NS1 dimer is formed and predominately important for 
both viral replication and assembly (Winkler et al. 1989). NS1 colocalises with dsRNA 
and is thought to be critical for replication complex formation and viral protein 
maturation (Mackenzie et al. 1998; Płaszczyca et al. 2019). NS1 is co-
immunoprecipitated with all the structural proteins and is hypothesised to play a critical 
role in infectious particle assembly (Scaturro et al. 2015). Hexameric NS1 is secreted 
(sNS1) from the infected cell and a significant contributor to the pathogenesis of DENV 
infection, where activation of multiple innate sensors including TLR4 results in 
development of proinflammatory cytokine storms, subsequent vascular leakage and 
increased endothelial permeability (Somnuke et al. 2011; Beatty et al. 2015; Modhiran 
et al. 2015).  
Although the viruses within the flaviviridae family have a similar genome structure to 
HCV, flaviviruses do not encode a non-structural protein with auto-protease activity 
equivalent to HCV NS2. Downstream of NS1 are two non-structural transmembrane 
proteins (NS2A and NS2B) with hydrophobic properties localised to the ER (Xie et al. 
2013). NS2A (~22kDa) is critical for both viral replication and assembly stages of the 
virus lifecycle (Xie et al. 2015; Xie et al. 2019b). Multifunctionality is achieved through 
interactions with not only viral RNA but also multiple viral proteins including prM, E 
and NS3 (Mackenzie et al. 1998). NS2A can also subvert the innate immune response 
through inhibition of interferon signalling pathways (Liu et al. 2004; Dalrymple et al. 
2015).  
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Flavivirus NS3 (~70kDa) is a multifunctional protein critical for both replication and 
assembly stages of the virus lifecycle. NS3 possess serine proteolytic activities, with 
cofactor NS2B (~15kDa) to release the remaining NS proteins from the polypeptide 
(Assenberg et al. 2009). NS2B is responsible for the localisation of NS3 to the ER and 
also can inhibit the innate immune response with or without NS3 (Aguirre et al. 2017; 
Wu et al. 2019b; Xing et al. 2020). NS3 also has both RNA and nucleoside 
triphosphatase and helicase activities to support viral replication and particle formation 
(Li et al. 1999).  
NS4A and NS4B (16kDa and 27kDa respectively) are both integral membrane bound 
proteins important for flavivirus replication which remain poorly characterised. A 
conserved signal peptide (2K) links both NS4A and NS4B and interaction with DENV 
NS1 is known to be important for viral RNA replication (Płaszczyca et al. 2019). NS4A 
and NS4B have multiple roles within the replication complex. WNV NS4A regulates 
ATPase activity of the NS3 helicase, similar to the role HCV NS4A plays (Shiryaev et 
al. 2009). However, DENV NS4B regulates NS3 helicase activity via dissociation of 
NS3 from single stranded RNA. Cleavage of 2K from DENV NS4A results in ER 
membrane rearrangements resembling virus replication complexes (Miller et al. 2007). 
In contrast, WNVKUN NS4A retains 2K for membrane rearrangements indicating subtle 
differences in flavivirus replication complex construction strategies (Roosendaal et al. 
2006). Both NS4A and NS4B are robust inhibitors of the innate immune signalling 
targeting multiple IFN signalling pathways (Castillo Ramirez and Urcuqui-Inchima 
2015; Wu et al. 2017).  
Flavivirus NS5 (~103kDa), the largest of all flaviviral encoded proteins is highly 
conserved among flaviviruses and is a critical component of the RNA replication 
complex. NS5 is composed of two domains, a N-terminal RNA methyltransferase 
domain (MTase domain) and a C-terminal RNA-dependent RNA polymerase (RdRp). 
The MTase domain is important for cap synthesis via methylation of the viral mRNA 
required for translation and also conceals the mRNA from innate immune sensors 
(Zhou et al. 2007; Daffis et al. 2010). The RdRp performs synthesis of de novo viral 
RNA from positive to negative polarity and vice versa with support from NS3 (Tay et 
al. 2015). NS5 is also a major inhibitor of innate immune signalling, primarily through 
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interactions with STAT2 or suppressing maturation of the IFNAR1 receptor (Grant et 
al. 2016; Best 2017).   
1.7.3  HCV Structural Proteins  
The immature core protein is located at the N-terminus of the HCV polyprotein. It is 
cleaved by an ER signal peptidase and undergoes further processing by 
intramembrane proteases and signal peptide peptidases to form the mature core 
protein (21kDa) that possess both RNA and lipid binding properties (McLauchlan et al. 
2002). The core protein multimerizes with itself to form the viral nucleocapsid, the 
protective shell that encapsulates the RNA genome for packaging into new virions. In 
addition to its main role in viral replication, core has also been implicated as both, a 
gene regulatory protein since it associates with multiple host factors, and major factor 
in the development of HCC, the penultimate stage of HCV pathogenesis (Shi et al. 
2002; Tsutsumi et al. 2002; Mahmoudvand et al. 2019).   
The HCV envelope glycoproteins E1 and E2 (30-35kDa and 70-75kDa respectively) 
are highly glycosylated type 1 transmembrane proteins which form non-covalent 
heterodimers to become a key component of the HCV virion (Goffard and Dubuisson 
2003). HCV E1 and E2 together mediate attachment and entry of the virion into a new 
target cell. E2 interacts with cellular host receptors including CD81 and SR-B1 while 
during the latter stages of the HCV entry process E1 facilitates the fusion between 
viral and cellular endosomes (Hsu et al. 2003; Zona et al. 2014).  
1.7.4  HCV Non-structural Proteins  
Immediately downstream of the structural proteins are the non-structural proteins, 
beginning with p7. The multifunctional p7 protein has roles in both viral assembly and 
ion channel activity, rendering it essential for infectious particle formation. Part of the 
viroporin family, p7 is also thought to orchestrate intracellular localisation of viral 
proteins with unclear interactions with NS2 (Ma et al. 2011). In addition, the amino 
terminus of p7 regulates cell secretory pathways to not only allow retention of 
intracellular E2 glycoproteins but also control the secretion of HCV particles and the 
infectivity of secreted virions (Denolly et al. 2017).  
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HCV NS2 (23kDa) like p7 is dispensable for HCV replication but is essential for 
infectious particle assembly. Localised to the ER with cysteine protease activity, NS2 
is able to form complexes with multiple structural (E1, E2) and non-structural proteins 
(p7, NS3 and NS5A), driving localisation of these interacting partners to the lipid 
droplet to support virion assembly (Jirasko et al. 2010; Ma et al. 2011).  
HCV NS3 is located at the ER membrane and replication complex and is a 
multifunctional protein critical for HCV replication. NS3 harbours serine protease 
activity at the N-terminus and helicase/NTPase activity at the C-terminal domain (Yao 
et al. 1999). In a stable, non-covalent complex with co-factor NS4A, NS3’s serine 
protease activity is responsible for the cleavage and release of the remaining 
downstream NS proteins from the HCV polyprotein (Brass et al. 2008). Additionally, 
NS3 plays a significant role in viral immune evasion through cleavage of key innate 
signalling adaptor molecules including MAVS and TRIF (Li et al. 2005; Meylan et al. 
2005; Ferreira et al. 2016).  
HCV NS4B is an ER localised hydrophobic membrane protein with a primary role in 
the modification of ER membranes to induce membranous web formation, the key site 
for HCV RNA replication (Gouttenoire et al. 2010). NS4B interacts with other NS 
proteins including NS5A, where the former ensures proper localisation of the latter 
(Biswas et al. 2016). Additional roles for NS4B include viral assembly and evasion of 
immune response through degradation of TRIF (Liang et al. 2018).  
HCV NS5A is a multifunctional zinc-metalloprotein that plays critical roles in the HCV 
lifecycle despite possessing no enzymatic activity. NS5A is able to interact with not 
only viral RNA but also a range of viral proteins including core, NS4A and NS5B to 
support both viral replication and assembly (Shimakami et al. 2004; Fiches et al. 2016; 
Biswas et al. 2016). Various states of serine phosphorylation within NS5A allows 
regulation of the level and stage of HCV replication within an infected cell (Appel et al. 
2005). NS5A is also able to interact with numerous host proteins including PI4KA, 
Rab5a and VAP-A, which support membranous web formation, regulate trafficking of 




HCV NS5B is the RNA-dependent RNA polymerase (RdRp) critical for synthesis of 
viral RNA of both positive and negative polarity. NS5B is an ER membrane-bound 
protein via anchorage by the C-terminal transmembrane domain (Moradpour et al. 
2004). Located within the replication complex, NS5B is able to interact with most, if 
not all non-structural proteins to allow for spatiotemporal regulation of virus replication 
(Tan et al. 2006). NS5B also interacts with multiple host proteins to support viral 
replication (Kyono et al. 2002; Goh et al. 2004; Kim et al. 2004). In contrast to flavivirus 
NS5, HCV NS5B activates innate signalling pathways, resulting in production of 
cytokines including type I interferons (IFN) and IL-6, likely triggering inflammation and 
inflicting damage to the liver (G.-Y. Yu et al. 2012; Gerold & Pietschmann 2013). As a 
crucial component of the HCV lifecycle, multiple direct acting antivirals (DAAs) have 
been developed to inhibit the polymerase activity of NS5 (Geddawy et al. 2017). 
1.8  Infection model systems of flaviviridae 
Historically, studies of the molecular virology and pathogenesis of flaviviridae 
especially HCV were limited due to the lack of efficient cell culture systems that 
supported the entire lifecycle. Establishment of the HCV sub-genomic replicon system 
in the human hepatocellular cell line (Huh-7), allowed for autonomous HCV replication 
and expression of the non-structural proteins to establish replication complexes 
(Lohmann et al. 1999). This was achieved through the replacement of the structural 
proteins with antibiotic resistance cassettes to select for cells with high levels of HCV 
replication and the introduction of an encephalomyocarditis (ECMV) IRES. 
Unfortunately, the lack of structural proteins results in no production of viral progeny 
and the inability to study the entire HCV lifecycle. However, this replicon system has 
been instrumental in elucidating key mechanisms of HCV replication. In 2005, the 
isolation of the genotype 2a HCV cDNA from a Japanese patient with fulminant 
hepatitis (JFH-1) led to efficient replication of HCV in cell culture and the production of 
infectious virus particles for the first time, enabling research into multiple stages within 
the HCV lifecycle (Wakita et al. 2005). Additional modifications have been introduced 
to improve usefulness of both these systems, including the introduction of reporter 
genes that express proteins with fluorescence and luminescence properties (Ikeda et 
al. 2005; Koutsoudakis et al. 2006; Schaller et al. 2007). 
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Flaviviruses including DENV generally replicate at high levels in vitro in a wider range 
of cell types and thus are less challenging to adapt to a cell culture model. Similar to 
HCV, replicons for flaviviruses including DENV and YFV have been generated with 
reporter tags to allow for more intricate study of virus replication and high-throughput 
screening of antiviral compounds (Pang et al. 2001; Patkar et al. 2009; Kato et al. 
2019). The first infectious clone for a flavivirus was obtained from YFV in 1989, 
followed by DENV-4, JEV and Kunjun virus within three years (Rice et al. 1989; Lai et 
al. 1991; Sumiyoshi et al. 1992; Khromykh and Westaway 1994). Unlike HCV, 
flavivirus genomes are inherently unstable in E.coli during plasmid propagation, 
resulting in recombination. Thus, low copy number plasmids are utilised at the 
expense of plasmid yield. Like HCV, reporter genes have been inserted into flavivirus 
infectious clones as a tool to visualise and analyse viral infection (Schoggins et al. 
2012; Eyre et al. 2017b).  
1.9  Host Factors required for flaviviridae lifecycle 
As the majority of viruses have a limited capacity to encode genetic information, they 
must exploit host factors to support replication and produce virus progeny and HCV is 
no exception. This is achieved through the secondment of host proteins, membrane 
structures, lipids and metabolites. An example of HCV’s absolute requirement for host 
factors is exemplified by the virus’s ability to remodel host intracellular membranes to 
generate sites of replication. This is facilitated by interactions of the viral non-structural 
proteins (NS3/4A, NS4B, NS5A and NS5B) with various target host factors. A common 
theme present in the currently characterised host factors for HCV replication is a role 
in protein trafficking or lipid biosynthesis and shuttling “supplies” into the replication 
complex (Fig. 1.12).  
 
Probably the best characterised HCV proviral host factor is phosphatidylinositol 4-
kinase III alpha (PI4KA). PI4KA is a host factor critical in HCV replication, identified by 
multiple small interfering RNA (siRNA) screens carried out to reveal co-factors of HCV 
replication. PI kinases are known to be essential for membrane trafficking and protein 
sorting and it is postulated that PI4KA, which predominately resides in the ER, helps 
in the remodelling of membranes required for the construction of the membranous web 
(Tai and Salloum 2011; Berger et al. 2011). This is accomplished via close association 
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of NS5A with PI4KA, where “hijacking” and subsequent enhancement of PI4KA 
enzymatic activity leads to local accumulation of PI4KA’s product PI(4)P, where it acts 
as a beacon in the recruitment of proteins with lipid binding motifs such as Oxysterol 
Binding Protein (OSBP) (Fig. 1.12) (Reiss et al. 2011; Berger et al. 2011). Through 
interactions with PI4KA, OSBP is able to regulate cholesterol trafficking to replication 
complexes, consistent with reports that cholesterol is required for the remodelling and 
integrity of cellular membranes during HCV replication (Fig. 1.12) (Wang et al. 2014). 
In addition, it is also postulated that together with NS5A, OSBP is able to assist in virus 
maturation (Amako et al. 2009) 
 
Human vesicle-associated membrane protein-associated protein subtypes A and B 
(hVAP-A and hVAP-B) have been shown to interact with both NS5A and NS5B and 
be essential for HCV replication (Fig. 1.12) (Tu et al. 1999). Situated in lipid rafts, 
hVAP-A is required for formation of the replication complex and recruitment of NS5B 
after polyprotein cleavage (Gao et al. 2004). hVAP-B has been postulated to play an 
important role in HCV RNA synthesis, however the precise mechanism by which it 
achieves this via interaction with NS5A has yet to be elucidated (Hamamoto et al. 
2005). 
  
Cyclophilin A (CypA) is a molecular chaperone which harbours peptidyl prolyl 
isomerase activity, important for the regulation of protein trafficking and folding, and is 
essential for HCV replication. Although it has been shown that through interactions of 
CypA with NS5A, binding of the latter to 3’ UTR of HCV RNA is enhanced (Fig 1.12). 
The precise molecular mechanism by which CypA assists in HCV replication remains 
largely unknown (Kaul et al. 2009; Foster et al. 2011). CypA had initially shown 
promise as an effective host-targeting antiviral to treat chronic HCV infection, where 
three inhibitors of CypA (Alisporivir (Novartis), NIM-811 (Novartis) and SCY-635 
(SCYNEXIS) progressed to phase I and II clinical trials with high efficacy and safety 
(Gallay 2012). Only Alisporivir which demonstrated efficacy against multiple HCV 
genotypes with an acceptable safety profile progressed to phase III clinical trials which 
are currently ongoing as of 2019 (Gallay 2012).  
 
In addition to protein host factors, miRNAs have also been implicated in HCV 
replication. Micro-RNA 122 (miR122) is highly abundant in hepatocytes and has been  
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Figure 1.12: Host factors critical for the replication stage of the HCV lifecycle.  
HCV utilises multiple host factors for the biogenesis and maintenance of the replication 
complex. NS5A interacts with phosphatidylinositol-4-kinase-alpha (PI4KA) to allow for 
local accumulation of PI4P, which recruits oxysterol binding protein (OSBP) to enable 
transportation of cholesterol to the membranous web. OSBP and vesicle-associated 
membrane protein-associated protein A (VAPA) recruits NS proteins to the replication 
complex and interactions between cyclophilin A and NS5A is critical for membranous 









implicated in multiple stages of the HCV lifecycle. Binding of miR122 to the 5’UTR of 
the HCV gRNA not only increases genome translation and initiation of replication but 
also confers resistance of degradation by host nucleases such as Xrn1 (Masaki et al. 
2008; Niepmann 2009; Y. Li et al. 2013; Schult et al. 2018; Chang et al. 2008). 
Primarily through interaction with the 5’ UTR, miR122 is able to protect the HCV RNA 
genome from host exonucleases and enhance binding of the 48S ribosome to HCV 
RNA, stimulating HCV translation (Henke et al. 2008; Li et al. 2013)Similar to HCV, 
host factors are also equally as important for flavivirus infection, often facilitated by 
interactions with multiple structural and non-structural viral proteins. Host factors 
identified usually have either direct roles in the virus lifecycle (i.e. entry of the virus into 
the cell or construction of membranous web through remodelling of ER membranes) 
or indirect roles, through alteration of the infected cell environment to favour virus 
replication (i.e. regulation of apoptosis and signalling cascades and immune evasion).  
Host factors required by flavivirus’ have been identified by either the usage of genome-
wide screening with RNAi and/or CRISPR technology or through proteomic 
approaches. SPCS1, a subunit within the signal peptidase complex was identified 
utilising a Huh7 cDNA library and the yeast 2 hybrid system utilising NS2 as the bait. 
Genome-wide screening identified that multiple subunits of the signal peptidase 
complex including SPCS1 was also important in flavivirus infection. However, the 
mechanism of action appears to be distinct, where SPCS1 is important in HCV 
assembly via interaction with NS2 and E2 compared to polyprotein processing for 
flaviviruses (R. Zhang et al. 2016; Suzuki et al. 2013).  
Although each flavivirus recruits and exploits a unique set of host factors to support 
the virus lifecycle, functional and mechanistic studies suggest that these diverse host 
factors actually have common roles in establishing and facilitating flavivirus replication 
(Fig 1.13). Unlike HCV which utilises PI4KA and OSBP among others to remodel 
membranes to form replication complexes, flaviviruses including DENV and WNV 
utilise cholesterol, fatty acid synthase (FASN) and reticulon 3.1A for replication 
complex and vesicle packet formation (Heaton et al. 2010; Martín-Acebes et al. 2011; 
Aktepe et al. 2017). Genome-wide CRISPR screens have also identified host factors 
which are required for multiple flaviviruses including proteins belonging to the 
oligosaccharyltransferase (OST) complex, where DENV requires both OST isoforms 
SST3A and SST3B for virus replication, while WNV, YFV and ZIKV depend solely on 
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SST3A (Fig 1.13) (Marceau et al. 2016). Differences in the roles of host factors 
recruited by flaviviruses do however exist, for example, down-regulation of 
sphingolipid ceramide has contrary effects on WNV and DENV replication (Aktepe et 
al. 2015). However, cholesterol is utilised for multiple steps of the virus lifecycle for not 
only HCV, but also most flaviviruses including DENV and WNV (reviewed in (Felmlee 
et al. 2013; Osuna-Ramos et al. 2018)).  
1.9.1  siRNA screens to identify host factors 
The discovery of short hairpin RNA (shRNA) and small interfering RNA (siRNAs) 
followed by artificial exploitation of the RNA interference system led to the 
development of experimental inhibition of endogenous protein expression for the first 
time. This is accomplished via delivery of a single dsRNA oligonucleotide (siRNA) or 
shRNA expression vector utilising the drosha/dicer RNA interference system where 
endogenous protein expression is silenced by elimination of the target transcript RNA 
via sequence homology mediated by cytosolic argonaut proteins (Meister and Tuschl 
2004). 
 
Numerous shRNA/siRNAs screens have been performed in the past 10 years for HCV. 
These screens have been predominately limited to host kinases, cellular receptors 
and their appropriate signalling pathways, transcription factors and transporter 
proteins (Ng et al. 2007; Randall et al. 2007; Supekova et al. 2008; Vaillancourt et al. 
2009; Berger et al. 2009; Borawski et al. 2009; Trotard et al. 2009; Reiss et al. 2011). 
It is theorised that these gene families mentioned above are most likely to have an 
impact on HCV replication and could likely targets for potential novel therapeutics. 
However, other gene families and genes with currently unexplored functions can’t be 
discounted as these may play a vital role in HCV replication. To overcome this 
limitation, two genome wide screens (i.e. targeting the complete human genome) 
utilising siRNA have been published targeting host factors important for HCV 
replication, where one utilised the HCV sub-genomic replicon system and the other 
utilised the infectious JFH-1 HCV cell culture system (Tai et al. 2009; Q. Li et al. 2009). 
However, out of the 96 factors identified in the former screen utilising the replicon, only 
15 hits overlapped with the latter utilising infectious virus, despite the necessity of both 
HCV model systems to enter the replication phase of the virus lifecycle. 
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Figure 1.13: Host factors critical for the DENV lifecycle.  
Host factors are critical to support the entire DENV lifecycle, where each gene is 
indicated in green text. In contrast, host factors indicated in red text are crucial in the 















The discovery of short hairpin RNA (shRNA) and small interfering RNA (siRNAs) 
followed by artificial exploitation of the RNA interference system led to the 
development of experimental inhibition of endogenous protein expression for the first 
time. This is accomplished via delivery of a single dsRNA oligonucleotide (siRNA) or 
shRNA expression vector utilising the drosha/dicer RNA interference system where 
endogenous protein expression is silenced by elimination of the target transcript RNA 
via sequence homology mediated by cytosolic argonaut proteins (Meister and Tuschl 
2004). 
 
Numerous shRNA/siRNAs screens have been performed in the past 10 years for HCV. 
These screens have been predominately limited to host kinases, cellular receptors 
and their appropriate signalling pathways, transcription factors and transporter 
proteins (Ng et al. 2007; Randall et al. 2007; Supekova et al. 2008; Vaillancourt et al. 
2009; Berger et al. 2009; Borawski et al. 2009; Trotard et al. 2009; Reiss et al. 2011). 
It is theorised that these gene families mentioned above are most likely to have an 
impact on HCV replication and could likely targets for potential novel therapeutics. 
However, other gene families and genes with currently unexplored functions can’t be 
discounted as these may play a vital role in HCV replication. To overcome this 
limitation, two genome wide screens (i.e. targeting the complete human genome) 
utilising siRNA have been published targeting host factors important for HCV 
replication, where one utilised the HCV sub-genomic replicon system and the other 
utilised the infectious JFH-1 HCV cell culture system (Tai et al. 2009; Q. Li et al. 2009). 
However, out of the 96 factors identified in the former screen utilising the replicon, only 
15 hits overlapped with the latter utilising infectious virus, despite the necessity of both 
HCV model systems to enter the replication phase of the virus lifecycle. 
 
The majority of siRNA screens that have been performed on flaviviruses have utilised 
either DENV, WNV or YFV as their main virus during the screening process to identify 
novel host factors and deduce pan-flaviviral activity with confirmatory experiments. 
siRNA screening using a kinase subpool revealed 7 genes which inhibited DENV2 
infection in excess of 40%, one hit (EIF2AK3) was present as a top hit in both genome-
wide siRNA screens and AP2M1 was present in one, indicating that there is poor 
overlap despite use of the same strain of DENV2 (New Guinea C) and similar 
screening methodology (Kwon et al. 2014). TNFSF12 and SPHK12, which were both 
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present in the apoptosis siRNA screen was not present as top hits in both siRNA 
genome-wide screens (Savidis et al. 2016a; Barrows et al. 2019). However, given the 
output was measuring caspase-3 levels within DENV infected Huh-7 cells, poor 
overlap was expected and thus demonstrates that significant alteration of the 
screening protocol can have adverse effects on the top hits observed (Morchang et al. 
2017).  
 
Savidis et al. utilised multiple genome-wide siRNA libraries with not only the same 
strain of DENV2 (New Guinea C) but also similar screening methodology. 
Comparisons in the top hits from each siRNA library demonstrated that despite 
significant overlap of genes belonging to similar signalling pathways and gene clusters, 
exact gene overlap was poor and is reflective of the limitations that siRNA technology 
possess which is discussed below (Savidis et al. 2016a). Overlap between genome-
wide screens with DENV2 performed by different groups is also poor, where the 
majority of genes were derived from the EMC complex (Savidis et al. 2016a; Barrows 
et al. 2019). In addition, proteins from the EMC complex were also present as top hits 
in genome-wide CRISPR screens performed with both DENV2 and ZIKV, 
demonstrating that usage of both siRNA and CRISPR technology concurrently can 
assist in validation of top hits and elimination of false positives. No ZIKV siRNA 
genome-wide screens have been performed to date as a result of the combination of 
low scientific interest of ZIKV biology prior to the pandemic within the Americas in 2015 
and the concurrent rise of CRISPR technology and availability of associated genome-
wide libraries. Despite the consensus that CRISPR has superseded siRNA technology 
to silence gene expression, performing a genome-wide siRNA screen would allow 
identification of host factors which are essential to cell survival.  
 
Both subset and genome wide screens listed above each produce a unique set of 
results, where the top hits impact HCV replication with high efficacy but in most cases 
there is little overlap besides the host factors described previously, such as PI4KA and 
Cyclophilin A.  This is primarily a result of the different siRNA sequences for each gene 
employed in each screen resulting in divergent off-target effects and knockdown 
efficiencies. The silencing efficiency of different siRNAs targeting the same gene can 
vary significantly (Kurreck 2006). Residual activity due to incomplete gene knockdown 
also makes it difficult to ascertain the degree of impact the host factor in question has 
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on HCV replication. Observation of high off-target rates observed in RNAi screens 
may also be attributed to (i) incomplete binding of siRNA onto the 3’ UTR of mRNA 
which can facilitate miRNA-like inhibition, resulting in down-regulation of non-target 
genes and (ii) during the delivery of siRNA into the cell, the innate immune response 
can be activated by recognition of RNA in the endosome by TLR7 and TLR8 (Judge 
et al. 2005). 
  
In addition, siRNA concentration and the associated method of transfection and 
subsequent duration of silencing may explain the variances observed between 
independent screens, where a shorter duration of silencing may bias proteins with a 
shorter half-life and vice versa, complicating data analysis. The presence of excess 
exogenous siRNA during transfection can also result in saturation of the endogenous 
RNAi machinery, where key components of the RNAi pathway, such as exportin 5 and 
the RISC complex have a limited capacity to bind siRNAs and pre-miRNA from shRNA, 
leading to a deficiency in gene knockdown (Hutvágner et al. 2004) Thus to ablate any 
concerns arising due to ineffective knockdown and high off-target effects  commonly 
seen in siRNA screens, it would be beneficial to employ a novel screen where target 
genes are completely knocked out. 
1.9.2  Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) 
Screens 
Clustered regularly interspaced short palindromic repeats (CRISPR) technology as we 
know it today has been adapted from a naturally existing system by which prokaryotes 
defend against invading bacteriophages. To confer bacterial adaptive immunity via 
CRISPR, protospacers consisting of approximately 20bps of foreign DNA is inserted 
into the CRISPR array. A precursor CRISPR targeting RNA (crRNA) containing newly 
inserted protospacers is processed and individual crRNAs formed. Target recognition 
of crRNA to homologous sequences of foreign DNA results in recruitment of cas 
nucleases and subsequent cleavage and elimination of foreign DNA to prevent 
reinfection by the same bacteriophage (Barrangou and Marraffini 2014). 
 
The basis of CRISPR editing technology as we know it today is derived from 
Streptococcus pyogenes, comprises of a single Cas9 protein complexed with an 
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engineered small guide RNA (sgRNA), which mimics the mature crRNA and a partially 
complementary trans-acting RNA (tracRNA) to allow RNA guided destruction of 
foreign nucleic acids. To facilitate cleavage and subsequent knockout of a target gene, 
a 20nt guide is designed complementary to the target site, flanked by a protospacer 
adjacent motif (PAM) sequence and in the case of Streptococcus pyogenes derived 
Cas9, 5’ NGG (Fig. 1.14). The PAM sequence is recognised first by the Cas9 before 
the guide is scanned for complementarity. Once targeted to the DNA sequence in 
question, Cas9 induces a double stranded break (DSB) in the DNA 3-4bp upstream of 
the PAM sequence, which is repaired by host machinery primarily by non-homologous 
end joining (NHEJ) (Fig 1.14). The DSB ends are directly ligated back together, 
resulting in the introduction of insertion/deletion mutations at the repair site, and 
subsequently, a nonsense mutation in the coding sequence (reviewed in (Lieber 
2010)). Using this methodology, it is now standard laboratory practice to knockout a 
gene of interest using CRISPR technology in an efficient cost-effective manner.  
Most recently, mutation of both the critical RuvC and HNH nuclease domains in Cas9 
results in an enzymatically inactive or “dead” cas9 (dCas9) that has lost the ability to 
cleave DNA but retains binding to sgRNA and targeting to specific DNA sites. This trait 
has been harnessed to target the dCas9 to specific DNA sequences with novel 
applications including activation and repressors of gene function and as a platform for 
dynamic fluorescence imaging of both DNA and RNA (Gilbert et al. 2013; Perez-Pinera 
et al. 2013; Chen et al. 2013; Nelles et al. 2016). In addition to genetic screening, 
CRISPR has also been instrumental to allow precise genetic engineering of both 
animals such as mice, mosquitos, pigs, chickens and ferrets (Kistler et al. 2015; Kou 
et al. 2015; Oishi et al. 2016; Lei et al. 2016). CRISPR is also a useful tool for the 
modification of large DNA viruses including EBV, vaccinia viruses and human pox 
viruses, where genomes range from 130kb-375kb in size, which has been challenging 
in the past to modify with conventional molecular cloning techniques (Bi et al. 2014; 
Yuan et al. 2015). CRISPR has also been considered as an antiviral strategy to 
combat persistent viral infection through cleavage of DNA, for example for cleaving 
the highly stable cccDNA in HBV infection or targeting of viral genes in EBV and HSV 
latent infection (Dong et al. 2015; van Diemen et al. 2016).  
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Figure 1.14: Canonical CRISPR editing technology. 
The single guide RNA (sgRNA) hybridises to a 20nt DNA sequence directly upstream 
to the PAM sequence (NGG for Cas9 originating from streptococcus pyogenes). Cas9 
cleavage is induced upon recognition of both the PAM sequence and sgRNA, resulting 
in double stranded breaks (DSB) within the target site of the genomic DNA. The 
genomic DNA can be repaired either through non-homologous end joining (NHEJ), 












Genomic screens utilising CRISPR are feasible due to Cas9’s ability to recognise a 
target site via specific DNA-RNA interactions. CRISPR is easily interchangeable from 
gene target to gene target by changing the sgRNA sequence and combined with the 
high efficiency of inducing DSBs, has resulted in an exponential rise of CRISPR driven 
genomic screens being performed in both human and murine cells. In these screens 
a pool of sgRNAs that target multiple genes in parallel is utilised (Shalem et al. 2014; 
Koike-Yusa et al. 2014; Konermann et al. 2015; Chen et al. 2015; Parnas et al. 2015). 
Results of CRISPR genomic screens mentioned above include analysis of phenotype 
resistant mutations from drug selection to pathogen invasion, to deduction of critical 
regulatory genes in multiple signalling pathways. Although on-target efficiencies 
between CRISPR and RNAi technology are similar, the latter is far less susceptible to 
systemic off-target effects (Smith et al. 2017). Screens utilising Cas9 (inducing DSBs) 
or dCas9 (with transcriptional activators/repressors) have both been performed, 
allowing complex gene expression patterns to be interrogated in a more flexible, 
accurate manner (Kweon and Kim 2018). 
Numerous genome-wide CRISPR screens have been performed with both the 
traditional knockout cas9 and activator/repressor dCas9 systems in attempts to 
identify novel host factors critical in supporting viral replication. Novel host factors can 
be identified through either loss of function screens, where a knockout of a host factor 
will result in a permissive cell line resistant to virus infection, or gain of function screens, 
where overexpression of novel proteins in non-permissive cell line is made permissive 
to virus infection. CRISPR screens have high reproducibility, where multiple 
independent screens performing infection with the same virus have overlapping hits, 
while infecting multiple cell types with the same virus has also yielded overlapping hits 
in addition to some cell type specific novel host factors. Table 1.1 lists the genome-
wide CRISPR screens which have been performed with regards to virus infection, 
where it is evident there are host factors which are important for numerous viruses 
within one viral family. However, it appears that slight modifications in screening 
technique and procedure can have a massive effect on the output of the sgRNA 
representation, and thus which novel host factors are present. 






































































































































































































































The innate immune response is the crucial first line of defence against invading 
pathogens, where a rapid non-specific inflammatory response is initiated to subvert 
virus infection. The innate immune response is also critical in driving a robust adaptive 
immune response, resulting in not only the clearance of specific pathogens but also 
the development of long-lasting immunological memory (Iwasaki and Medzhitov 2015). 
Activation of the innate immune response relies on the detection of foreign microbial 
molecules known as pathogen associated molecular patterns (PAMPs) which 
accumulate within a cell during infection (Akira et al. 2006). PAMPs are recognised by 
pattern recognition receptors (PRRs) that are present in multiple compartments of the 
cell, including the cell surface, endosome and cytoplasm, where pathogens are likely 
to reside during infection (Saito and Gale 2007). Binding of PAMPs to PRRs results in 
the activation of multiple signalling cascades, culminating in the production of 
cytokines and the upregulation of multiple innate immune effector molecules 
(Brubaker et al. 2015). The interferons (IFN) are the most critical cytokines in 
combating viral infection and orchestrating an antiviral environment within infected and 
neighbouring uninfected cells, as well as regulation of immune cell activation and 
trafficking (Ivashkiv and Donlin 2014). 
1.11  Recognition of DENV and ZIKV by RIG-I like Receptor (RLR) signalling 
pathways 
During infection with either DENV or ZIKV, PAMPs such as single-stranded and 
double-stranded RNAs (ssRNA and dsRNA) are produced and can be readily 
recognised by the members of the DExD/H box RNA helicase family of cytoplasmic 
RIG-I like receptors (RLRs). The RLR family is currently composed of three members; 
retinoic acid-induced gene-I (RIG-I), melanoma differentiation associated factor 5 
(MDA5) and laboratory of genetics and physiology 2 (LGP2)  (Rehwinkel and Gack 
2020) (Fig. 1.15). RIG-I and MDA5 have similar domain organisation, where an N-
terminal tandem caspase recruitment and activation domains (CARD) is followed by a 
central RNA helicase domain (Yoneyama et al. 2005). The C-terminal domain (CTD) 
is multifunctional, allowing for both recognition of viral RNA, protein dimerisation and 
autoregulatory functions (Saito et al. 2007; Cui et al. 2008). In contrast, while LGP2 
shares the conserved central RNA helicase domain and CTD, the N-terminal CARD 
domains are lost and therefore signalling incompetent. LGP2 is thought to possess 
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Figure 1.15: Structural representation of RLR family and adapter MAVS (IPS-1).  
Key domains critical for signalling include the CARD (caspase activation and 
recruitment domain), ATPase containing DEAD box helicase (DEAD Helicase) and a 
C-terminal domain (CTD). A repression domain (RD) within the CTD is present in RIG-
I and MDA5 but not LGP2. MAVS (IPS-1) consists of a complimentary CARD domain, 

















negative regulatory roles within RIG-I and MDA5 signalling (Rodriguez et al. 2014). 
Recognition of either short dsRNA or 5’ triphosphate (5’ppp) uncapped ssRNA by RIG-
I or long dsRNA by MDA5 results in multiple protein modifications (de-phosphorylation 
and K63-ubiqutiniation), ultimately resulting in conformation change via exposing the 
CARD domains (Loo and Gale 2011). The importance of RIG-I as a sensor for both 
DENV and ZIKV infection is exemplified by increased virus replication and subsequent 
apoptosis in A549 RIG-I-/- CRISPR KO infected cell lines (Schilling et al. 2020). 
Similarly, siRNA knockdown of either RIG-I or MDA5 resulted in increased DENV 
infection and both are required for the initiation of an effective IFN response 
(Nasirudeen et al. 2011). Shuttling of RIG-I/MDA5 to mitochondrial membranes is 
possible via interactions with translocation mediators TRIM25 and mitochondrial 
targeting chaperone 14-3-3e (Gack et al. 2007; Liu et al. 2012a). Interaction with the 
complimentary CARD domains on the signalling intermediate mitochondrial antiviral 
signalling protein (MAVS) allows formation of the MAVS signalosome or innate 
immune synapse, where multiple cytosolic kinases including TANK-binding kinase 1 
(TBK1) and Ikb kinase-e (IKKe) are activated and phosphorylate essential transcription 
factors in the RLR signalling pathway interferon regulatory factor 3 (IRF3) and 
interferon regulatory factor 7 (IRF7) (Kell and Gale 2015) (Fig. 1.16). CRISPR 
knockout of the signalling intermediate MAVS within human trophoblast cell lines 
resulted in both increased ZIKV virus infection and abolition of type I interferon 
signalling, further demonstrating the importance of MAVS within the RIG-I signalling 
pathway (Ma et al. 2018). The transcription factor NF-kB is also activated by the IKK 
complex (IKKa/b/g), responsible for the upregulation of proinflammatory genes (Liu et 
al. 2017). Collectively, the RLR signalling pathway is crucial to both the detection and 
activation of the IFN response against flavivirus infection.  
1.12  Recognition of DENV and ZIKV by Toll-like Receptors (TLRs) 
Although the RLR pathway is the main driver for the activation of the innate immune 
response against DENV and ZIKV infection, secondary sensors including TLRs and 
cGAS-STING are also able to act synergistically with RLRs to induce an effective IFN 
response (Zevini et al. 2017). During viral entry, the accumulation of viral RNAs can 
activate TLR3/7 present within the endosomal membrane. TLRs are type I integral 
glycoprotein receptors where the transmembrane protein is flanked by a N-terminal 
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Figure 1.16: Recognition of DENV and ZIKV infection by the innate immune 
response and immune evasion by viral molecular components. 
PAMPS such as viral RNA (vRNA) produced during virus replication can be 
recognised by PRRs (RLRs or TLR3). In addition, mitoDNA is released by the 
mitochondria within a stressed environment during flavivirus infection, resulting in the 
activation of the cGAS-STING pathway. These pathways culminate in the 
phosphorylation of TBK1 and IKKe which activate IRF3/7 and NF-kB to drive 
production of type I IFN. The importance of the pathways mentioned above is 
highlighted in red where both DENV and ZIKV have evolved mechanisms to inhibit 








ligand binding ectodomain and a C-terminal cytoplasmic toll/interleukin-1 (TIR) domain 
(Botos et al. 2011). Expression of TLR3 is ubiquitous within multiple cell types in 
contrast to TLR7, which is present in specialised immune cells such as plasmacytoid 
dendritic cells (pDCs) (Takagi et al. 2016). Upon recognition of dsRNA by TLR3 or 
ssRNA by TLR7 and receptor dimerisation, two separate signalling pathways are 
activated both of which are dependent on further adapter binding (Fig. 1.16). Both 
CRISPR induced TLR3 KO macrophages and siRNA mediated TLR3 knockdown in 
fibroblast cell lines (HFF-1) are highly susceptible to DENV and ZIKV infection 
respectively (Nasirudeen et al. 2011; Hamel et al. 2015). Conversely, DENV infected 
HEK293 that were overexpressing TLR3 or TLR7 had elevated levels of cytokine 
production (Tsai et al. 2009). Activated TLR3 binds the TIR domain containing adapter 
inducing interferon-b protein (TRIF) resulting in upregulation of type I IFN by the TRIF 
dependent pathway (Yamamoto et al. 2003). In contrast, activated TLR7 forms a 
complex containing MyD88 with IRAK kinase family proteins, which are recruited to 
form the myddosome, where the MyD88 dependent pathway ultimately results in 
translocation of NF-kB and AP-1 to the nucleus to upregulate expression of both type 
I IFN and pro-inflammatory cytokines (Kawasaki and Kawai 2014). Flaviviruses can 
also activate TLR signalling pathways, resulting in elevated production of pro-
inflammatory cytokines, leading to clinical manifestations (Thompson and Iwasaki 
2008). For example, TLR3 is activated within human cerebral organoids by ZIKV 
infection, resulting in enhanced viral replication and hyper-activation of the innate 
immune response and transcriptional perturbation of neurodevelopment genes – a 
hallmark in the development of microcephaly (Hamel et al. 2015; Dang et al. 2016). 
Collectively, the TLRs pathways are an important innate sensor to detect and respond 
against flavivirus infection.  
1.13  Recognition of DENV and ZIKV by cGAS-STING 
Both DENV and ZIKV infection also impair mitochondrial function, where viral proteins 
can disrupt both mitochondrial membrane potential and homeostasis (Yu et al. 2015; 
Ledur et al. 2020). Following viral induced mitochondrial stress, mitoDNA is released 
into the cytoplasm and binds to the cytosolic sensor cyclic-GMP-AMP synthase 
(cGAS), resulting in a conformational change and allowing cGAS to convert ATP and 
GTP into 2’3’-cyclic GMP-AMP (cGAMP) (Sun et al. 2013). This molecule can then be 
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recognised by the ER-associated protein Stimulator of Interferon Genes (STING). 
Activation of STING results in phosphorylation of both TBK1 and IKKe to drive 
expression of type I IFN and pro-inflammatory cytokines (Motwani et al. 2019) (Fig. 
1.16). Not only is ZIKV replication increased within infected cGAS-/- PBMCs, but IFN-
b production is also reduced, highlighting the importance of cGAS-STING pathway in 
controlling ZIKV infection (Zheng et al. 2018). In addition, DENV replication is 
enhanced within cell lines which lack expression of the adapter molecule STING 
(Aguirre et al. 2012). Altogether, the RLR, TLR and cGAS innate signalling pathways 
are critical for the detection of both DENV and ZIKV infection, culminating in the 
production of type I IFNs and subsequent upregulation of ISGs.  
1.14  Activation and signalling by type I IFNs 
The downstream outcome of the recognition of viral components by PRRs described 
above results in the production of the Interferons (IFNs) and associated ISGs, that 
allow induction of an antiviral state within a cell. IFN are glycoproteins and are divided 
into three classes (I, II and III). Within a cluster located within chromosome 9, the type 
I IFN class consists of 14 subtypes of IFN-a and a single gene of IFN-b, IFN-e, IFN-j, 
IFN-t, IFN-k and IFN-w (Hertzog and Williams 2013). Type II IFN is solely comprised 
of IFN-g, while type III IFN consists of IFN-l1, IFN-l2 and IFN-l3 (Platanias 2005; 
Iversen and Paludan 2010). Although all IFNs have function as antiviral agents, IFN-
a and IFN-b are the main IFNs produced downstream of PRR activation.  
Type I IFNs bind to the ubiquitously expressed heterodimer receptor composed of IFN-
a receptor 1 (IFNAR1) and IFNAR2 subunits in an autocrine or paracrine manner (de 
Weerd and Nguyen 2012) (Fig. 1.17). Ligand binding results in heterodimerisation of 
the IFN-a receptor complex, where tyrosine kinase 2 (TYK2) and janus kinase 1 (JAK1) 
which are associated with IFNAR1 and IFNAR2 respectively are brought into close 
proximity and activated by trans-phosphorylation (Lamken et al. 2004). Following 
tyrosine phosphorylation of the intracellular domains of IFNAR by JAK1 and TYK2, 
signal transducer and activator of transcription 1 and 2 (STAT1 and STAT2) are 
recruited and docked on the receptor. STAT1 and STAT2 are phosphorylated at 
tyrosine residues 701 and 690 respectively, resulting in the formation of 
STAT1/STAT2 heterodimers to which IFN regulatory factor 9 (IRF9) binds to form the 
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Figure 1.17: Upregulation of ISGs by the IFN pathway and subsequent inhibition 
mechanisms by DENV and ZIKV infection. 
Type I IFN can bind their cognate receptors (IFNAR1 and IFNAR2) located on infected 
and neighbouring cells, activating the JAK-STAT pathway and culminating in the 
upregulation of hundreds of ISGs which induce an antiviral state within the cell. Both 
DENV and ZIKV have evolved mechanisms to inhibit multiple stages within the JAK-










transcription complex IFN stimulated gene factor 3 (ISGF3) (Fig. 1.17) (Ivashkiv and 
Donlin 2014). This complex then translocates to the nucleus to bind IFN-stimulated 
response element (ISRE) present within the proximal promoter upstream of in excess 
of 300 ISGs, to initiate transcription and translation of proteins that control virus 
replication and activate the immune system (Kessler et al. 1990; Bluyssen et al. 1994).  
1.15  Interferon Stimulated Genes (ISGs)  
The definition of an ISG is a gene that is upregulated during an IFN response. They 
were first discovered more than 30 years ago (Knight and Korant 1979). Although a 
handful of classical ISGs such as PKR, OAS and Mx1 were initially thought to be the 
only genes displaying antiviral activity, subsequent microarray studies coupled with 
advances in RNA sequencing have shown that there are in excess of 300 ISGs, as 
approximately 10% of the human genome is subject to regulation by IFN (Schoggins 
et al. 2011; Shaw et al. 2017). In addition to upregulation of canonical ISGs that have 
direct acting antiviral activity, a small subset of ISGs can also be upregulated 
independently from IFN signalling by IRF or NF-kB transcription factors (Wang et al. 
2017). Some ISGs are expressed basally and upregulated further by IFN while others 
are only induced in the presence of IFN stimulus. Although the main role of ISGs is to 
directly interfere with the virus lifecycle, others can augment activated innate signalling 
pathways, resulting in multiple mechanisms by which a single ISG can be upregulated 
(Fujita et al. 1989; Sato et al. 1998). 
Numerous ISGs act in tandem to supress virus replication at multiple stages within the 
viral lifecycle (Fig. 1.18). The functions of many ISGs have been reviewed extensively 
elsewhere and therefore this section will be focused on ISGs which impact the DENV 
and ZIKV lifecycle due to their similar replication strategies (Schoggins 2019).  
IFN stimulated gene 15 (ISG15) is a 15kDa ubiquitin like protein and has many roles 
within innate immunity that have been extensively reviewed (Perng and Lenschow 
2018). The first ubiquitin-like protein to be discovered, ISG15 is a highly evolutionary 
conserved protein, consisting of a N-and C-terminal domain which are connected by 
a flexible polypeptide hinge (Dzimianski et al. 2019). The C-terminus of ISG15 also 
contains the LRLRGG motif, allowing for conjugation with target proteins (Lenschow 
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Figure 1.18 Function of ISGs 








et al. 2005). One of the roles unique to ISG15 is its ability to conjugate with target 
protein (ISGylation) to disrupt localisation and interactions of the latter which may 
benefit virus replication. ISG15 can inhibit both the entry and replication stage of the 
ZIKV lifecycle while siRNA knockdown of ISG15 in infected human primary corneal 
epithelial cells (HCEC) results in elevated levels of DENV and ZIKV replication (Singh 
et al. 2019). This observation was mimicked in ISG15-/- mice following infection with 
ZIKV and also resulted in impaired expression of other ISGs such as RIG-I (which is 
also a PRR) and IFI6 (Singh et al. 2019). 
Virus inhibitory endoplasmic reticulum associated interferon inducible protein (Viperin) 
is a 42kDa protein, which like ISG15, has diverse roles within the innate immune 
response and has direct antiviral activity against numerous viruses within multiple 
RNA and DNA viral families [reviewed in (Helbig and Beard 2014)] (Fig. 1.18). Viperin 
consists of 3 main structural elements; An evolutionary diverse N-terminal amphipathic 
helix and leucine zipper which allows tethering to ER membranes and association with 
lipid droplets, a highly conserved central domain which contains motifs belonging to 
the radical SAM enzyme family and a highly conserved C-terminal domain critical for 
antiviral activity against the flaviviridae family including HCV, DENV, TBEV and ZIKV, 
the latter which is explored in this thesis (Helbig et al. 2011; Helbig et al. 2013; Van 
der Hoek et al. 2017; Upadhyay et al. 2014). Viperin is one of the few ISGs which can 
be upregulated with or without IFN. It catalyses the conversion of cytidine triphosphate 
(CTP) to 3’-deoxy-3’,4’-didehydro-CTP (ddhCTP), an antiviral ribonucleotide that 
inhibits flavivirus NS5 polymerases (DeFilippis et al. 2006; Gizzi et al. 2018). Viperin 
also affects the assembly of flavivirus virions by enhancing production of non-
infectious capsid particles via interaction with Golgi brefeldin A-resistant guanine 
nucleotide exchange factor 1 (GBF1) (Vonderstein et al. 2018). During the course of 
this thesis, Viperin also interacts with ZIKV NS3 protein, resulting in proteasome 
dependent degradation of the latter and subsequently reduced virus replication, 
demonstrating the redundant functions present within one ISG (Panayiotou et al. 
2018). In addition to its direct antiviral roles, Viperin can also augment innate signalling, 
through binding to STING and enhancing the type I IFN response following detection 
of virally derived dsDNA, resulting in an enhanced antiviral state (Crosse et al. 2020). 
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Proteins within the IFN-inducible transmembrane (IFITM) family are found within 
cellular membranes and exert their functions against virus infection via inhibition of 
viral membrane-endosomal fusion during the entry stage of the virus lifecycle (Bailey 
et al. 2014). The IFITM family consist of five proteins, three of which (IFITM1, IFITM2 
and IFITM3) are inducible by both type I and II IFN (Fig. 1.18) (Lewin et al. 1991). The 
IFITM protein family have common structural topology, where short variable luminal 
N- and C-termini are separated by two anti-parallel transmembranes and connected 
with a conserved cytoplasmic region (Zhao et al. 2018). IFITM2 and IFITM3 have a 
20aa and 21aa extension of the N-terminus compared to IFITIM1 respectively. 
Deletion of the 21aa extension within the N-terminus in IFITM3 resulted in impaired 
antiviral activity against DENV infection (John et al. 2013). In addition, siRNA 
knockdown of IFITM1 or IFITM3 within ZIKV infected cells resulted in elevated levels 
of virus replication whereas ectopically expression of IFITM2 or IFITM3 inhibited 
DENV replication (Jiang et al. 2010; Savidis et al. 2016b). Interestingly, all three IFITM 
proteins inhibit HCV replication, localising to both early and late endosomes 
(Narayana et al. 2015).  
IFN-inducible protein 6 (IFI6) is a 13kDa is a recently discovered ISG which has been 
thrust into the spotlight as a top hit within genome-wide CRISPR activation screens 
against multiple flaviviruses (Fig. 1.18) (Richardson et al. 2018; Dukhovny et al. 2019). 
IFI6 is a mitochondrial targeted protein and delays apoptosis in DENV infection, 
potentially through the inhibition of release of cytochrome C from the mitochondria 
(Cheriyath et al. 2007; Qi et al. 2015). Infection of DENV and ZIKV in CRISPR KO IFI6 
cells resulted in elevated levels of virus replication and that ectopic expression of IFI6 
also prevented apoptosis in ZIKV infected Huh7 cells (Richardson et al. 2018). The 
mechanism of action is unclear but localisation of IFI6 to ZIKV replication complexes 
suggest that the former may disrupt virus replication or virion production (Dukhovny et 
al. 2019).  
1.16  Immune evasion by the flaviviridae family 
Given that viruses are obligate intracellular pathogens, viruses have evolved multiple 
mechanisms to subvert activation of innate immune signalling cascades. Viruses 
within the flaviviridae family can either passively conceal their viral molecules by 
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mimicking host cell components or directly antagonise or disrupt innate signalling 
pathways.  
1.16.1  Passive mechanisms to hide from innate immune response 
Upon release of the viral genomic RNA (gRNA) into the cytoplasm post entry, a 7-
methylguanylate cap is present within the 5’ end of the viral positive sense RNA 
genome (Decroly et al. 2011). This assists in the binding of host translation initiation 
factors required for production of the viral polyprotein and establishment of the 
replication complex. In addition, the gRNA mimics the appearance of host mRNA and 
prevents its degradation by cytoplasmic exonucleases (Saeedi and Geiss 2013). 
Furthermore, capping of flavivirus gRNA prevents recognition by both PRRs such as 
MDA5 and ISGs including IFIT1 which can bind and sequester gRNA of uncapped 
flavivirus genomes (Kimura et al. 2013). Flaviviruses can also ‘hide’ from the innate 
immune response through the construction of a replication complex (RC) during virus 
replication, here modified ER membranes act as a barrier between gRNA and 
cytoplasmic PRRs preventing recognition of both gRNA (Scutigliani and Kikkert 2017) 
and the forming viral nucleocapsid by the ISG MxA (Hoenen et al. 2007).  
1.16.2  Direct antagonism of innate immune response by viral proteins 
Although the main role of the NS proteins within the flavivirus lifecycle is to establish 
active virus replication and assembly of new progeny, these proteins also act to sever 
innate immune signalling pathways preventing the production of IFN and subsequent 
upregulation of ISGs. Viral NS proteins employ many diverse mechanisms to disrupt 
the PRR and IFN JAK STAT signalling pathways and these are summarised for DENV 
and ZIKV infection below. 
Competitive binding is a common mechanism utilised by both DENV and ZIKV NS 
proteins to block innate signalling (Fig. 1.16). ZIKV NS4A is able to inhibit RLR 
signalling by both RIG-I and MDA5 via competitive binding to the N-terminal CARD 
domain of the common adapter protein MAVS, resulting in decreased IFN production 
(Ma et al. 2018; Ngueyen et al. 2019). ZIKV NS1 and NS4B also directly interact with 
TBK1, blocking phosphorylation and oligomerisation required for activation of IRF3 
and subsequent IFN production (Wu et al. 2017). ZIKV NS5 is also able to interact 
 87 
with not only the other prominent kinase required for IRF3 activation, IKKe but also 
IRF3 itself. ZIKV NS5-IKKe interactions result in both decreased protein levels and 
phosphorylation of IKKe, again preventing activation of IRF3 and subsequent IFN 
production (Xia et al. 2018; Lundberg et al. 2019). DENV NS2B/3 also interacts with 
IKKe and is predicted, via computational analysis, to mask the kinase domain of the 
latter inhibiting activation of downstream transcription factors (Angleró-Rodríguez et 
al. 2014).  
In addition to above, ZIKV NS proteins are also able to bind to other innate immune 
signalling factors (Fig. 1.16). ZIKV NS3 interacts and competitively binds with 
members of the 14-3-3 family, where several (14-3-3e and 14-3-3h) are mitochondria 
targeting chaperones allowing for translocation of activated RIG-I and MDA5 to MAVS 
anchored to the mitochondria membrane (Liu et al. 2012a; Lin et al. 2019b). This 
interaction is mediated by an aspartic acid residue located within a conserved binding 
motif present within ZIKV NS3 that when phosphorylated outcompetes binding of both 
14-3-3e and 14-3-3h to RIG-I and MDA5 (Riedl et al. 2019). 
Another mechanism by which DENV and ZIKV NS proteins inhibit innate signalling is 
through the promotion of degradation of key signalling proteins. ZIKV NS1 possesses 
no de-ubiquitinase activity and therefore interacts with the host ubiquitinase USP8 to 
cleave K11-linked polyubiquitin chains from caspase-1. This conformational change 
confers stability to caspase-1 and results in proteolytic cleavage of cGAS and 
subsequent decreases in IFN production (Zheng et al. 2018). Both DENV and ZIKV 
NS5 is able to interact with STAT2, resulting in the degradation of the latter in a 
proteasome mediated manner (Fig. 1.17) (Ashour et al. 2009; Grant et al. 2016). This 
interaction is mediated by the RdRp domain of both DENV and ZIKV NS5 with the N-
terminal domain of STAT2 (Wang et al. 2020). However, unlike ZIKV, DENV NS5 
mediated degradation of STAT2 is dependent on the E3 ubiquitin ligase UBR4 
(Morrison et al. 2013). ZIKV NS2B3 also induces proteasome mediated degradation 
of JAK1, resulting in deceased ISG expression (Wu et al. 2017). DENV NS2B induces 
degradation of cGAS by an autophagy-lysosome dependent mechanism to prevent 
activation of the latter by mitoDNA release during DENV infection (Fig. 1.16) (Aguirre 
et al. 2017). In addition, both DENV and ZIKV NS2B/3 are also able to cleave the 
adapter molecule of cGAS, STING. Two key residues (R78 and G79) in human STING 
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are crucial for cleavage by not only DENV and ZIKV NS2B3, but also JEV and WNV 
NS2B3. This evolutionary conserved mechanisms by which flaviviruses inhibit the 
cGAS-STING pathway highlight the importance of this innate signalling pathway for 
detection of this virus genus.  
1.17  Hypothesis and Aims 
Rationale 
 
Viruses in general rely heavily on cellular host factors for efficient replication and 
spread. In contrast, following viral infection, activation of the innate immune response 
increases the expression of hundreds of genes that aim to not only limit viral replication 
but also shape the adaptive response. While our knowledge of proviral and antiviral 
cellular factors has expanded over recent years for the flaviviridae family of viruses, 
our understanding is not complete. The explosion of CRISPR technology has 
significantly enhanced our ability to modify cellular genomic sequences to efficiently 
knockout specific alleles. However, recent development of CRISPR technology now 
allows for genome-wide knockout screening for proviral host factors, which overcomes 
the limitations of widely used siRNA screens and may allow for the identification of 
novel proviral host factors for the flaviviridae life cycle. Identification of novel host 
factors will further our understanding of flavivirus biology and possibly identify novel 
targets for antiviral therapeutics. Moreover, identification of cellular antiviral strategies 




The ability of viruses within the flaviviridae family to infect and establish replication 
involves numerous as yet, unidentified host factors which remain to be characterised. 
Furthermore, the interferon stimulated gene, Viperin, which has antiviral activity 






The overall aim of this thesis is to identify novel host factors which both positively and 
negatively influence flaviviridae replication.  
 
1. To develop and optimise a CRISPR genome-wide knock out screening protocol 
(GeCKO LentiCRISPRv2) for the identification of novel proviral host factors for 
HCV (Chapter 3) and ZIKV and related flaviviruses (Chapter 4).  
2. Determine the mechanism of action of novel proviral host factors identified from 
the genome-wide CRISPR screen (Chapter 4).  
3. Characterise the cellular innate immune response to ZIKV infection in multiple 
relevant cell types and in particular, the antiviral activity against ZIKV by the 













Chapter 2 - Materials and Methods 
2.1  General Molecular Methods 
2.1.1  Synthetic oligonucleotides 
Synthetic oligonucleotides/primers to be used in PCR, Sanger sequencing or 
LentiCRISPRv2 cloning were ordered from Sigma at PCR/sequencing purity grade 
(see primer sequences in Appendix I). All primers were ordered resuspended in 
100μm stock with TE buffer and stored at -20oC.  
2.1.2  Bacterial transformation 
The frozen α-Select Chemically Competent E. coli cells were purchased from Bioline 
for bacterial transformation for canonical plasmid construct generation. Competent 
cells were thawed on ice and 50μl aliquots per transformation placed within a pre-
chilled microcentrifuge tube. Approximately 10ng of plasmid DNA or 5μl of ligation 
product was added to the competent cells and tube gently mixed by tapping and 
incubated on ice for 30 minutes. The mixture was heat shocked for 30 seconds prior 
to immediate incubation in ice for 2 minutes. 450μl of SOC medium (see Appendix II) 
was added to the transformation reaction and incubated at 37oC for 1 hour. To 
transform intact plasmid DNA, 50μl was added straight to an appropriate antibiotic 
coated agar plate and spread and incubated overnight at 37oC. If transformation the 
ligation product, cells were centrifuged at 2000 x g for 3 minutes, where 450μl of the 
SOC medium removed and the entire pellet resuspended and spread to an appropriate 
antibiotic coated agar plate and incubated overnight at 37oC. 
2.1.3  Small scale plasmid DNA extraction (mini-preparation) 
A single transformed bacterial colony was inoculated with 5ml of LB broth containing 
appropriate antibiotic prior to incubation with shaking at 200-250 rpm at 37°C overnight. 
Following centrifugation at 5,000 ´ g for 5 minutes, the LB broth was removed and the 
NucleoSpin Plasmid Kit (Macherey-Nagel) was used. Briefly, bacterial pellets were 
resuspended in 250μl containing ribonuclease A (RNaseA). 250μl of buffer A2 was 
added to lyse the bacteria for 5 minutes prior to neutralisation with 300μl of buffer A3. 
All centrifugation steps were performed at 11,000 x g. The mixture was spun for 5 
 91 
minutes and supernatant transferred to the mini spin column to be centrifuged for an 
additional 5 minutes. The column was washed with 600μl buffer A4 and centrifuged 
for 1 minute before further centrifugation for 2 minutes to dry the column. 50μl of buffer 
AE was added to the column and centrifuged for 1 minute to elute the plasmid DNA.  
2.1.4  Large scale plasmid DNA extraction (maxi-preparation) 
A single transformed bacterial colony was inoculated into 200ml of LB broth containing 
the appropriate antibiotic and the culture incubated with shaking at 37°C overnight. 
The bacterial culture was pelleted by centrifugation at 5,000 ´ g for 15 minutes using 
an AvantiTM J-25I Beckman Coulter JA-25.50 fixed-angle rotor. Plasmid DNA 
extraction was performed using a NucleoBond Xtra Maxi Kit (Macherey-Nagel) as per 
manufacturer’s instructions. Briefly, bacterial pellets were resuspended in 12ml of RES 
buffer containing ribonuclease A (RNaseA). The mixture was 12ml incubated with 
12ml of LYS buffer and gently mixed by inverting the tube and incubated at room 
temperature (RT) for 5 minutes. 12ml of NEU buffer was added to the mixture and 
mixed by inverting 10-15 times before transferring to a pre-equilibrated NucleoBond 
Xtra column with filter. 15ml of EQU buffer was added to the column. The filter 
discarded prior to the addition of 25ml of WASH buffer. Plasmid DNA was eluted with 
15ml of ELU buffer and subsequently precipitated with 10.5ml of cold isopropanol. The 
precipitated plasmid DNA was pelleted by centrifugation at 15,000 ´ g, 4°C for 30 
minutes using an AvantiTM J-25I Beckman Coulter centrifuge (JA25.50 rotor). The 
pellet was washed with 70% ethanol and resuspended with an appropriate volume of 
TE buffer.  
2.1.5  Restriction endonuclease digestion 
Restriction enzymes were obtained from New England Biolabs (NEB). Restriction 
enzyme digestions were performed in a 20µl total volume, which contained 1µg of 
plasmid DNA or 5µl of ligation reaction (see section 2.1.7), 10 units of restriction 
enzyme(s) and 1´ appropriate NEBuffer. The digestion reactions were incubated at 
37°C overnight prior to visualisation on a 1% agarose gel (see section 2.1.6). 
2.1.6  Agarose gel electrophoresis 
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Agarose gel electrophoresis was performed using 1% w/v agarose gel. The gels were 
prepared by dissolving molecular grade agarose (Bioline) in 1´ TAE buffer (see 
Appendix II) and 3µl of Redsafe Nucleic Acid Staining Solution (iNtRON) per 100ml of 
1% agarose solution. Gels were cast in a BioRad® Sub-Cell GT Minitank. DNA 
samples were mixed with 6´ Loading dye (NEB) and loaded into wells on the agarose 
gel. Electrophoresis was performed at 100 Volts. To estimate product size, 0.5µg of 1 
kb, 100 bp or 2log DNA marker (NEB) were run simultaneously dependent on the 
expected band size. Following electrophoresis, DNA bands were visualised under the 
UV Transilluminator (BioDoc-ItTM Imaging System, UVP) using Quantity One Version 
4.6 Basic software (BioRad).  
2.1.7  DNA ligation 
Ligation reactions were performed using the Quick Ligation Kit (NEB). Ligation 
mixtures contained 50ng of digested plasmid, a 3-fold molar excess of the similarly 
digested insert DNA, 10μl of Quick Ligation Reaction Buffer (2´) and 1μl of Quick T4 
DNA Ligase (2,000 Units/μl) and dH2O to a final volume of 20µl. The reaction was 
incubated at RT for 5 minutes and chilled on ice before utilisation in bacterial 
transformation (see section 2.1.2). 
2.1.8  Gibson Assembly 
15μl of 2x Gibson Assembly reactions (see appendix II) were pre-aliquoted in PCR 
tubes and mixed with 50ng of digested plasmid, a 2-fold molar excess of each insert 
DNA and dH2O to a final volume of 20µl. The reaction was incubated at 50oC for 30 
minutes and chilled on ice before utilisation in bacterial transformation (see section 
2.1.2).  
2.1.9  DNA purification from agarose gel 
DNA bands were purified from agarose gels using an ISOLATE II PCR and Gel Kit 
(Bioline) according to manufacturer’s recommendations. Briefly, the DNA fragment 
was excised from the gel with a clean, sharp scalpel and gel slices mixed with 2 
volumes of binding buffer CB (100mg of the gel slice was equal to 100µl) and the agar 
melted at 50°C for 5-10 minutes until the gel slice was completely dissolved. The 
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mixture was added to collection tubes and centrifuged at 11,000 x g for 30 seconds. 
After the flow-through was discarded, the collection tube was washed with 700µl of 
wash buffer CW and also centrifuged for 11,000 x g for 30 seconds. After an additional 
centrifugation of 11,000 x g for 1 minute to dry the membrane within the column, 15µl 
of elution buffer C was added to the collection tube and centrifuged at 11,000 x g for 
1 minute to elute the DNA.  
2.1.10  DNA sequencing 
DNA sequencing (Sanger sequencing) was performed by the Australian Genome 
Research Facility (AGRF, Australia). Samples were prepared according to the sample 
submission guidelines, which consisted of 1μg of plasmid DNA, 9.6pmol of an 
appropriate forward or reverse primer and adjusted to 12 µl with dH2O. DNA 
sequencing results were analysed using SnapGene and compared to sequences in 
the Genbank database using the Basic Local Alignment Search Tool (BLAST) from 
the National Center for Biotechnology Information website 
(http://www.ncbi.nlm.nih.gov/blast/Blast.cgi).  
2.1.11  Total RNA extraction 
Total cellular RNA was extracted using TRIzol Reagent (Life Technologies) and the 
manufacturer’s protocol followed. Briefly, cells grown in a monolayer in 12-well or 24-
well culture trays (Corning Life Sciences) were washed once with PBS and lysed by 
adding 0.5ml of TRIzol Reagent per well of a 12-well tray and adjusted accordingly for 
other tray sizes. Cell lysates were transferred to RNase-Free 1.5ml microcentrifuge 
tubes (Eppendorf). One-fifth volume of chloroform (0.1 ml for 0.5ml of TRIzol) was 
added to the preparation and incubated at RT for 2-3 minutes, and subsequently 
centrifuged at 12,000 ́  g at 4°C for 15 minutes. The top aqueous layer was transferred 
to a new tube. Total RNA was precipitated by adding 0.5 volume of cold isopropanol, 
mixed well and incubated at RT for 10 minutes. The RNA pellet was precipitated by 
centrifugation at 12,000 ´ g at 4°C for 10 minutes and washed with 1 volume of 75% 
(v/v) ethanol in RNase-free dH2O. After centrifugation at 7,500 ́  g at 4°C for 5 minutes, 
the total RNA pellet was air-dried at RT. The RNA pellet was dissolved in 10µl of 
RNase-free dH2O. RNA samples were kept at -80°C until use.  
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2.1.12  Nucleic acid quantification 
DNA or RNA samples were quantified using the Nanophotometer (Implen GmbH). The 
absorbance at 260nm was read and concentrations of samples were calculated using 
the following formula:  
!"#$%&#	(#&)	(+,/.$) = (_2605. × )&$"7&85	9:#78;		 × 50	(=!()		8;	40	(?!()	
The purity of nucleic acids was determined by measuring the ratio of the absorbance 
at 260nm and 280nm (A260/A280). The DNA and RNA preparations used in this study 
generally had an A260nm/A280nm of 1.8 and 2.0, respectively.  
2.1.13  First-strand cDNA synthesis 
First-strand cDNA was produced from the total RNA using M-MLV Reverse 
Transcriptase RNase H minus, point mutant (Promega). The reaction was performed 
in a pre-chilled RNase-free microcentrifuge tube containing 1µg of total RNA, 50ng of 
random hexamer primer (IDT) or oligoDT primer (Invitrogen) and RNase-free dH2O to 
a final volume of 14 µl. The mixture was incubated within the thermocycler (S1000TM, 
BioRad) at 70°C for 5 minutes. The tube was cooled down at 4°C for a further 5 
minutes and the following mixture was added consisting of 5μl of 5´ M-MLV RT 
Reaction Buffer (Promega), 1.25μl of 10mM each dNTP mix (Promega), 0.5μl of 40 
Units/μl RNAsin RNase Inhibitor (Promega), 1μl of 200 Units M-MLV RT, RNase H (-) 
Point Mutant (Promega) and 3.25 µl dH2O was added to the tube. Samples were 
incubated at RT for 10 minutes, then 42°C for 50 min within the thermocycler. Finally, 
samples were diluted to a final volume of 100 µl with dH2O and stored at -20°C for 
PCR (see section 2.1.14) or qPCR (2.1.15).  
To generate cDNA transcripts longer than 1kb, the Superscript III First-Strand 
Synthesis System (Thermo Fisher Scientific) was used and the manufacturer’s 
recommended protocol followed. Briefly, 1µg of RNA was mixed with 1µl of 2µm gene-
specific primer, 1µl of 10mM dNTP mix and RNase-free dH2O to a total volume of 10µl 
in a RNase free PCR tube. The mixture was incubated at 65oC for 5 minutes and 
placed on ice for 1 minute before the addition of the cDNA synthesis mix which 
consisted of 2µl of 10x RT buffer, 4µl of 25mM MgCl2, 2µl of 0.1M DTT, 1µl of 40U/µl 
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RNaseOUT and finally 1µl of 200U/µl SuperScript III RT. The mixture was incubated 
at 25oC for 10 minutes, 50oC for 50 minutes and reaction terminated at 85oC for 5 
minutes. 1µl of RNase H was added and tubes incubated at 37oC for 20 minutes and 
stored at -20oC.  
2.1.14  Polymerase Chain Reaction (PCR) 
PCR reactions were performed using a thermal cycler (S1000TM, BioRad). Q5 High-
Fidelity DNA polymerase enzymes (NEB) was mainly used for cloning purposes, due 
to the possession of high fidelity. The reactions were prepared in a PCR tube 
containing 12.5µl of Q5 High-Fidelity 2´ Master Mix, 1.25µl each of 20µM forward and 
reverse primers, 1ng of DNA template and dH2O to a final volume of 25 µl. PCR 
thermal cycling conditions consisted of initial denaturation at 98°C for 30 seconds, 
followed by 30 cycles of 98°C for 10 seconds, an appropriate annealing temperature 
for 30 seconds, 72°C for 20-30 seconds/kb and finally, a final extension at 72°C for 2 
minutes. The PCR reactions were visualised by agarose gel electrophoresis (see 
section 2.1.6) or stored at 4°C.  
2.1.15  Real-Time Quantitative PCR (qRT-PCR) 
Quantitative real-time PCR was used to determine relative levels of the target RNA via 
the comparative CT method. qRT-PCR reactions were performed with the Luna 
Universal One-Step RT-qPCR Kit (NEB), where the manufacturer’s recommended 
protocol was followed. Briefly, each reaction consisted of 5µl of 2x Luna Universal 
One-Step Reaction Mix, 0.2µl each of 20µM forward and reverse primers (see 
Appendix II), 1.6µl of nuclease free dH2O and 0.5µl of Luna WarmStart RT Enzyme 
Mix. All samples were analysed in duplicate and also processed to quantify the RPLPO 
housekeeping gene in parallel to normalise input cDNA levels. An ABI StepOnePlus 
Real-Time PCR System (Applied Biosystems) coupled with the ABI PRISM 7000 SDS 
Software was used to control the reaction and cycling conditions consisted of reverse 
transcription at 55°C for 10 minutes prior to initial denaturation at 95°C for 1 minute 
followed by 40 cycles of 95°C for 10 seconds and 60°C for 1 minute. A final step of 
95°C for 15 seconds, 60°C for 1 minute, followed by increasing the temperature by 
0.5°C increments up to 95°C was performed to facilitate the melting curve. Data were 
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analysed using the StepOne v2.2 software and the threshold was set at 0.2 for all 
experiments.  
2.1.16  Extraction of cellular proteins 
Whole cell lysates were extracted from 80-90% confluent cell monolayers in 12-well 
trays. Culture media was first removed and cells washed with PBS prior to the addition 
of pre-chilled RIPA buffer or NP-40 buffer (200µl) (see Appendix II) containing 
protease inhibitor cocktail (Sigma Aldrich). Cell lysate was then transferred to a 1.5 ml 
microcentrifuge tube and placed on ice for 20 min. Whole cell lysates were centrifuged 
at 21,000 ´ g at 4°C for 10 minutes and the supernatant collected and used for further 
experiments or stored at -20°C.  
To extract organelle fractionated whole cell lysates, cells were trypsinised (see section 
2.3.2), resuspended with culture medium into microcentrifuge tubes and centrifuged 
at 500 x g for 5 minutes. The cell pellet was washed once with PBS by centrifugation 
prior to incubation with pre-chilled digitonin lysis buffer (see Appendix II) containing 
protease inhibitor cocktail (Sigma Aldrich) for 10 minutes. The whole cell lysates 
incubated with digitonin lysis buffer were centrifuged at 2,000 x g for 10 minutes and 
the cytosolic containing supernatant transferred to microcentrifuge tubes. The cellular 
pellet was washed once with PBS by centrifugation prior to incubation with pre-chilled 
NP-40 lysis buffer (see Appendix II) containing protease inhibitor cocktail (Sigma 
Aldrich) for 20 minutes. The whole cell lysates incubated with NP-40 lysis buffer were 
centrifuged at 2,000 x g for 10 minutes and the membranous organelle containing 
supernatant collected and used for western blot (see section 2.1.17) or stored at -20°C. 
2.1.17  Western Blot 
Protein samples were prepared by boiling for 5 min with 1´ SDS PAGE sample buffer 
(see Appendix II) before loading onto the gel (Mini Protean 4-15% Precast Gels, Bio-
Rad) alongside 5µl Precision Plus Protein Standards-Kaleidoscope (Bio-Rad). Gels 
were run in SDS-PAGE running buffer (see Appendix II) at 100 Volts for 90 minutes. 
Proteins were transferred onto nitrocellulose membrane via assembly with the Trans-
Blot Turbo RTA Mini 0.2µm Nitrocellulose Transfer Kit (Bio-Rad) and utilisation of the 
Trans-Blot Turbo Transfer system (Bio-Rad) per manufacturer’s instructions. The 
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transfer setting used was MINI-MIXED MW with 1.3 Amps, 25 Volts for 7 minutes. 
Following protein transfer, membranes were blocked with 5% skim milk in 0.1% TBS-
T for 1 hour with gentle agitation prior to incubation with primary antibody at the 
appropriate dilution in 1% skim milk (see Appendix III) overnight at 4°C. Membranes 
were washed three times, each time for 5 minutes in 0.1% TBS-T with gentle agitation 
to remove unbound primary antibody before incubation with the appropriate 
horseradish peroxidase-conjugated secondary antibody for 1 hour and washed five 
times, each time for 10 minutes in 0.1% TBS-T with gentle agitation. HRP detection 
was carried out using the Clarity ECL Western Blotting Substrate (Bio-Rad) or the 
Supersignal West Femto Maximum Sensitivity Substrate detection kit (Thermo Fisher 
Scientific) with chemiluminescent detection as per manufacturer’s instructions. Protein 
bands were visualised by a Chemi-DocTM MP Imaging System (Bio-Rad).  
2.1.18  Co-immunoprecipitation 
Whole cell lysate was harvested from cell monolayers as described in section 2.1.16. 
0.5µg of the appropriate antibody was added to each sample and incubated overnight 
on a rotator at low speed at 4oC overnight. The Protein A MagBeads MX (GenScript) 
(50µl per sample) were washed with wash buffer (see Appendix II) twice with the 
MagnaRack (Invitrogen) and resuspended to the desired volume with wash buffer 
(50µl per sample). 50µl of Protein A MagBeads were added to each antibody bound 
whole cell lysate sample and placed on a rotator at low speed at RT for 1 hour. The 
beads were collected on the MagnaRack and the supernatant removed.  Each sample 
was washed 5 times with wash buffer prior to incubation with 80µl of 2x SDS-PAGE 
loading buffer (see Appendix II) at 100oC for 10 minutes. The supernatant was 
collected utilising the MagnaRack followed by Western Blot analysis as per section 
2.1.17. 
2.1.19  Dual Luciferase Assay 
Firefly and Renilla luciferase activity were measured using the Dual Luciferase Assay 
System (Promega). Cells were seeded into 24-well or 48-well trays, cultured overnight 
and co- transfected with the plasmid of interest (500 ng), ISRE-luc or IFN-β-Luc (500 
ng) and pRL-TK (10 ng). Cells were treated with IFN-α (for ISRE-luc) or poly I:C (for 
IFN-β-Luc) at the indicated time points the following day and then washed once with 
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PBS. 5× Passive Lysis Buffer (Promega) was diluted to 1× lysis buffer with MilliQ water, 
and 80µl of 1x Passive Lysis Buffer was added to each well followed by a single freeze-
thaw to harvest the cell lysate. 20µl of cell lysate was then added to an Opti-plate 96 
(Perkin Elmer) and luciferase output measured on a GloMax Microplate Luminometer 
(Promega). Data were analysed using GraphPad Prism 6 software.  
2.1.20  Nano-luciferase Assay 
Nano-luciferase activity were measured using the Nano-Glo Luciferase Assay System 
(Promega). Cells were seeded into 48-well trays, cultured overnight and infected with 
DENV-NS1-NLuc (Eyre et al. 2017a) at the appropriate MOI for 3 hours at 37oC and 
5% CO2. The culture medium was removed and cultured with fresh culture medium at 
the desired time point. To detect nano-luciferase activity within supernatant, 2x 
Passive Lysis Buffer (Promega) was added to the supernatant at a 2 Passive Lysis 
Buffer:3 supernatant ratio. To detect nano-luciferase activity within the cell monolayer, 
cells were washed once with PBS prior to the addition of 50µl of 1x Passive Lysis 
Buffer per well followed by a single freeze-thaw to harvest the cell lysate. 20µl of cell 
lysate was then added to an Opti-plate 96 (Perkin Elmer) and luciferase output 
measured on a GloMax Microplate Luminometer (Promega). Data were analysed 
using GraphPad Prism 6 software.  
2.1.21  Duolink In-situ Proximity Ligation Assay 
Cells were seeded into 48-well trays and cultured overnight prior to transient 
transfection with desired plasmids. Cells were fixed the following day with cold 
acetone:methanol (1:1) for 5 minutes and washed 3 times with PBS. Proximity ligation 
assays (PLA) were conducted using the Duolink in situ kit (Olink Biosciences) as per 
manufacturer’s instructions. Briefly, cells were blocked with 5% BSA in PBS for 1 hour 
at RT and washed 3 times with PBS. A mixture of desired primary antibodies (different 
species such as mouse and rabbit) was added and the plate was incubated for 1 hour 
at RT before 5 washes with PBS. An isotype control for each primary antibody species 
was used as a negative control. PLA probe mixture (anti-mouse minus and anti-rabbit 
plus) in 1% BSA was added to the wells and the plate was incubated at 37°C in a 
humidity chamber for 1 hour. The humidity chamber was constructed by placing wet 
paper towels onto the bottom of a black container. Cells were washed with wash buffer 
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A (Olink Biosciences) 2 times for 5 minutes each. The ligation solution was prepared 
by mixing 8µl of 5´ ligation stock, 31µl of dH2O and 1µl of ligase. 40µl of ligation 
solution was added to wells and incubated at 37°C in humidity chamber for 30 minutes. 
The plate was washed 2 times with wash buffer A for 2 minutes each. An amplification 
step was performed by adding the mixture of 8µl of 5´ amplification stock, 31.5µl of 
dH2O and 0.5µl of polymerase to the wells and incubating at 37°C in a humidity 
chamber for 1 hour. The reaction was washed 2 times with wash buffer B (Olink 
Biosciences) for 10 minutes each, before a final wash with 0.01´ wash buffer B for 1 
min. Nuclear DAPI staining was performed after proximity ligation assay. The cells 
were visualised by fluorescence microscopy (see section 2.5.4) and a red dot indicated 
a protein-protein interaction.  
2.1.22  In vitro RNA transcription  
The HCV SGR RNA for transfection into Huh7.5 cells was synthesised using a T7 
High Yield RNA Synthesis Kit (NEB) per manufacturer’s recommended protocol. Prior 
to in vitro RNA transcription, the HCV pSGRm-JFH1-Bla was digested with PmeI 
overnight. The RNA synthesis mixture was prepared in a pre-chilled PCR tube and 
comprised of 2μl of each ATP, CTP, GTP, UTP, 2μl of 10´ Reaction Buffer, 2μl of T7 
RNA polymerase enzyme and 1μg of PmeI digested pSGRm-JFH1-Bla in a total 
volume of 20μl. The preparation was thoroughly mixed and incubated at 37°C for 3 
hours. After incubation, samples were subsequently treated with 1μl (2 Units) of 
TURBO DNAseTM (Ambion®) for 15 minutes at 37°C. Reactions were transferred to 
pre-chilled RNAse free microcentrifuge tubes to perform RNA extraction (section 
2.1.11). The concentration of RNA was measured using a UV spectrophotometer 
Nanophotometer® (Implen GmbH) and RNA integrity was checked by 1% agarose gel 
electrophoresis (section 2.1.6). 
2.1.22  Plaque assay 
Virus infectivity was determined by plaque assay as described previously (Van der 
Hoek et al. 2017). Briefly, Vero cells in 24-well plates were infected with 200 µl of 
serially-diluted virus-containing supernatants for 1 hour at 37 °C before the addition of 
1ml overlay of complete media containing 1.5% (w/v) carboxymethylcellulose (CMC) 
(Sigma Aldrich) and cells returned to culture for various days dependent on the virus 
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(5 days for ZIKV and WNVKUN, 2 days for HSV). The plate was flooded with 10% 
formalin for 1 hour before removal of the CMC overlay with PBS and crystal violet 
solution (see Appendix II) added to the well for 20 minutes. Wells were washed with 
dH2O and plaques counted and virus infectivity expressed as plaque-forming units 




2.1.23  Flow cytometry 
Cells of interest were trypsinised and resuspended in complete cell medium prior to 
centrifugation at 1,000 x g for 5 minutes. All subsequent steps were incubated at 4oC. 
After 1 wash with PBS, cells were fixed in 100μl of 4% paraformaldehyde per sample 
for 20 minutes prior to centrifugation at 500 x g for 5 minutes. All subsequent 
centrifugation steps were performed at 500 x g for 5 minutes. The 4% 
paraformaldehyde was removed and 100μl of 0.1% Triton X-100 was added to 
permeabilise cells. After centrifugation, 100μl of 5% BSA in PBS was added prior to 
staining with the desired primary antibody (anti NS5A – 1/5 dilution/anti-CD81 1/100 
dilution) for 1 hour and cells washed once with PBS. The desired secondary antibody 
(anti-mouse Alexa Fluor 488 – Life Technologies) was incubated with the cells for 1 
hour and cells washed twice with PBS. The cell pellet was resuspended in 1% 
paraformaldehyde and run through a 70μm cell strainer (Corning Life Sciences) prior 
to flow cytometry. Stained cells were acquired on BD LSR II and FACSAria flow 
cytometer (BD Biosciences).  
2.2  Construction of CRISPR lentiviral library 
2.2.1  Expansion of CRISPR plasmid DNA library 
The GeCKO LentiCRISPRv2 library was purchased from Addgene and delivered with 
the library dissolved in TE buffer. To expand the library, Endura Electrocompetent cells 
(Lucigen) were thawed on ice and 25μl aliquoted into pre-chilled microcentrifuge tubes. 
2μl of 50ng/μl library A or B was added to electrocompetent cells and mixed gently 
before addition into a chilled 0.1cm Gene Pulser electroporation cuvette (Bio-Rad). 
The cuvette was quickly flicked downwards to deposit cells across the bottom of the 
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well. The plasmid/cell mixture was quickly pulsed with the following parameters: 10μF, 
600 Ohms and 1800 Volts using a Gene Pulser XcellTM (Bio-Rad). 975μl of recovery 
medium was added directly to the cuvette and pipetted up and down three times to 
resuspend cells and transferred into microcentrifuge tubes. Tubes were incubated on 
an orbital shaker at 250rpm for 1 hour at 37oC. Four electroporations were performed 
per half library and pooled together prior to spreading. The entire mixture was spread 
on 20 20cm ampicillin coated agar plates (400μl per plate) and plates incubated 
overnight at 32oC to reduce plasmid recombination. 10μl of the mixture was diluted 
with 1ml of recovery media and 20μl spread onto a 10cm agar plate with ampicillin to 
deduce transformation efficiency. Transformation efficiency was calculated the 
following day and total colonies must exceed 3x106 to enable complete representation 
of the library. 
Colonies were scraped with the addition of 500μl of LB broth and a cell spreader and 
bacterial suspension collected into Falcon tubes (Thermo Fisher Scientific). After 
centrifugation at 5,000 x g for 15 minutes, the bacterial pellet was weighed and 0.45g 
of pellet transferred to one maxi-preparation column and plasmid extraction performed 
per section 2.1.4.  
2.2.2  Generation of lentivirus from the CRISPR plasmid DNA library 
To generate sufficient lentivirus to enable complete representation of the GeCKO 
LentiCRISPRv2 library, an upscaled version of section 2.3.8 was followed. Briefly, 10 
20cm2 dishes consisting of HEK293T cells at 90% confluency were transfected with 
Lipofectamine 2000 per section 2.3.6. For each dish, Tube A consisted of 20μg of 
GeCKO LentiCRISPRv2 library A or B, 15μg of psPAX2 (Addgene) and 10μg of 
pMD2.G (Addgene) and 4ml of Opti-MEM (Gibco). Tube B consisted of 100μl of 
Lipofectamine 2000 and 4ml of Opti-MEM. After incubation for 5 minutes at RT, 
contents of tube B were added to tube A and mixed gently. After 20 minutes of 
incubation at RT, the transfection mixture was added to each dish and fresh culture 
media replaced the following day. Lentiviruses within the supernatant were harvested 
72 hours post transfection and filtered through a 0.45μm filter membrane and stored 
at -20oC.  
2.2.3  Titration of the lentiviral GeCKO LentiCRISPRv2 library 
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To deduce the concentration of lentivirus generated in section 2.2.2, functional titration 
was performed utilising puromycin. Briefly, cells which will be transduced for genome-
wide screening were seeded within a 12-well tray and transduced with a dilution series 
of lentivirus encoding the GeCKO LentiCRISPRv2 library. Cells were trypsinised the 
following day per section 2.3.2 and half of the cells were placed in one 12 well and the 
other in another 12 well. Following 3 days of incubation, puromycin was added only to 
half the cells at the appropriate dilution necessary to ensure cell death of un-
transduced cells (3μg/ml for Huh7.5), leaving the duplicate well selection free. 
Following complete cell death of the mock transduced control cells, cells were 
trypsinised again and counted using a haemocytometer per section 2.3.3. The 
following formula was used and the closest dilution which yielded 0.3 was upscaled 




2.3  Tissue Culture Techniques 
2.3.1  Tissue culture medium 
All mammalian cell lines excluding HTR8/SVneo were maintained in Dulbecco’s 
Modified Eagle Medium (DMEM) containing 25 mM HEPES (Gibco). Standard DMEM 
was supplemented with 10% (w/v) foetal calf serum (Corning Life Sciences), Penicillin 
(Invitrogen; 100 U/ml) and Streptomycin (Invitrogen; 100μg/ml). Blasticidin-HCL 
5μg/ml (Invitrogen), Puromycin 3μg/ml (Sigma-Aldrich) or Geneticin (G418) 800μg/ml 
(Invitrogen) were added for selection and maintenance of stable cell lines.  
The HTR8/SVneo were maintained in Roswell Park Memorial Institute (RPMI) 1640 
medium (Gibco) and supplemented with 10% (w/v) foetal calf serum (Corning Life 
Sciences), Penicillin (Invitrogen; 100 U/ml) and Streptomycin (Invitrogen; 100μg/ml).  
The C6/36 Aedes albopictus cell line was maintained in Basal Medium Eagle (BME) 
medium (Gibco) supplemented with 1x MEM Non-Essential Amino Acids Solution 
(Gibco), 1mM Sodium Pyruvate (Gibco), 1% GlutaMAX Supplement (Gibco), 10% (w/v) 
foetal calf serum (Corning Life Sciences), Penicillin (Invitrogen; 100 U/ml) and 
Streptomycin (Invitrogen; 100μg/ml). 
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2.3.2  Cell maintenance 
Cultured cell lines were maintained in sterile 0.2µm vented tissue culture flasks (25 
cm2, 75cm2 or 175cm2), tissue culture dishes (10cm2 and 20 cm2) or tissue culture 
trays (6, 12, 24, 48 or 96-well) (Corning Life Sciences). Near-confluent cells were 
passaged by removing culture medium, washing once with 1´ PBS prior to the addition 
of a small volume of Trypsin-EDTA (see Appendix II). Cells were then placed in the 
CO2 incubator at 37°C for 5 minutes or when cells are detached. Fresh culture medium 
was added to resuspend the cells. Cells were counted using a Neubauer 
Haemocytometer (Livingstone) with Trypan Blue (see section 2.3.3). Cells were grown 
at 37°C, 5% CO2 in a humidified Panasonic CO2 incubator (Panasonic Healthcare CO., 
Ltd). Cells were passaged every 2- 3 days depending on cell types and confluency. 
For the C6/36 cell line, cells were maintained as above but grown at 28°C with 5% 
CO2.  
2.3.3  Trypan blue exclusion 
Cells were counted using a Neubauer Haemocytometer (Livingstone) and Trypan Blue 
Stain solution (prepared by the Tissue Culture Service Unit). Trypsinised cells were 
mixed with an equal volume of Trypan Blue and loaded into a haemocytometer. Cell 
concentration was then calculated using the following equation:  
G%$$	#85#%57;:7&85	(#%$$C/.$) = #%$$	#8"57	A%;	,;&)	 × 	2	()&$"7&85	9:#78;	) 		× 	10" 
2.3.4  Cryopreservation of cells 
Cells at 80-90% confluency were trypsinised, resuspended in fresh culture media and 
centrifuged at 1,000 ´ g for 5 minutes. Culture media was removed and cell pellets 
were resuspended in fresh culture media. An equal volume of 2´ freezing media [50% 
media, 30% FCS, 20% DMSO (Sigma Aldrich)] was added to the cell suspension and 
mixed gently. Cells were aliquoted (1ml/vial) in sterile cryopreservation tubes (Corning 
Life Sciences). Cryotubes were transferred to a freezing chamber (Nalgene) 
containing fresh isopropanol and placed in a -80°C freezer. For long-term storage, 
vials were stored in a liquid nitrogen based cryopreservation system.  
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2.3.5  Resuscitation of cryopreserved cells 
Cryopreserved vials containing frozen cell lines were thawed quickly in a 37°C water 
bath and transferred to T25cm2 tissue culture flask containing pre- warmed standard 
tissue culture medium. Cells were incubated in the CO2 incubator overnight. Fresh 
tissue culture medium containing an appropriate antibiotic (if necessary) was replaced 
the next day to remove dead cells.  
2.3.6  Transient transfection of plasmid DNA and RNA 
Cells were transiently transfected with expression plasmid DNA with either 
Lipofectamine 2000 or Lipofectamine 3000 (Life Technologies) to achieve protein 
overexpression following the manufacturers recommended protocol. Lipofectamine 
3000 was also used to transfect in vitro transcribed SGR RNA or poly I:C into cells. 
Cells were seeded 24 hours prior to transfection and at approximately 80% confluency, 
either Lipofectamine 2000 or 3000 were incubated at RT for 15 minutes before usage. 
Transfection complexes for a single 12-well with Lipofectamine 2000 or 3000 
consisted of two tubes, where tube A contained 1µg of plasmid DNA/RNA with 100µl 
of Opti-MEM media (Life Technologies) and tube B contained 3µl of Lipofectamine 
2000 or 3000 with 100µl of Opti-MEM and incubated for 5 minutes at RT. Volumes 
were adjusted accordingly for trays with different well sizes. For Lipofectamine 3000, 
3µl of P3000 was also added to tube A for only plasmid DNA transfections. Contents 
of Tube A were mixed directly into Tube B and after an additional 15 minutes 
incubation, mixture was added drop-wise to the cell monolayer.  The plates were 
gently swirled and returned to normal tissue culture conditions.  
2.3.7  Transient transfection of siRNA 
Cells were transiently transfected with siRNA with Lipofectamine RNAiMAX Reagent 
(Life Technologies) per manufacturer’s recommended protocol. Briefly, cells were 
seeded 24 hours prior to transfection and at approximately 80% confluency, 
Lipofectamine RNAiMAX Reagent incubated at RT for 5 minutes before usage. 
Transfection complexes for a single 12-well consisted of two tubes, where tube A 
contained 1µl of 20µm siRNA with 100µl of Opti-MEM media (Life Technologies) and 
tube B contained 3µl of Lipofectamine RNAiMAX Reagent with 100µl of Opti-MEM and 
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incubated for 5 minutes at RT. Contents of Tube A were mixed directly into Tube B 
and after an additional 5-minute incubation period, mixture was added drop-wise to 
the cell monolayer.  The plates were gently swirled and returned to normal tissue 
culture conditions.  
2.3.8  Lentiviral particle production 
The lentiviral particles were produced in the 293T cell line due to their high transfection 
efficiency. 293T cells were seeded in a 6-well tray 24 hours prior to transfection. Cells 
were transfected with equal amounts of target plasmid DNA with the lentiviral 
packaging plasmids psPAX2 (a packaging plasmid, Addgene) and pMD2.G (VSV-G 
envelope expressing plasmid, Addgene) with Lipofectamine 2000 per section 2.3.6. 
Culture media were changed the following day and remove transfection reagent and 
plasmid present in the media. The supernatants from 293T cells were harvested 72 hr 
post-transfection and filtered through a 0.45μm filter membrane, aliquoted into vials 
and stored at -20°C.  
To generate the stable cells, the cells were seeded in a 6-well tray prior to lentiviral 
transduction. The lentiviral aliquot was rapidly thawed, diluted 1:3 in complete media 
and added to the target cells. Culture media were replaced 5 hours post-transduction 
and cells returned to the incubator. The antibiotic selection was started 3 days post-
transduction (Blasticidin at 5μg/ml and puromycin at 3μg/ml for Huh7 cells – adjusted 
accordingly for other cell types). Treatment of non-transduced cells was used as a 
negative control. The polyclonal cell line was considered as stable cells when the 
negative control culture was non-viable.  
2.3.9  Generation of EGFP/CD81/PI4KA knockout (EGFP-KO/CD81-KO/PI4KA-
KO) cell lines by CRISPR/Cas9 technology 
20 nucleotides guide sequences (sgRNA) targeting the gene of interest 
(EGFP/CD81/PI4KA) were designed on Benchling and generated with BsmBI 
overhangs as complementary DNA primers (see Appendix I). These primers were 
annealed and ligated into BsmBI digested LentiCRISPRv2 plasmid (Addgene). 
Following transformation into competent cells (see section 2.1.2) and mini-preparation 
(see section 2.1.3), a diagnostic BsmBI digestion was performed to deduce which 
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clones have the correct guide sequence. Lentivirus was generated and transduced as 
described previously in section 2.3.8. Monoclonal populations of each potential 
knockout colony were obtained by dilution (1:100-1:200) onto 150 mm dishes to 
separate the cellular population into single cell and once at a suitable size 
(approximately 4 weeks), colonies were isolated using a colony ring. Knockout cells 
were confirmed by immunofluorescence staining (see section 2.5.3) western blot 
analysis (see section 2.1.17) and FACS (section 2.1.24).  
2.4  Cell lines 
2.4.1  HeLa 
The HeLa cell line is derived from cervical cancer cells taken from Henrietta Lacks 
(Scherer et al. 1953).  
2.4.2  293T 
The 293T cell line is derived from human embryonal kidney (HEK) cells transformed 
with the SV40 large T antigen.   
2.4.3  Huh7 
The Huh7 cell line is a human hepatocyte-derived carcinoma cell line, isolated from a 
liver tumour from a 57-year-old Japanese male (Nakabayashi et al. 1982). 
2.4.4  Huh7.5 
Derived from Huh7 cells, the Huh7.5 cell line used to harbour replication of an HCV 
sub-genomic replicon (SGR) but cured after IFN-α treatment. This cell line is highly 
permissive to HCV infection due to defective RIG-I signalling (Blight et al. 2002; 
Sumpter et al. 2005). These cells were kindly provided by Charles Rice (Rockefeller 
University, New York, USA).  
2.4.5  Huh7-T7 
The HuhT-T7 cell line is the Huh7 cell line with stable expression of the T7 
bacteriophage RNA polymerase and maintained with puromycin selection. 
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2.4.6  Huh7-EGFP 
The Huh7-EGFP cell line is the Huh7 cell line with stable expression of EGFP and 
maintained with blasticidin selection. 
2.4.7  HTR8/SVneo 
The HTR8/SVneo cell line was derived by chronic villi explant cells from human first 
trimester placenta transformed with the SV40 large T antigen.  
2.4.8  JEG3 
The JEG3 cell line are human choriocarcinoma cells derived and isolated from the 
Woods strain of the Erwin-Turner tumour (Kohler and Bridson 1971).  
2.4.9  Vero 
The Vero cell line are epithelial cells isolated from the kidney of a healthy adult African 
green monkey in Japan.  
2.4.10  EGFP-KO Huh7 cells 
EGFP-KO Huh7 cells are Huh7 cells that display a complete loss of EGFP expression 
generated by CRISPR/Cas9 editing technology.  
2.4.11  CD81-KO Huh7.5 cells 
CD81-KO Huh7 cells are Huh7 cells that display a complete loss of CD81 expression 
generated by CRISPR/Cas9 editing technology.  
2.4.12  Sub-genomic replicon (SGR) 
Huh7.5 cells were transfected with in vitro RNA transcribed from pSGRm-JFH1-BlaRL 
derived plasmids. Individual blasticidin-resistant colonies harbouring replication of the 
pSGRm-JFH1-BlaRL replicons were expanded and screened. Colonies displaying the 
desired phenotypes (NS5A expression) with functional reporter genes (mCherry, GFP, 
renilla luciferase or thymidine kinase expression) were chosen for further experiments.  
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2.4.13  Mouse embryonic fibroblasts (MEFs) 
Viperin KO MEFs were derived from viperin deficient mice generated by 
CRISPR/Cas9 technology (Van der Hoek et al. 2017). PCR of the viperin locus from 
genomic DNA and sanger sequencing confirmed disruption of the viperin coding 
region. Wild type MEFs from the original inbred C57BL/6 mouse strain were used as 
a control.  
2.5  Fluorescence Microscopy 
2.5.1  Acetone/methanol fixation 
To prepare acetone:methanol (1:1, v/v) fixative solution, an equal volume of Acetone 
(Chem-Supply) and Methanol (Chem-Supply) were mixed and stored at -20°C. Cell 
monolayers were washed with 1× PBS prior to the addition of cold acetone:methanol 
solution for 5 minutes at 4°C. Following removal of the fixation solution, cells were 
washed 3 times with PBS. Fixed cells were kept in PBS at 4°C before 
immunofluorescence labelling (see section 2.5.3). 
2.5.2  4% Paraformaldehyde fixation 
Cell monolayers were washed once with PBS prior to the addition of 4% 
paraformaldehyde solution (see Appendix II) for 20 minutes at RT. Following removal 
of the fixation solution, cells were washed 3 times with PBS. 0.1% Triton X-100 (Sigma 
Aldrich) was added to permeabilise cells for 10 minutes and washed twice with PBS 
before immunofluorescence labelling (see section 2.5.3). 
2.5.3  Immunofluorescence labelling 
Immunofluorescence labelling was performed after fixation with either 
acetone/methanol or 4% paraformaldehyde (see section 2.5.1 and 2.5.2). Fixed cells 
were first blocked with 5% BSA in PBS (see Appendix II) for 1 hour at RT before 2 
washes with PBS. Cells were labelled with primary antibody (see Appendix III) diluted 
in 1% BSA in PBS (see Appendix II) for 1 hour at RT. After 3 washes with PBS, an 
appropriate dilution of fluorescence-conjugated secondary antibody (see Appendix III) 
was added to the wells and samples were incubated for 1 hour in the dark at RT. 
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Samples were washed 3 times with PBS prior to nuclear DAPI staining cells for 5 
minutes in the dark. Cells were finally washed 2 times with PBS and samples stored 
in PBS at 4°C. Samples were visualised using a Nikon Eclipse TiE fluorescence 
inverted microscope and images were captured using NIS Elements software.  
2.5.4  Confocal microscopy 
Confocal microscopy was performed on the Olympus FV3000 at Adelaide Microscopy 
(Olympus Life Science). Cells were seeded on a 8-well chamber slide (μ-slide 8 well 
glass bottom – ibidi) and immunofluorescence labelling performed per section 2.5.3. 
Following DAPI staining, two drops of Vectashield PLUS Antifade Mounting Medium 
(Vector Laboratories) was added per well to prevent bleaching. Two drops of 60X 
immersion oil was placed on the objective lens before mounting the chamber slide. 
Images were captured with Fluoview software (Olympus Life Science) with line 
sequential scanning for each channel, which consisted of DAPI, Alexa Fluor 488 and 
Alexa Fluor 555.  
2.6  Data analysis 











Chapter 3 - Identification of novel host factors for HCV replication  
3.1  Introduction 
In general, viruses with RNA genomes, including the Hepatitis C Virus (HCV) have 
limited coding capacity and thus depend on host cellular components to support their 
entire lifecycle. A prime example are the cellular factors required for HCV entry, where 
the virus binds to host cell receptors including CD81, SRB1, Claudin-1 and occludin 
(see section 1.6.1). Additionally, cellular factors such as PI4KA and hVAP-A are 
instrumental to the formation of the membranous web required for HCV replication 
(see section 1.9). While we have a good understanding of HCV dependent host factors, 
it is likely that more remain to be identified and characterised. Identification of HCV 
proviral host factors has largely been dependent on RNAi technology, where both 
small-scale and genome-wide siRNA screens have uncovered the function of 
numerous cellular proteins which support the HCV lifecycle (Tai et al. 2009; Li et al. 
2009). Although characterisation of these HCV proviral host factors has greatly 
contributed to the knowledge of the virus lifecycle and possible therapeutic 
interventions, limitations within RNAi technology which include incomplete knockout 
of protein expression, suggest that additional host factors remain to be discovered. 
However, the recent advent of CRISPR as a tool to allow for the possibility of genome-
wide knockout screening and thus circumventing the limitations that RNAi poses, will 
allow for the elucidation of novel host factors that are essential for HCV replication. 
Therefore, the aim of this chapter was to optimise CRISPR technology to perform a 
genome-wide screen to identify additional host factors critical for the HCV lifecycle.   
3.2  Proof of concept experiments using CRISPR technology to investigate 
proviral host factors 
At the time this project was conceived, CRISPR genome-wide screen technology was 
in its infancy and the majority of studies to knockout targeted gene expression relied 
exclusively on transient transfection of plasmids encoding both the sgRNA and Cas9 
(Yang et al. 2014). However, in contrast to above, the GeCKO LentiCRISPRv2 library 
that was used in this thesis, relies on lentiviral delivery of the CRISPR/Cas9 system 
and guides for genome-wide knockout across a population of cells (Sanjana et al. 
2014). The use of the lentiviral delivery system overcomes any issues that may be 
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encountered when using lipid-based transfection protocols. These include control of 
delivery of Cas9 and sgRNAs on one plasmid and the lower cost associated with 
lentiviral transduction. Therefore, as a proof of concept before embarking on a large 
scale genome-wide screen, we used the LentiCRISPRv2 system to knockout a 
number of HCV proviral host factors and also EGFP expression in Huh7.5-EGFP 
stable cell lines. 
3.2.1  Generation and validation of EGFP CRISPR KO cell line 
We first evaluated LentiCRISPRv2’s ability to knockout EGFP expression that had 
been ectopically stably introduced within the Huh7 genome. The EGFP coding region 
contained no intron/exons as the entire open reading frame was integrated within the 
genome, eliminating the possibility of unintentional alternative splicing during mRNA 
transcription, allowing for simple investigation of CRISPR/Cas9 knockout efficiency. 
Finally, we could monitor EGFP fluorescence levels in real time throughout the entire 
course of the process from the introduction of the Cas9 to isolation of monoclonal 
populations for further analysis.  
Design of the sgRNA sequences that target EGFP mRNA was performed using the 
online tool Benchling (http://benchling.com), who have refined their sgRNA 
computational design rules to detect the optimum sequences ensuring effective Cas9 
cleavage and maximum knockout efficiency (Hsu et al. 2013). Benchling arranges the 
potential sgRNA sequences based on on-target and off-target scores, and binding 
locations of sgRNAs, results are annotated in a simplistic manner (Doench et al. 2016). 
Two sets of oligonucleotides which bind within 100bp to the 5’ end of the start codon 
for EGFP were designed and selected, where each bound on opposite strands of the 
EGFP coding DNA to determine if there was Cas9 knockout efficiency bias towards 
either sense strand. These oligos also contained BsmBI overhangs to allow insertion 
into the LentiCRISPRv2 plasmid via traditional restriction enzyme cloning (see 
Appendix 1). These primers were annealed and ligated into BsmBI digested 
LentiCRISPRv2 plasmid (see section 2.1.7). Following transformation and plasmid 
mini-preparation, a diagnostic BsmBI digestion was performed to isolate clones which 
have successful integration of the sgRNA targeting EGFP (LCv2-EGFP.1 and LCv2-
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Figure 3.1: sgRNAs which target EGFP were successfully cloned into 
pLentiCRISPRv2. 
To determine if the annealed sgRNAs which target EGFP were ligated into 
pLentiCRISPRv2, plasmid DNA was extracted from transformant clones and digested 
with BsmBI. Lane M, 1kb DNA ladder, lanes 1-4, recombinant plasmid from 
transformant clones no. 1-4 respectively, lane 5, LCv2-WT plasmid. 
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EGFP.2) (see section 2.1.2 & 2.1.3) (Fig. 3.1). Lentivirus was generated (see section 
2.3.8) with LCv2-EGFP.1 or LCv2-EGFP.2 and Huh7-EGFP stable cell lines were 
transduced with lentivirus, and puromycin selection of monoclonal populations of cells 
were isolated using cloning rings and expanded for analysis. 
Immunofluorescence was first used to confirm EGFP knockout in the Huh7.5 EGFP 
stable cell lines. Transduction of the LentiCRISPRv2 wildtype (LCv2-WT), which 
contains a 2kb filler region instead of a 20nt sgRNA resulted in retention of EGFP 
fluorescence as expected (Fig. 3.2). In contrast, cells transduced with either LCv2-
EGFP guide displayed complete loss of EGFP fluorescence, suggesting no influence 
was observed in polarity of binding by the sgRNA (Fig. 3.2). In addition, western 
blotting of EGFP indicated high levels of EGFP protein expression in the lysates of 
LCv2-WT cells but a complete loss of EGFP protein expression in cells transduced 
with either LCv2-EGFP guide, in multiple monoclonal populations (see section 2.1.17) 
(Fig. 3.3). Finally, flow cytometry was also used to investigate EGFP expression in 
LCv2-EGFP transduced KO cells (see section 2.1.24). Gated LCv2-WT cells had 
significant expression of EGFP as expected, however the loss of EGFP within the 
LCv2-EGFP transduced KO cells was similar to that of the negative control which had 
no EGFP expression (Fig. 3.4). Collectively, the data above indicates that the 
LentiCRISPRv2 system is able to knockout a specific gene of interest with high 
efficiency required for genome-wide screening.  
3.2.2  Generation and validation of CD81 and PI4KA CRISPR KO cell lines 
Following successful knockout of EGFP, we next determined whether LentiCRISPRv2 
could knockout endogenous genes as efficiently. We therefore elected to knockout 
host factors that are critical for HCV replication. We selected CD81, one of the 
receptors required for HCV entry and PI4KA, an essential kinase for lipid metabolism 
and establishment of the HCV replication complex (see section 1.61 and 1.9). 
Since we were now targeting an endogenous gene which contains multiple exons, we 
designed one sgRNA binding site within exon two (sgRNA, CD81.1) and the second 
within exon three (sgRNA, CD81.2) via Benchling with BsmBI overhangs as described 
previously (see Appendix 1). This was done to improve the probability of CD81 frame 
shift mutations if alternative splicing occurs. Following ligation and transformation 
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Figure 3.2: Transduction of LCv2-EGFP results in elimination of EGFP 
fluorescence in Huh7-EGFP stable cell line via immunofluorescence 
microscopy. 
To evaluate LentiCRISPRv2 efficiency, we needed to determine if EGFP could be 
knocked out in a Huh-7 EGFP stable cell line. LentiCRISPRv2 wildtype control (LCv2-
WT), LCv2-EGFP.1 and LCv2-EGFP.2 were stained with DAPI and endogenous 
EGFP expression visualised using a Nikon TiE inverted fluorescence microscope. 
Scale bars are 100µm. Representative of multiple monoclonal populations. 
 
 115 
Figure 3.3: Transduction of LCv2-EGFP results in elimination of EGFP protein 
in Huh7-EGFP stable cell line via western blot. 
To evaluate LentiCRISPRv2 efficiency, we needed to determine if EGFP could be 
knocked out in a Huh-7 EGFP stable cell line. Whole cell lysates of LentiCRISPRv2 
wildtype control (LCv2-WT), LCv2-EGFP.1 and LCv2-EGFP.2 (where there are 3 
individual monoclonal populations each) were harvested and western blot run, 
incubated with anti-EGFP and anti-β-actin antibodies. Lane M, Bio-Rad Kaleidoscope 
Ladder, lane 1 LCv2-WT, lane 2-4, three monoclonal populations of LCv2-EGFP.1, 





Figure 3.4: Transduction of LCv2-EGFP results in elimination of EGFP 
fluorescence in Huh7-EGFP stable cell line via flow cytometry. 
To evaluate LentiCRISPRv2 efficiency, we needed to determine if EGFP could be 
knocked out in a Huh-7 EGFP stable cell line. LCv2-WT, LCv2-EGFP.1 and LCv2-
EGFP.2 (where there are 3 individual monoclonal populations each) were harvested 





of the annealing oligonucleotides into the BsmBI digested LentiCRISPRv2 plasmid, 
colonies were diagnostically digested with BsmBI to detect colonies that contained 
successful integration of the sgRNA targeting CD81 (LCv2-CD81) (Fig. 3.5). As 
described previously, lentivirus was generated using LCv2-CD81 and Huh7.5 cells 
were transduced and puromycin resistant monoclonal populations isolated using 
cloning rings and puromycin resistant colonies expanded for downstream experiments. 
Immunofluorescence (see section 2.5.3) was employed to confirm CD81 knockout 
within the Huh7.5 monoclonal population. Cells transduced with LCv2-WT lentivirus 
revealed positive staining for CD81 as expected that was clearly present on the cell 
membrane and consistent with previous reports (Farquhar et al. 2012). In contrast, 
cells transduced with either LCv2-CD81 guide, resulted in complete loss of CD81 
expression (Fig. 3.6). Flow cytometry was also used as a complementary method to 
ascertain CD81 expression in LCv2-CD81 cells. Gated LCv2-WT cells had high 
expression of CD81 as expected, while transduction with LCv2-CD81.1 resulted in 
complete loss of CD81 as shown by the lack of overlap between the two and indicating 
efficient knockout of CD81 expression (Fig. 3.7). Interestingly despite no visible CD81 
immunofluorescence staining for LCv2-CD81.2, these cells had incomplete knockout 
of CD81 as is evidenced by a broader peak which overlaps with the LCv2-WT (Fig. 
3.7). This implies that variable KO efficiency is observed with genes with multiple 
alleles and likely originates from the cancerous origins of the parental Huh7 cells, 
which possess between 55 and 63 chromosomes (Kasai et al. 2018). This would likely 
result in insufficient cleavage by Cas9, and incomplete knockout of CD81. This 
limitation may be rectified by repeating the transduction of LentiCRISPRv2 targeting 
CD81 and optimising time points prior to BSD selection. 
To determine if the two LCv2-CD81 monoclonal populations were resistant to HCV 
infection due to the loss of CD81 expression, cells were infected with HCV JC1-GFP 
infectious virus at an approximate MOI of 2 for 48 hours prior to acetone/methanol 
fixation (see section 2.5.1) (Eyre et al. 2014). Immunofluorescence staining revealed 
high levels of NS5A staining in LCv2-WT cells when CD81 is present, indicative of 
efficient HCV replication. However, there was significantly reduced NS5A staining in 
both LCv2-CD81 monoclonal populations, indicating reduced HCV replication as a 
result of ablated CD81 expression (Fig. 3.8). qRT-PCR was also employed as a 
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Figure 3.5: sgRNAs which target CD81 were successfully cloned into 
pLentiCRISPRv2. 
To determine if the annealed sgRNAs which target CD81 were ligated into 
pLentiCRISPRv2, plasmid DNA was extracted from transformant clones and digested 
with BsmBI. Lane M, 1kb DNA ladder, lanes 1-4, recombinant plasmid from 








Figure 3.6: Transduction of LCv2-CD81 results in elimination of CD81 
fluorescence in Huh7.5 cell line via immunofluorescence microscopy. 
To evaluate LentiCRISPRv2 efficiency to knockout host factors important for the HCV 
lifecycle, LentiCRISPRv2 wildtype control (LCv2-WT), LCv2-CD81.1 and LCv2-
CD81.2 were stained with mouse anti-CD81 and Alexa Fluor 555-conjugated goat 
anti-mouse IgG secondary Ab. Post DAPI staining, cells were visualised using a Nikon 








Figure 3.7: Transduction of LCv2-CD81 results in elimination of CD81 
fluorescence in Huh7.5 cell line via flow cytometry. 
To evaluate LentiCRISPRv2 efficiency to knockout host factors important for the HCV 
lifecycle, LentiCRISPRv2 wildtype control (LCv2-WT), LCv2-CD81.1 and LCv2-
CD81.2 transduced cell lines were harvested and stained with mouse anti-CD81 and 
Alexa Fluor 488-conjugated goat anti-mouse IgG secondary Ab. Single cells were 
analysed by flow cytometry. LCv2-WT is indicated as yellow, LCv2-CD81.1 is shown 









confirmatory assay to assess HCV RNA abundance (see section 2.1.15). As expected, 
both LCv2-CD81 monoclonal populations, indicating reduced HCV replication as a 
result of ablated CD81 expression (Fig. 3.8). qRT-PCR was also employed as a 
confirmatory assay to assess HCV RNA abundance (see section 2.1.15). As expected, 
LCv2-WT are readily infected with HCV as determined by high levels of HCV RNA 
within the cell (Fig. 3.9). In contrast, both LCv2-CD81 monoclonal populations have 
significant reduction in HCV RNA levels (Fig. 3.9). Collectively, these results 
demonstrate that knockout of an endogenous host factor critical for entry of HCV, 
results in the inhibition of HCV replication within the cell, as expected. Additionally, 
despite incomplete knockout of CD81, it is still possible for HCV entry to be halted 
demonstrating the sensitivity of the genome-wide screen is not compromised should 
potential novel host factors have incomplete knockout.  
Although we have validated LentiCRISPRv2’s ability to knockout a host factor that 
resulted in inhibition of HCV entry, the HCV-SGR replicon system which will be used 
in the CRISPR genome-wide screen bypasses the HCV entry phase and focuses 
solely on the replication stage of the virus lifecycle (Zhou et al. 2011). Therefore, we 
deemed it important to determine if LentiCRISPRv2 could knockout a host factor 
important in the genome replication stage of the HCV lifecycle. Phosphatidylinositol 4-
kinase Alpha (PI4KA), which is a highly characterised host factor critical for HCV 
replication was selected as it was one of fifteen novel host factors which had overlap 
between two siRNA genome-wide knockdown screen with HCV, where one screen 
used the HCV-SGR JFH-1 strain which we intend to use (Tai et al. 2009; Li et al. 2009). 
Thus, it was useful to determine whether there could be any overlap in results between 
genome-wide screens with either siRNA or CRISPR technology.  
As described previously, two single guide RNA (sgRNA), each 20 nucleotides long 
targeting PI4KA were designed using Benchling and generated with BsmBI overhangs 
as complementary primers (see Appendix 1). Following ligation and transformation of 
the anneal oligonucleotides into the BsmBI digested LentiCRISPRv2 plasmid, colonies 
were diagnostically digested with BsmBI to detect colonies which contain successful 
integration of the sgRNA targeting PI4KA (LCv2-PI4KA). Lentivirus was generated 
with LCv2-PI4KA and Huh7.5 were transduced with lentivirus, monoclonal populations 
isolated using cloning rings and selected colonies expanded. Unfortunately, using this 
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Figure 3.8: Knockout of CD81 results in complete perturbation of HCV entry into 
Huh7.5 cells via immunofluorescence microscopy. 
To determine whether loss of CD81 via LentiCRISPRv2 activity would result in a loss 
of HCV entry and therefore replication, LentiCRISPRv2 wildtype control (LCv2-WT), 
LCv2-CD81.1 and LCv2-CD81.2 were infected with HCV-JC1-GFP infectious virus 
(MOI=2). Cells were stained with mouse anti-NS5A and Alexa Fluor 555-conjugated 
goat anti-mouse IgG secondary Ab. Post DAPI staining, cells were visualised using a 










Figure 3.9: Knockout of CD81 results in complete perturbation of HCV 
replication into Huh7.5 cells via qRT-PCR. 
To determine whether loss of CD81 by LentiCRISPRv2 would result in a loss of HCV 
entry and therefore replication, LentiCRISPRv2 wildtype control (LCv2-WT), LCv2-
CD81.1 and LCv2-CD81.2 were infected with HCV-JC1-GFP infectious virus (MOI=2). 
RNA was extracted from infected cells and cDNA synthesised. qRT-PCR was 
performed with primers targeting the house-keeping gene RPLPO (36B4) and HCV 












experimental approach, a high number of monoclonal cell lines that survived 
puromycin selection, perished during the expansion process, suggesting that PI4KA 
is critical for cell survival. Western blotting to ascertain PI4KA expression levels in the 
surviving puromycin resistant cell lines were unsuccessful.  
However, one colony survived the expansion process and was tested for HCV-JC1 
GFP permissibility with a MOI of approximately two. 24 hours post infection, 
immunofluorescence was performed and unfortunately, this line was found to be 
positive for NS5A staining, indicating that this colony remained permissive to HCV 
replication (Fig. 3.10). Since PI4KA expression is critical for active HCV replication, 
positive staining for NS5A implies that this one colony retained expression of the 
former and thus not pursued further.  
The inability of CRISPR/Cas9 to knockout PI4KA illustrates a limitation of our CRISPR 
genome-wide screen approach, as essential genes for cell function will not be 
represented. On the contrary, these host factors where reduced expression can still 
support HCV replication would be missed in a siRNA-based screen but will be detected 
in our CRISPR knockout screen. PI4KA is important in the IP3/DAG pathway and is 
responsible for the production of phosphatidylinositol 4-phosphate (PtdIns(4)P), an 
intermediate to phosphatidylinositol 4,5-bisphophate (PtdIns(4,5)P2), and one of the 
most critical regulatory lipids in the plasma membrane (D'Angelo et al. 2008). 
Furthermore, addition of inhibitors of PI4KA in mice results in sudden death, likely due 
to cardiovascular insufficiency (Bojjireddy et al. 2014). In addition, Cre-KO mice for 
PI4KA exhibited moribund properties where histopathology after 7 days showed 
severe epithelial cell degeneration and/or necrosis, indicating that PI4KA is an 
essential gene and that siRNA knockdown of PI4KA results in sufficient protein 
expression levels to fulfil its housekeeping functions (Bojjireddy et al. 2014). 
3.3  Generation of HCV replicon reporter cell lines 
In any genome-wide CRISPR screen, it is critical that the factors that determine 
selection are robust and reproducible. Replication of HCV in culture can result in a 
moderate cytopathic effect, however, HCV in general is considered to be non-
cytopathic relative to other members of the flaviviridae family, and as such, the use of 
a survival screen following knockout of an essential host factor is not applicable to 
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Figure 3.10: Incomplete knockout of PI4KA results in HCV replication in Huh7.5 
cells via immunofluorescence microscopy. 
To determine whether incomplete knockout of PI4KA via LentiCRISPRv2 activity 
would result in establishment of HCV replication, LentiCRISPRv2 wildtype control 
(LCv2-WT), and LCv2-PI4KA were infected with HCV-JC1-GFP infectious virus 
(MOI=2). Cells were stained with mouse anti-NS5A and Alexa Fluor 555-conjugated 
goat anti-mouse IgG secondary Ab. Post DAPI staining, cells were visualised using a 














HCV. Therefore, it was necessary to develop a suitable screening system in which 
knockout of host genes that affect HCV replication could be identified and 
characterised. To achieve this aim, we decided to use the HCV sub-genomic replicon 
(HCV-SGR) (see section 1.8). This sub-genomic replicon consists of a modified HCV 
genome that includes essential parts of the viral replication machinery, including the 
HCV 5’ and 3’ UTRs and the non-structural proteins NS3-NS5B (Fig. 3.11) (Zhou et 
al. 2011). A Blasticidin resistance gene (BSD) is encoded immediately downstream of 
the HCV IRES to allow for selection of cells with high levels of HCV replication (Fig. 
3.11). A 2A-cleavage site from VP-1 foot and mouth disease virus is located between 
the BSD-HCV polyprotein to retain coding integrity of the HCV polyprotein. Due to the 
loss of the structural HCV proteins required for virus progeny production, this tool 
allows for the identification of host factors critical for virus replication stage of the 
lifecycle. High levels of HCV replication due to BSD allows for selection of a 
homogeneous pool across the entire cell population, which should result in improved 
consistency during screening compared to the infectious based system.  
While this HCV-SGR setup is useful for replication studies, the lack of a suitable 
marker of viral clearance following knockout of an essential host factor makes the 
system inefficient for genome-wide screening studies. Thus, to identify cells which 
have lost HCV replication and facilitate subsequent extraction of enrichment of 
sgRNAs, reporter cell lines were generated. To achieve this, we inserted a reporter 
protein located immediately downstream of BSD, resulting in a BSD-reporter fusion 
protein (Fig. 3.11). Current HCV-SGR plasmid constructs within the laboratory 
consisted of a BSD-renilla luciferase fusion protein, however, this is not practical for 
CRISPR genome-wide screening since expression of renilla luciferase will not allow 
for selection of cells which are negative for HCV replication. To overcome this obstacle, 
renilla luciferase was removed and a more appropriate reporter protein inserted in its 
place. Reporter proteins chosen included the fluorescent proteins, GFP or mCherry 
and the negative selection marker thymidine kinase. Utilising fluorescence proteins 
will allow for direct visualisation of HCV replication during the entire screening process 
and will enable separation of cells with loss of HCV replication using flow cytometry. 
Our second approach involved the utilisation of the thymidine kinase negative 
selection marker, which will enable selection of cells which have lost HCV replication 
through their ability to survive ganciclovir (GCV) treatment, as thymidine kinase 
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Figure 3.11: Schematic of the parental pSGRm-JFH1-Bla and generated reporter 
systems. 
To develop the required reporter systems in order to commence the genome-wide 
CRISPR screen with HCV, (A) renilla luciferase was removed from parental pSGRm-
JFH1-Bla and (B) mCherry, (C) GFP or (D) thymidine kinase inserted in its place. A is 
the HCV IRES, BSD is the Blasticidin resistance gene fused to the renilla luciferase 
(Rluc), mCherry (mC), GFP or thymidine kinase (TK). Downstream of the fusion 
protein is a 2A auto-cleavage site (2A) and ubiquitin (Ub) to allow for separation from 









phosphorylates GCV into a potent DNA synthesis inhibitor, killing expressing cells 
(Tomicic et al. 2002). Utilising both approaches will enable comparison between 
enriched novel host factors and allow for the elimination of false positives. 
To generate the three desired constructs for potential use in our CRISPR genome-
wide screen, the renilla luciferase gene from parental pHCV-SGR-RL (pSGRm-JFH1-
BlaRL) was removed via MluI and BglII restriction enzyme digestion (Zhou et al. 2011). 
Amplification of mCherry, GFP or thymidine kinase was achieved via PCR with primers 
containing the MluI/BglII restriction enzymes sites (see Appendix I) and subsequently 
digested with the former restriction enzymes. PCR fragments were ligated into 
MluI/BglII digested parental pHCV-SGR-RL plasmid and transformation yielded HCV-
SGR recombinant plasmids containing either mCherry (pHCV-SGR-MC), GFP (pHCV-
SGR-GFP) or thymidine kinase (pHCV-SGR-TK). Recombinant plasmids were 
digested with MluI and BglII to release the corresponding bands sizes (mCherry= 
~700bp, GFP=~700bp, Thymidine kinase=~1.2kb), confirming generation of HCV-
SGR with the three reporter plasmids (Fig. 3.12). All three reporter plasmids were 
sequenced (see section 2.1.10) and confirmed no mutations were present and in 
frame insertion of the reporter proteins.  
To generate HCV RNA which can be transfected into Huh7.5 cells to allow for initiation 
of HCV replication, all three reporter constructs were digested with PmeI overnight to 
linearise the plasmid template for in vitro T7 polymerase HCV RNA transcription. 
Following RNA transcription and assessment of RNA integrity by gel electrophoresis, 
HCV RNA was transfected into Huh7.5 cells with DMRIE-C. Cells were serial diluted 
onto 100mm dishes and individual colonies formed following selection with BSD. 
Individual colonies were isolated using cloning rings and expanded to produce 
monoclonal HCV replicon cell lines containing either mCherry, GFP or thymidine 
kinase expression. Only monoclonal Huh7.5 cells that contained high levels of 
mCherry or GFP expression and were also positive for NS5A staining were 
perpetuated for use in the screen (Fig. 3.13). In contrast, monoclonal Huh7.5 cells 
harbouring HCV genomes containing thymidine kinase were selected only if cells 
showed high levels of NS5A staining based on fluorescence intensity and cell death 
was observed within approximately five days post addition of GCV. Illustration of HCV 
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Figure 3.12: mCherry, GFP or thymidine kinase was successfully cloned into 
pSGRm-JFH1-Bla. 
To confirm that mCherry, GFP or thymidine kinase was inserted into pSGRm-JFH1-
Bla, plasmid DNA was extracted from transformant clones and digested with MluI and 
BglII. Lane M, 1kb DNA ladder, lane 1, parental pSGRm-JFH1-BlaRL, lane 2, pSGRm-
JFH1-Bla with mCherry, lane 3, pSGRm-JFH1-Bla with GFP and lane 4, pSGRm-









Figure 3.13: All pSGRm-JFH1-BSD reporter lines express their reporter genes 
and are competent for HCV replication. 
(A) To determine if monoclonal pSGR-HCV reporter cell lines were functional, 
endogenous mCherry or GFP was observed using a Nikon TiE inverted fluorescence 
microscope. Scale bars are 200µm. (B) Cells were also stained with mouse anti-NS5A 
and Alexa Fluor 488-conjugated goat anti-mouse IgG secondary Ab (pSGR-HCV-MC) 
or Alexa Fluor 555-conjugated goat anti-mouse IgG secondary Ab (pSGR-HCV-GFP 
and pSGR-HCV-TK). Scale bars are 100µm. (C) 50µm of GCV was added to the 
pSGR-HCV-TK and pSGR-HCV-MC reporter cell line as well as DMSO vehicle control 
was added to determine if the thymidine kinase was functional. Five days post 
infection, cells were stained with DAPI and imaged using a Nikon TiE inverted 
fluorescence microscope. Note the significant cell death in pSGR-HCV-TK cells in the 







replicon harbouring cells with fully functional inserts in all three constructs 
demonstrates that these constructs harbour HCV replication. These cell lines now 
provide a tool for use in our genome-wide CRISPR screen. 
3.4  Validation of LentiCRISPRv2 GeCKO plasmid library 
The Zhang Lab located within the Broad Institute at the Massachusetts Institute of 
Technology (MIT) provided the LentiCRISPRv2 plasmid library via Addgene (cat. 
#1000000048 and cat. #1000000049) to enable CRISPR based genome-wide 
screening. This library consists of two libraries that when combined have a total 
number of 122,411 sgRNAs which target 19,050 genes representing the complete 
human genome (Sanjana et al. 2014). 65,383 sgRNAs are present in library A and 
58,028 sgRNAs are present in library B, all of which have the same LentiCRISPRv2 
plasmid backbone used in the proof-of-concept experiments above (see Appendix 1). 
The ratio between sgRNA and targeted gene is 6:1, split evenly between the two 
libraries. The library also contains sgRNAs which target 1864 miRNAs and 1000 non-
targeting sgRNAs, the latter of which functions as controls.  
To generate a sufficient quantity of lentiviruses to enable full representation of the 
library during transduction, an appropriate stock of plasmid must be generated before 
screening can proceed. It is critical that during the expansion process that none of the 
~120,000 sgRNAs are lost potentially jeopardising the integrity of the library. To 
generate additional stock of the LentiCRISPRv2 plasmid library, each library was 
electroporated into Endura competent cells. These have the highest efficiency among 
commercially available cells for lentiviral based constructs and were recommended by 
the Zhang Lab for transformation of the libraries. A total of 4 electroporations were 
completed per library, which were then pooled and spread onto pre-warmed agar 
containing ampicillin petri dishes. All petri dishes were grown at 32oC for 14 hours to 
decrease plasmid recombination and a confluent lawn of bacteria developed, 
indicating successful transformation of the LentiCRISPRv2 library. To ascertain 
whether transformation efficiency was sufficient to enable complete representation of 
the libraries, a 40,000 dilution of the transformation was plated on a separate petri dish 
and counted to determine if the total number of colonies exceeded 3x106. 
Approximately 415 colonies were present on the 40,000-dilution plate for library A and 
241 colonies in library B, giving an estimated total colony count of 1.6x107 and 9.6x106 
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Figure 3.14: Efficient transformation allows for complete representation of the 
LentiCRISPRv2 libraries.  
To gauge the transformation efficiency during the amplification process of the 
LentiCRISPRv2 library, a 40,000 dilution of the bacterial transformation of each half 
library was spread onto ampicillin agar plates and colonies counted the following day. 














for library A and B respectively and therefore sufficient transformation of the 
LentiCRISPRv2 library to retain representation of all the sgRNAs (Fig. 3.14). A 
sufficient number of colonies present indicated that no sgRNAs were lost in the 
transformation process, where it is assumed that one bacterial colony observed on an 
agar plate contains a sgRNA targeting a single gene. The colonies were subsequently 
harvested directly to isolate the LentiCRISPRv2 library plasmid through maxi-
preparation (see section 2.1.4).  
Lentivirus harbouring representation of the LentiCRISPRv2 library was generated via 
transfection of 293T cells with plasmid and lipofectamine 2000 as per section 2.3.9. A 
critical aspect of the CRISPR-mediated screening process is to use a low MOI during 
transduction to ensure only one gene knockout per cell and therefore, it is critical to 
determine the titre of the lentivirus produced. The Zhang Lab recommended an indirect 
method to determine the lentiviral supernatant titre by calculation of transduction 
efficiency via exploitation of the puromycin resistance gene (Joung et al. 2017). 
Huh7.5 cells in a 12 well plate was transduced with increasing volumes of virus (in the 
ranges of 5-500µl) and supplemented with cell media. 5 hours post transduction, 
media was replaced, and cells left to incubate overnight. Cells were trypsinised, split 
across 2 wells of a 6 well plate and seeded into separate wells. Five days post 
transduction, cells were treated with puromycin, to not only remove un-transduced 
cells but also to simulate conditions during the genome-wide CRISPR screening 
process. After three days or after the mock-transduced control with puromycin were 





The volume of lentiviruses added which yielded a transduction percentage closest to 
30% was selected and scaled accordingly during the genome-wide CRISPR screening 
process, with the assumption that a 30% transduction percentage correlates with one 
lentivirus transduction and subsequently one targeted gene knockout per cell.  
It is essential that all sgRNAs are present within the LentiCRISPRv2 library to ensure 
broad coverage knockout across the genome. Loss of any sgRNAs may result in 
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overlooking a subset of genes that could be important, compromising the integrity of 
the genome-wide screening process. Thus, to ensure that the LentiCRISPRv2 plasmid 
library has complete representation, the sgRNA sequences were PCR amplified and 
analysed by next generation sequencing.  
The GeCKO LentiCRISPRv2 plasmid library was first PCR amplified using Q5 
polymerase and custom primers generated by the Zhang Lab (see Appendix 1) as per 
section 2.1.12. The first PCR is required for the amplification of the area of interest 
(sgRNA) and to generate the necessary binding sites for subsequent primers to bind 
to in the second PCR stage. A band size of ~300bp which includes the sgRNA region 
was observed during the first step PCR stage, as expected (Fig. 3.15 and 3.16). 
Following gel extraction, the second PCR stage was performed utilising a mixture of 
custom forward and reverse primers generated by the Zhang Lab (see Appendix 1), 
which contain the necessary Illumina adaptors and barcode sequences to be 
compatible with the Illumina Miseq system. A band size of ~350bp was visible and gel 
extracted (Fig. 3.15 and 3.16). Following the second round of PCR amplification, the 
samples were sequences at the David Gunn Genomics Facility (SAHMRI) using the 
MiSeq system. The MiSeq paired end 150 cycles reagent kit was used to allow for the 
sequencing of 80bp from the 5’ end of the PCR product where the sgRNA sequence 
is located (Fig. 3.15). Cycling conditions include 80 cycles of read one (forward) and 
eight cycles of index one. 5% of PhiX was also spiked with the sgRNA-PCR products 
to improve library diversity, as the 5’ end of each PCR fragment to be sequenced are 
almost identical. The adaptors were trimmed post sequencing in silico and barcodes 
used to group sequences based on their origin (library A or B).  
Analysis by our collaborator, Dr. Auda Eltahla at the Kirby Institute, UNSW revealed 
10 million of the total 20 million reads aligned to the reference library provided by the 
Zhang Lab. One million of the 20 million reads aligned to the PhiX control library with 
the remainder (nine million) consisting of poor reads. Approximately half of the 10 
million reads aligned to each half library (library A or B). 62,558 out of 65,383 or 96% 
of sgRNAs were present in library A and 51,620 out of 53,627 or 96% of sgRNAs were 
present in library B. Although the loss of 4859 sgRNAs was initially concerning, design 
of the GeCKO LentiCRISPRv2 library consists of six sgRNAs per gene, where on 
average approximately 4000 out of 18,080 genes would have five sgRNAs instead of 
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Figure 3.15 Schematic of two-step PCR performed to enable guide sequences 
to be sequenced by NGS 
GeCKO LentiCRISPRv2 plasmid library or genomic DNA harvested from cells after 
genome-wide CRISPR screening will be amplified twice by PCR to enable sequencing 
by NGS. The primers for the 1st PCR bind to the priming site either side of the 20nt 
guide sequence to allow for enrichment of this region to perform the 2nd PCR. The 
primers for the 2nd PCR bind to the priming site of the PCR product from the 1st PCR 
and introduces the required components to enable compatibility of the PCR product 
for NGS (Illumina P5 and P7 adapters and sequencing sites) as well as barcodes to 












Figure 3.16: Successful PCR amplification of the sgRNA region of interest to 
enable compatibility with next-generation sequencing. 
To determine if all the sgRNAs are present in the GeCKO LentiCRISPRv2 library, a 
two-step PCR amplification process was followed, where the first amplifies the region 
of interest and the second includes the addition of Illumina adaptors to enable 
compatibility for MiSeq next-generation sequencing. Both reactions were performed 
with NEB Q5 polymerase, where a sample was run on an agarose gel to verify that 
both the first (A) and second (B) PCR amplification steps were successful. (A) Lane 
M1, 2-log DNA ladder. Lane A, B and WT, first amplification step with LentiCRISPRv2 
library A, B or WT plasmid respectively. (B) Lane M2, 100bp ladder, all lanes present 
after lane M2 are combinations of primer utilised in the second amplification step i.e. 








six, and thus it is highly unlikely that all six sgRNAs for one gene were lost out of the 
4859 sgRNAs not present. This coupled with the knockout efficiency of CRISPR/Cas9, 
led us to conclude that 96% of the intact GeCKO lentiCRISPRv2 library was sufficient 
to commence genome-wide screening. 
3.5  Optimisation of LentiCRISPRv2 library screening conditions with HCV 
replicon systems 
Monoclonal populations of the HCV-SGR reporter cell lines containing either mCherry, 
GFP or thymidine kinase were successfully generated and ready to be used for 
genome-wide screening as per section 3.2. In addition, each LentiCRISPRv2 half 
library was successfully verified to contain 96% of sgRNAs and lentivirus generated to 
necessary concentrations to allow for transduction of the required cell quantity to 
enable complete representation of the library as per section 3.6. Thus, it was now 
possible to begin the CRISPR genome-wide knockout screen with the HCV SGR 
reporter cell lines.  
3.5.1  Genome-wide screening using HCV-SGR-MC/GFP cell lines 
Our strategy to perform the genome-wide CRISPR screen using the Huh7.5 cells 
harbouring HCV-SGR-MC or -GFP involves transduction with the LentiCRISPRv2 
library, where half of the cells will be transduced with library A or library B respectively 
at a MOI of approximately 0.3 to allow for one transduction event per cell and therefore 
one knockout per cell. Five days post transduction, puromycin will be added to select 
for cells which had successfully undergone lentivirus integration of the sgRNA 
cassette and Cas9 complex and the puromycin resistance gene. Cells surviving 
puromycin treatment represent cells which, (A) retain fluorescence (i.e. either MC or 
GFP) is indicative of active HCV replication, where knockout of a gene within these 
cells is not required for virus replication or (B), cells which have lost fluorescence 
activity represent cells in which knockout of a potential proviral host factor has 
occurred resulting in a loss of HCV replication. Genomic DNA will be harvested from 
both cellular populations displaying either mCherry and GFP positive and negative 
fluorescence and the two stage PCR and next generation sequencing performed as 
per section 3.6. This screening method is summarised in figure 3.17. 
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Figure 3.17: Screening process for the identification of novel host factors for 
HCV replication with HCV-SGR-MC/GFP. 
The GeCKO LentiCRISPR library in a lentivirus pool infects HCV replicon positive cells 
expressing either GFP (or mCherry - not illustrated). If a host factor single knockout is 
important for HCV replication (illustrated as a blue or green virus), fluorescence 
expression will be lost as a result (illustrated as a grey cell). Cells can be sorted based 
on flow cytometry to sort fluorescence positive and negative cells and next generation 







Although the HCV-SGR-MC and HCV-SGR-GFP reporter cell lines were resistant to 
BSD, a high proportion of cells were negative for either MC or GFP fluorescence 
activity, which would ultimately impact the genome-wide screening process. This 
mixed cell population is intriguing as BSD resistance suggests active HCV replication 
in all cells. The reason for this mixed population is not immediately apparent. One 
plausible explanation is the reliance of active virus replication on the HCV IRES, which 
controls the expression of both the HCV non-structural proteins and the BSD-reporter 
protein (either MC, GFP or thymidine kinase). The HCV IRES has been shown to be 
enhanced during the mitotic phase (G2/M) and relatively inactive during the early S 
phase of the cell cycle (Honda et al. 2000). This could explain our observation of 
fluctuating expression levels of our reporter protein of interest. Alternatively, selected 
cells may have inherent differences in HCV replication efficiency and therefore 
differences in reporter gene expression. Therefore to address the latter, we proceeded 
to enrich the cells with maximal fluorescence activity using flow cytometry. Following 
FACS, HCV-SGR-MC cells with the highest expression of mCherry were pooled into 
a separate flask and grown to reach suitable cell density levels for genome-wide 
screening. Initially, all pooled HCV-SGR-MC cells contained a high level of mCherry 
expression, however, after three passages the expression of mCherry reverted to 
levels prior to flow cytometry (Fig. 3.18). Reversion of fluctuating mCherry levels within 
the cell population post-sort may suggest that upon multiple passages, the SGR 
system may have removed the mCherry reporter protein whilst retaining BSD 
resistance, likely due to decreased fitness of virus replication as the mCherry reporter 
contributes no significant advantage to HCV replication. Although this observation was 
of concern, we proceeded to modify the screening process where multiple rounds of 
flow cytometry were performed to ensure only cells with a complete loss of mCherry 
were selected for the next step of extraction of gDNA and next-generation sequencing. 
Although feasible, this approach was deemed not viable due to time constraints and 
the exposure of the flow sorting facility to high numbers of HCV positive (albeit non-
infectious SGR) cells. 
3.5.2  Genome-wide screening using HCV-SGR-TK cell line 
Given the issues faced above, we next moved to using the genome-wide CRISPR 
screen utilising the TK cell survival model. 3x108 of Huh7.5 cells containing HCV-SGR- 
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Figure 3.18: Attempted enrichment of mCherry positive HCV-SGR-MC cells 
through flow cytometry. 
Huh7.5 cells with HCV-SGR-MC with high levels of HCV replication were selected 
utilising flow cytometry, gating for cells with the highest levels of mCherry 
fluorescence. To determine if enrichment of mCherry cells were successful, cells were 
imaged either one day prior (A), the day post sorting (B) and three days post sorting 
(C) via flow cytometry utilising a a Nikon TiE inverted fluorescence microscope. Scale 











Figure 3.19: Screening process for the identification of novel host factors for 
HCV replication with HCV-SGR-TK.  
The GeCKO LentiCRISPR library in a lentivirus pool infects HCV replicon positive cells 
expressing thymidine kinase. If a host factor single knockout is important for HCV 
replication (illustrated as a blue or green virus), thymidine kinase expression and HCV 
replication will be lost as a result (illustrated as a grey cell). Addition of Ganciclovir in 
the presence of thymidine kinase will ultimately result in a toxic analogue that 
integrates into DNA, where cells which have lost HCV replication will survive. Next 






TK were transduced with the LentiCRISPRv2 library, where each half of the cells were 
transduced with library A or library B respectively at a MOI of approximately 0.3 to 
allow for one transduction event per cell and therefore one knockout per cell. Five days 
post transduction, 3µg/ml of puromycin was added to select for cells that had 
successfully undergone lentivirus integration and were expressing both the 
sgRNA/Cas9 complex and the puromycin resistance gene. Following complete cell 
death of the mock transduced control cells, 50µm of ganciclovir (GCV) was added so 
cells that retained HCV replication and thus thymidine kinase expression, would 
phosphorylate the GCV to a toxic metabolite, resulting in cell death. Therefore, cells 
that have lost HCV replication due to knockout of a host factor will be resistant to GCV 
induced cell death. A small percentage of cells were expected to survive due to the 
assumption that a vast majority of genes would not be important for HCV replication. 
Following complete cell death by GCV in the mock lentivirus transduced control cells, 
genomic DNA would then be harvested from the surviving GCV resistant cells and the 
two stage PCR and next generation sequencing performed as per section 3.6. 
Genomic DNA would also be harvested from cells that had been successfully 
transduced with the LentiCRISPRv2 library prior to treatment with GCV, as a reference 
to ensure that there was good representation of all sgRNAs prior to cell selection. This 
screening process is illustrated in figure 3.19. 
Following the addition of puromycin to 3x108 HCV-SGR-TK cells that had been 
transduced with the LentiCRISPRv2 library, one third of the cells died as expected, 
due to unsuccessful integration of the lentivirus. 50µm of GCV was added to the 
puromycin resistant cells for one week to enrich for cells which have lost thymidine 
kinase expression and subsequently HCV replication as a result of the knockout of a 
key proviral host factor. Unfortunately, after one week of incubation of cells with GCV, 
cell death was not of the magnitude expected, based on the assumption that most 
genes within the genome are not important for HCV replication. Further incubation with 
an increased concentration of GCV (100µm) also yielded minimal cell death, indicating 
the entire cell population was resistant to GCV induced cell death and suggests the 
majority of cells had lost HCV replication. GCV was biologically active as the un-
transduced HCV-SGR-TK cells remained susceptible to GCV induced cell death 
(100%), indicating production of thymidine kinase catalysed production of toxic 
metabolites. 
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Given that the HCV-SGR-TK GeCKO LentiCRISPRv2 library transduced cells were 
resistant to GCV treatment, it was imperative to determine the status of cellular 
population with regards to both active HCV replication and expression of the thymidine 
kinase gene. Cells transduced with GeCKO LentiCRISPRv2 library (A+B) resistant to 
GCV displayed significantly reduced levels of NS5A staining via immunofluorescence 
microscopy, indicating that the majority of cells contained no active HCV replication 
compared to the parental HCV-SGR-TK cell line (Fig. 3.20A). For the surviving 
population to be resistant to GCV induced cell death, thymidine kinase must be absent 
to enable the cells to survive. Since we had no access to an antibody to detect the 
HSV thymidine kinase, total RNA was harvested as an indirect measure to determine 
thymidine RNA levels. RNA was extracted from the GCV resistant cell population as 
per section 2.1.10. RNA extraction was also performed on HCV-SGR-TK cells prior to 
lentivirus transduction as positive controls. cDNA was synthesised with the HCV 5970 
reverse primer used for cloning the HCV JFH strain to enable conversion of the HCV 
SGR RNA into cDNA (see Appendix 1 and as per section 2.1.13) (Wakita 2009). PCR 
amplification with primers that bind to thymidine kinase was performed to determine if 
surviving cells still retained the capability to express thymidine kinase (see Appendix 
1). A band with an approximate size of 1kb was observed for the plasmid positive 
control, indicating that PCR amplification of thymidine kinase was successful (Fig. 
3.20B). A similar band was also evident for the HCV-SGR-TK positive control sample, 
demonstrating that HCV SGR specific cDNA was produced from RNA within the cells 
and the cells were capable of expressing thymidine kinase. However, no band was 
present for both GCV resistant HCV-SGR-TK transduced with either library, indicating 
that the entire cell population had lost the ability to express thymidine kinase and was 
thus resistant to GCV induced cell death. 
A potential source of the loss of thymidine kinase and the entire HCV-SGR RNA could 
be caused by lentiviral transduction of the LentiCRISPRv2 library during the screening 
process. All genome-wide CRISPR screens with viruses from the flaviviridae family 
performed to date have used infectious virus, where infection occurs after transduction 
of the genome-wide CRISPR library. Our system also relies on the removal of BSD 
prior to the transduction of the GeCKO lentiCRISPRv2 library as knockout of a proviral 
host factor (and consequently HCV replication) will also render the cell susceptible to 
BSD. Therefore, there may be a possibility where introduction of the LentiCRISPRv2 
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Figure 3.20: HCV-SGR-TK cells transduced with LentiCRISPRv2 library which 
have survived GCV treatment are both HCV replication and thymidine kinase 
deficient. 
To ascertain whether HCV-SGR-TK cells which survive GCV treatment post 
LentiCRISPRv2 transduction contain active HCV replication, immunofluorescence 
microscopy was employed to determine presence of NS5A protein within the cell 
population. (A) Cells were stained with mouse anti-NS5A and Alexa Fluor 555-
conjugated goat anti-mouse IgG secondary Ab. Post DAPI staining, cells were 
visualised using a Nikon TiE inverted fluorescence microscope. Scale bars are 100µm. 
(B) To determine if thymidine kinase was present and therefore resistant to GCV 
induced cell death, RNA was extracted and cDNA synthesised from HCV-SGR-TK 
cells transduced with either library A (lane 1) or B (lane 2). RNA from parental HCV-
SGR-TK cells (lane 3) were also extracted in addition to HCV-SGR-TK plasmid (lane 
4) as controls. Thymidine kinase was amplified with Q5 polymerase and run on a 1% 






library after the establishment of HCV replication may directly or indirectly interfere 
with the former due to the loss of selection pressure by the removal of BSD within the 
culture media. To test this theory, where the addition of lentivirus may interfere with 
HCV replication, lentiviruses encoding mCherry were transduced into cells expressing 
either HCV-SGR-TK or parental HCV-SGR and NS5A visualised 
(Immunofluorescence) to determine the levels of both HCV replication and lentivirus 
transduction expression via flow cytometry. To mimic our genome-wide screening 
process, cells were fixed five (prior to addition of puromycin) and 20 days post 
transduction (expected end point of screen). Five days post transduction, 
approximately 70% of cells were positive for NS5A for the parental HCV-SGR and 
slightly lower for the HCV-SGR-TK (top left and right quadrants). 50% of cells were 
also positive for mCherry expression, indicating successful lentivirus transduction 
(bottom right quadrant) (Fig. 3.21A). However, 20 days post transduction, which is the 
expected end point of the screening process, 95% of the population for both HCV-
SGR and HCV-SGR-TK were negative for NS5A staining (bottom left and right 
quadrants), while the remaining were positive for mCherry expression (top left and 
right quadrants). Since mCherry expression was expected to not have an effect on 
HCV replication, it is likely that lentivirus transduction indirectly resulted in the ejection 
of the HCV-SGR RNA and subsequent loss NS5A expression, due to the loss of BSD 
selection pressure prior to commencement of genome-wide screening (illustrated in 
Fig. 3.22). Unfortunately, these results indicate the HCV-SGR-TK system is not 
suitable for genome-wide screening and was thus not pursued further.  
3.6  Discussion 
Although direct acting antivirals are the main treatment for chronic hepatitis C, HCV 
infection still remains a major health issue worldwide, primarily through the lack of an 
effective vaccine. Secondary factors include the high cost and availability of HCV 
antivirals within developing countries. Thus, further understanding of the HCV lifecycle 
is critical to enable development of cost-effective antivirals and efficacious vaccines. 
Viruses including HCV have a limited coding capacity and thus exploit host proteins to 
fully support the entire lifecycle from entry to egress. Through the use of both RNAi 
and CRISPR technology, host factors have been identified and characterised for HCV 
replication. For example, PI4KA, which is a critical host factor for the construction of 
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Figure 3.21: Transduction of lentiviruses with a loss of Blasticidin selection 
results in the reduction of HCV replication.    
To visualise the effect of transduction of the LentiCRISPRv2 library on HCV replication 
in HCV-SGR-TK cells, lentiviruses encoding mCherry were transduced into HCV-
SGR-TK and grown without BSD 5 (A) or 20 (B) days prior to flow cytometry. Cells 
were stained with mouse anti-NS5A and Alexa Fluor 488-conjugated goat anti-mouse 









Figure 3.22: Projected outcomes when utilising the HCV-SGR-TK system for 
genome-wide CRISPR screening. 
When Huh7.5-HCV-SGR-TK cells are cultured with no BSD throughout the genome-
wide screening process, cells which retain HCV replication undergo Ganciclovir (GCV) 
induced cell death due to thymidine kinase expression. However, the majority of the 
cellular population which survive GCV treatment have lost HCV replication due to the 
combination of lentivirus transduction of the library with the loss of selection pressure 
from BSD. In contrast, when Huh7.5-HCV-SGR-TK cells are cultured with BSD 
throughout the genome-wide screening process, cell death is observed in both HCV 
positive and negative populations as loss of the HCV SGR results in loss of BSD 







the replication complex through the recruitment of both host (OSBP, hVAP-A and 
CypA) and viral proteins (NS5A) towards the ER membrane (see section 1.9) 
(Chukkapalli and Randall 2014). Exploitation of host-viral interactions has resulted in 
the identification of inhibitors which target host factors such as OSBP and CypA, 
leading to a reduction of HCV replication (see section 1.9). However, additional host 
factors for the HCV lifecycle remain to be characterised and utilisation of CRISPR 
technology to screen at the genome level will allow for the identification of novel HCV 
proviral host factors.  
There are two main aspects to consider when designing a genome-wide CRISPR 
screen to identify novel proviral host factors, (i) the selection of a genome-wide 
CRISPR library with the appropriate Cas9/dCas9 and (ii) the phenotypic output of the 
screen (Albulescu et al. 2017). A number of lentiviral based CRISPR knockout libraries 
were available to screen for novel host factors using the SGR system at the 
commencement of this project. These were readily available for purchase via Addgene 
and include, (i) the GeCKO LentiCRISPRv2 library (Shalem et al. 2014), (ii) the human 
activity-optimised CRISPR knockout library (Wang et al. 2015) and (iii) the human 
genome-wide library v1 (Ma et al. 2015). The most popular library at the time was the 
GeCKO LentiCRISPRv2 library, with a number of publications from broad research 
fields successfully utilising this system (Virreira Winter et al. 2016; Sun et al. 2018; 
Han et al. 2019; Wheeler et al. 2019; Du et al. 2020). In addition, protocols for 
screening and troubleshooting with lentiviral CRISPR libraries were not established, 
unlike today, and thus it was important to choose a library that had dedicated support. 
The Zhang lab who constructed the GeCKO LentiCRISPRv2 library provides a Google 
support forum webpage and was the system of choice. The one-plasmid system 
(LentiCRISPRv2) was selected over the two-plasmid system (LentiGuide) due to the 
need of stably integrated expression of Cas9 within the Huh7.5 cells harbouring HCV 
SGR prior to transduction of the sgRNA for the latter and may impact HCV replication. 
In addition, selection of Cas9 stable cells relies on BSD, which is also present within 
the HCV SGR system. Thus, the one-plasmid GeCKO LentiCRISPRv2 library was 
chosen to be used in conjunction with the SGR system for genome-wide CRISPR 
screening of HCV novel host factors.  
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After selection of the GeCKO LentiCRISPRv2 library and commencement of our 
genome-wide screening, lentiviral based CRISPR libraries developed by other 
laboratories were released onto the Addgene market. Refinement of sgRNA 
computational design rules also resulted in maximised activity of Cas9 at target sites 
with minimisation of off-target cleavage, further improving on library performance 
during screening (Doench et al. 2016; Ong et al. 2018). Thus, CRISPR knockout 
libraries developed after GeCKO LentiCRISPRv2 incorporate the improved sgRNA 
design rules like the Brunello LentiCRISPRv2 library that has fewer sgRNAs (77,441 
total sgRNAs compared to 122,471 total sgRNAs in GeCKO) targeting each gene but 
outperforms the GeCKO LentiCRISPRv2 library in both on-target activity and 
generation of frame shift mutations (Doench et al. 2016; Sanson et al. 2018). Repeat 
of a genome-wide CRISPR screen with HCV would likely use one of the newer libraries 
described above due to improved performance over our current library in combination 
with fewer resources required to retain full complexity of the library due to the reduction 
in total sgRNAs present.  
In addition to the traditional CRISPR knockout libraries described above, the mutation 
of the catalytically active RuvC and HNH nuclease domains of Cas9 (dCas9) creates 
a RNA-guided DNA binding protein that when coupled with the addition of numerous 
activation or repression domains has ushered in a new group of CRISPR libraries for 
molecular research, namely CRISPR activation (CRISPRa) and CRISPR interference 
(CRISPRi) (Fig. 3.23). As an example, introduction of a dCas9-KRAB fusion protein 
with sgRNAs to target transcription start sites (TSS) of a target gene results in reduced 
expression of a target gene. In contrast, the addition of gene transcription activator 
domains to dCas9 such as VP64 have isolated numerous interferon stimulated genes 
critical in controlling virus infection (IFI6, TRIM25) and the glycotransferase 
B4GALNT2, which is an inhibitory factor for Influenza A Virus (IAV) entry (Heaton et 
al. 2017; Richardson et al. 2018; Orchard et al. 2019). To date, a CRISPRi screen that 
investigates host factor involvement in viral infection has not been published and thus 
represents an opportunity where CRISPRi and a traditional CRISPR knockout screen 
can be performed simultaneously and the novel host factors identified and compared.  
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Figure 3.23: Comparison between traditional CRISPR KO and CRISPRi and 
CRISPRa. 
Traditional CRISPR KO involves the binding of Cas9 to the target gene of interest 
resulting in the formation of a double stranded break (DSB). Frameshift mutations are 
introduced upon DNA repair, resulting in knockout of the target gene. In contrast, both 
CRISPRa and CRISPRi utilise a dead Cas9 (dCas9) where attached effector domains 








In addition, CRISPRi can target long non-coding RNAs (lncRNA), which are critical for 
numerous host cellular processes, where traditional Cas9 induced NHEJ are often 
incapable of blocking (Ponting et al. 2009; Sun and Kraus 2015). Genome-wide 
CRISPRi screens have not been performed with virus infection, compared to the 
numerous traditional Cas9 knockout screens, likely due to the lack of robustness of 
the sgRNA computational design rules.  
The other main aspect to consider when designing a genome-wide CRISPR screen to 
identify novel proviral host factors is the output of the screen and the associated 
enrichment of a selected pool of cells (i.e., cells which have lost HCV replication). With 
regards to genome-wide CRISPR screens as they apply to virus infection to identify 
essential host factors, it is critical to have a clear phenotypical outcome following viral 
infection. In identifying novel proviral host factors, other investigations using CRISPR 
technology have taken advantage of the cytopathic effect (CPE) viruses induce during 
infection, rendering the infected cell unviable. These include the flaviviruses (DENV, 
WNV, ZIKV) as well as influenza A virus and norovirus (see table 1.1). This strategy 
is useful for loss of function screens using CRISPR technology as cells that are 
resistant to virus infection survive due to a knockout of a novel proviral host factor. 
However, HCV is generally non-cytopathic relative to other flaviviridae family members 
(Larrubia et al. 2014). However, one group has used HCV infectious virus and its ability 
to cause CPE as a readout for a genome-wide CRISPR screen post commencement 
of this project. Marceau et al. used Huh7.5.1-Cas9 stable cells which were transduced 
with the GeCKO LentiGuide library (the two-plasmid system described earlier) 
(Marceau et al. 2016). CPE was visible 5 days post infection with HCV JFH-1 virus, 
where clusters of virus resistant surviving cells were expanded. Although our HCV 
viral stocks are the same strain as the one Marceau et al. used for their genome-wide 
CRISPR screen, we rarely see HCV induced CPE to the levels required to enable virus 
resistant cells to be separated. One reason for this contradiction could be due to the 
Huh7.5 cells, where Huh7 cells from multiple laboratories can differ significantly in their 
ability to support not only HCV infection and replication but also viral induced CPE 
(Sainz et al. 2009). Given that our Huh7.5 cells are not susceptible to HCV induced 
CPE, other viral systems must be considered to enable separation of cells which have 
lost HCV replication due to knockout of a proviral host factor for further analysis.  
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Reporter constructs with HCV infectious virus are also a suitable alternative as a 
readout of a genome-wide CRISPR screen. The isolation of the genotype type 2A 
JFH1 strain, which can support high levels of HCV replication was improved via the 
generation of chimeric HCV genomes stitched together from multiple isolates, which 
yielded infectious titres 100 fold higher than parental JFH1 (T. Kato et al. 2003; 
Pietschmann et al. 2006; Wakita 2009). Introduction of cell culture adapted replication 
enhancing mutations through serial passage, primarily in NS5A, has resulted in 
reporter constructs that produce acceptable levels of infectious virus titres to enabling 
study the HCV lifecycle (Hughes et al. 2009; Liu et al. 2012b). In addition, multiple 
reporter constructs such as EGFP and nano-luciferase have been inserted into 
domain III of NS5A within the HCV infectious virus system to study the intricate details 
of HCV replication (Gottwein et al. 2011; Eyre et al. 2014; Eyre et al. 2017a). However, 
use of the infectious virus-based reporter systems can be limited by the insertion size 
of the reporter construct, where the virus is unable to tolerate large insertions such as 
thymidine kinase, and the gradual loss of reporter construct expression after virus 
passaging. To overcome these limitations, reporter systems have been developed 
where the reporter system is located within the infected cell and exploitation of unique 
functions within the HCV non-structural proteins drive the activation of the reporter 
system. One such reporter system, NIrD, consists of 2 modules, the sensor which 
during HCV infection, NS3 is able to cleave rtTA-MAVS(C) attached to the 
mitochondria. The free rtTA is able to enter the nucleus and activate the tight-TRE 
promoter located within the amplifier module, resulting in the production of thymidine 
kinase and mCherry, which can be utilised in genome-wide CRISPR screening 
scenarios to sort populations which contains HCV positive and negative cells (Fig. 
3.24) (Ren et al. 2015). Although the NIrD reporter system was able to satisfy our 
requirements, we ultimately decided to utilise the HCV SGR system for our genome-
wide CRISPR screen as our laboratory had many years of experience with the HCV 
replicon system. In addition, we wanted to eliminate the need to produce infectious 
HCV to high titre, which in itself is time consuming and problematic. In addition, our 
access to flow cytometry in a PC2 laboratory was limited in Adelaide and for the above 
reasons, we utilised the HCV SGR system described herein.  
The HCV sub-genomic replicon (SGR) was developed for our screen due to the need 
for a reporter system that had high homogeneity of HCV replication within a cell 
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Figure 3.24: The NIrD reporter system enables genome-wide CRISPR screening 
with HCV infectious virus. 
The NIrD reporter system consists of 2 modules, the sensor which during HCV 
infection, NS3 is able to cleave rtTA-MAVS(C) attached to the mitochondria. The free 
rtTA is able to enter the nucleus and activate the tight-TRE promoter located within 
the amplifier module, resulting in the production of mCherry, resulting in fluorescence 
within HCV infected cells. Addition of GCV results in phosphorylation by thymidine 












population coupled with a simple readout to easily determine levels of HCV replication, 
both of which are required for a genome-wide CRISPR screen. The HCV SGR system 
was originally constructed by the removal of the structural proteins and replacement 
with a selection resistance cassette (neomycin or BSD) and a reporter gene (renilla 
luciferase) [reviewed extensively in (Lohmann 2019)]. The advantage of the SGR 
system is the ability to select for cells with high levels of HCV replication through the 
selection resistance cassette (BSD) and therefore the elimination of the dynamics of 
HCV replication and spread compared to the heterogenous nature of infectious virus-
based systems. The other main benefit of the SGR system is the ability to add a 
reporter protein to allow for accurate measurement of HCV replication levels with the 
desired treatment conditions in a fast, simplistic and safe manner, as no infectious 
virus is produced. However, a disadvantage of removal of the structural proteins 
needed to construct HCV progeny is that only the genome replication stage of the HCV 
lifecycle can be studied. In addition, the lack of structural proteins in the SGR system 
can result in both altered HCV replication dynamics and structures as all three 
structural proteins play minor roles in the replication stage through interactions with 
the non-structural proteins due to the high association of the assembly stage with the 
replication phase (see section 1.7.3). If the required time and facilities were available, 
performing the genome-wide CRISPR screen with both the SGR and NIrD systems 
simultaneously would allow for comparison between novel host factors identified. As 
the NIrD system uses HCV infectious virus, novel host factors present in the NIrD 
which are absent in the SGR system would allow easy separation of novel host factors 
critical for HCV entry and assembly of virions. 
Given that we had chosen the HCV SGR system for our genome-wide CRISPR screen, 
we noticed that both our monoclonal populations of Huh7.5 cells harbouring either 
HCV-SGR-MC or -GFP had variable fluorescence intensity (Fig. 3.18). Our genome-
wide CRISPR screen strategy relied on homogenous expression of our reporter 
protein, where cells which have lost fluorescence after GeCKO LentiCRISPRv2 library 
transduction were assumed to have deletion of a novel proviral host factor (Fig. 3.17). 
An explanation for the heterogenous expression of mCherry and GFP within cells 
harbouring HCV-SGR could be explained by the influence of cell cycle on the activity 
of the HCV IRES, which controls the expression of the BSD-reporter protein (either 
MC, GFP or thymidine kinase). The activity of the HCV IRES has been shown to be 
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enhanced during the mitotic phase (G2/M) and relatively inactive in both the early S 
phase of the cell cycle and in poorly proliferating confluent cells (Honda et al. 2000; 
Pietschmann et al. 2001; Scholle et al. 2004). The reliance of HCV genome replication 
to occur in dividing cells, in combination with inherent differences in virus replication 
levels and therefore reporter protein expression in select cells may also explain the 
heterogeneity of HCV replication noted in our population of Huh7.5 cells. To 
investigate if we could select for cells that inherently have increased HCV replication 
(independent of cell cycle), we performed flow cytometry to enrich for cells with higher 
levels of active HCV replication and therefore reporter protein expression. 
Unfortunately, five days post FACS sorting, mCherry fluorescence within the 
population reverted to levels prior to enrichment (Fig. 3.18). This was unexpected and 
we speculate that although all cells had high levels of mCherry expression post FACS 
sorting, the cellular population were still at varying stages of the cell cycle and thus 
synchronisation with serum starvation or small molecule inhibitors such as 
Nocodazole may need to be used (Bindels et al. 2017). Additional rounds of flow 
cytometry were proposed to ensure all cells within the mCherry negative population 
remained negative due to fluctuating levels observed within the cellular population. 
Although feasible, this approach was deemed not viable due to time constraints.  
The simple phenotypic screen used in a majority of genome-wide CRISPR screens 
with other viruses involves the ability to cause cell death that allows for selection of 
resistant cells where a proviral host factor has been knocked out. To adapt this 
concept to HCV, we developed a HCV-SGR-TK genome-wide CRISPR screen that 
relies on the capability of thymidine kinase to phosphorylate GCV into a toxic 
metabolite, resulting in cell death and thus separation of the population with no HCV 
replication (Tomicic et al. 2002). The HCV-SGR-TK genome-wide CRISPR screen 
was performed as per figure 3.18, where the GeCKO lentiCRISPRv2 library was 
transduced into HCV-SGR-TK expressing cells. Following the addition of puromycin, 
significant cell death was observed which was expected due to the addition of the 
lentiviral library at a low MOI. Upon the addition of GCV, it was expected that a majority 
of cells would initiate TK-mediated cell death due to the retention of active HCV 
replication. However, minimal cell death was observed, indicating that all the GeCKO 
lentiCRISPRv2 library transduced HCV-SGR-TK cells were resistant to GCV-induced 
cell death. This could suggest a number of scenarios where either a large number of 
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proviral host factors had been knocked out or replication had been lost which was 
independent of CRISPR knockout. The latter was indeed the case as the majority of 
living cells did not retain HCV replication (as determined by immunofluorescence of 
NS5A and PCR amplification of the thymidine kinase RNA – Fig. 3.20). The reasons 
for the lack of HCV replication across the entire GCV resistant cellular population is 
not entirely clear, but further experiments suggest that lentiviral transduction in the 
absence of BSD selection results in removal of the HCV-SGR which is discussed 
below.  
For both genome-wide LentiCRISPRv2 screens utilising either the fluorescence or 
thymidine kinase cell survival methods, a dilemma emerged within the protocol of 
when to remove the BSD. This nucleoside antibiotic promotes positive retention of the 
replicon and therefore selects for HCV replicating cells. However, upon knockout of a 
potential host factor, HCV replication will be lost along with BSD resistance and cells 
will be susceptible to BSD induced cell death (Fig. 3.22). Therefore, to preserve cells 
which have lost HCV replication due to knockout of a proviral host factor, BSD must 
be removed prior to LentiCRISPRv2 library transduction. However, the loss of BSD 
selection may impact the HCV replicon’s ability to remain within the cell, especially 
during lentivirus transduction. Using mCherry lentivirus to mimic transduction of the 
GeCKO LentiCRISPRv2 library, we revealed that Huh7.5 cells harbouring HCV-SGR-
TK transduced with mCherry lentivirus and cultured in the absence of BSD resulted in 
a loss of HCV replication (Fig. 3.21 and 3.22). Other genome-wide CRISPR screens 
regarding virus infection do not face this issue due to the transduction of the CRISPR 
library prior to virus infection. As active HCV replication is required for the entire 
duration of the genome-wide screening process, our toolkit would need to be modified 
and utilisation of the NIrD system may be required to allow for HCV entry post 
transduction of the GeCKO LentiCRISPRv2 library to ensure active HCV replication is 
present throughout the screening process.  
In summary, we have validated the use of LentiCRISPRv2 to knockout genes from 
both endogenous (CD81) and exogenous (EGFP) origins, where high knockout 
efficiency was observed within five days post lentiviral transduction. In addition, we 
have developed the HCV sub-genomic replicon to express multiple reporter proteins 
with the intention to be used in genome-wide CRISPR screens. The GecKO 
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LentiCRISPRv2 plasmid library was successfully amplified and library complexity 
verified via next-generation sequencing. However, the proposed genome-wide 
CRISPR screens to be performed with either the fluorescence cell sort based or cell 
survival with thymidine kinase were ultimately incompatible with the HCV-SGR system 
as lentiviral transduction of mCherry and therefore LentiCRISPRv2 without BSD 
selection resulted in loss of active HCV replication regardless if the protein which was 
knocked out in question was important for HCV replication or not (Fig. 3.22). However, 
given that the complexity of the expanded GecKO LentiCRISPRv2 plasmid library had 
been successfully verified and lentiviral pools constructed, we decided to repurpose 
our genome-wide screen with infectious ZIKV, which would circumvent the limitations 
with utilising a sub-genomic replicon based system and is illustrated in the manuscript 
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Cellular factors have important roles in all facets of the flavivirus replication cycle. 
Deciphering viral-host protein interactions is essential for understanding the flavivirus 
lifecycle as well as development of effective antiviral strategies. To uncover novel host 
factors that are co-opted by multiple flaviviruses, a CRISPR/Cas9 genome wide 
knockout (KO) screen was employed to identify genes required for replication of Zika 
virus (ZIKV). Receptor for Activated Protein C Kinase 1 (RACK1) was identified as a 
novel host factor required for ZIKV replication, which was confirmed via 
complementary experiments. Depletion of RACK1 via siRNA demonstrated that 
RACK1 is important for replication of a wide range of mosquito- and tick-borne 
flaviviruses, including West Nile Virus Kunjin (WNVKUN), Dengue Virus (DENV), 
Powassan Virus (POWV) and Langat Virus (LGTV) as well as the coronavirus SARS-
CoV-2, but not for YFV, EBOV, VSV or HSV. Notably, flavivirus replication was only 
abrogated when RACK1 expression was dampened prior to infection. Utilising a non-
replicative flavivirus model, we show altered morphology of viral replication factories 
and reduced formation of vesicle packets (VPs) in cells lacking RACK1 expression. In 
addition, RACK1 interacted with NS1 protein from multiple flaviviruses; a key protein 
for replication complex formation. Overall, these findings reveal RACK1’s crucial role 
to the biogenesis of pan-flavivirus replication organelles.  
Introduction 
The Flavivirus genus includes dozens of virus species transmitted by arthropods and 
with high potential to inflict significant morbidity and mortality worldwide (Daep et al. 
2014). Antiviral therapeutics are not available for the vast majority of these flaviviruses 
and vaccines remain limited in efficacy and not suitable for extremes of ages (Dawes 
et al. 2016; Deen 2016). Thus, further investigation of host-viral interactions in the 
flavivirus lifecycle may potentially expedite development of novel treatments and 
vaccines. Flaviviruses have single stranded positive sense RNA genomes, similar 
virion structure, and replicate exclusively in the cytoplasm. Binding and entry is 
mediated by numerous host receptors followed by endocytosis of the viral particle and 
release of viral RNA into the cytosol via endosomal acidification. The positive sense 
RNA genome is then translated to yield a large single polyprotein that is then cleaved 
by host and viral proteases to produce the structural proteins (capsid [C], pre-
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membrane [prM] and envelope [Env] and non-structural (NS) proteins (NS1, NS2A, 
NS2B, NS3, NS4A, NS4B and NS5). Expression of the NS proteins induces 
invagination of the ER membrane, allowing formation of the replication complex; a viral 
specific membrane structure that harbours active viral replication (Chatel-Chaix and 
Bartenschlager 2014). At all stages of the viral life-cycle, interactions between host 
factors and viral proteins are crucial in the replication process and biogenesis of ER 
membrane rearrangement to allow formation and maintenance of the replication 
complex (Aktepe and Mackenzie 2018). Following budding into the ER, immature 
virions are transported via the Golgi pathway to enable release of viral particles via 
exocytosis. Thus, identification and characterisation of virus-host interactions 
impacting replication will inform our understanding not only of flavivirus biology but 
possible targets for therapeutic intervention.  
Recent advances in genome-wide screening technology provides a platform to further 
identify novel viral host factors [reviewed in (Puschnik et al. 2017a)]. One such 
technology is clustered regularly interspaced short palindromic repeats (CRISPR) 
genome-wide silencing in which the GeCKO (genome-wide CRISPR knockout) 
screening library has been used to investigate virus-host interactions across multiple 
viral families and mammalian cell types (Ma et al. 2015; Savidis et al. 2016a; Marceau 
et al. 2016; Zhang et al. 2016; Li et al. 2019). Although identification of a number of 
host factors are reproducible from one CRISPR screen to the next, variations in 
experimental design and the screening process can influence the potential hits and 
thus host factors which may surface.  
In this study, we sought to identify cellular proteins involved in ZIKV replication through 
the use of a genome-wide GeCKO screen. This screen identified Receptor for 
Activated C Kinase 1 (RACK1) as a critical host factor for not only ZIKV infection, but 
other mosquito and tick-borne flaviviruses. RACK1 is a highly conserved 
multifunctional protein and a member of the tryptophan-aspartate repeat (WD-repeat) 
family of proteins that shares significant homology to the ß-subunit of G-proteins. 
Through its interaction directly or in a complex with other cellular proteins, it functions  
in shuttling proteins throughout the cell, anchoring proteins at particular locations, 
stabilising protein activity and has specific roles in modulation of signalling pathways 
[reviewed in (Adams et al. 2011)]. Here, we show that RACK1 interacts with flavivirus 
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NS1 protein and localises to replication complexes to specifically alter the latter’s 
cellular morphology. Depletion of RACK1 resulted in both altered morphology and a 
decrease in the number of VPs generated by DENV and ZIKV non-structural protein 
expression. These results indicate that RACK1 through the interaction with NS1 is 
crucial for the construction of flaviviral replication complexes.  
Results 
CRISPR/Cas9 genome-wide KO screen reveals RACK1 as a critical host factor 
for ZIKV replication 
To identify host genes required for the ZIKV lifecycle, we performed a lentiviral-
mediated whole genome CRISPR screen to uncover sgRNAs that rendered cells 
resistant to ZIKV-induced cytopathic effect (CPE) (Fig. 1A). The LentiCRISPRv2-
GecKO library was stably transduced into Huh7.5 cells, selected with puromycin, and 
infected with ZIKV (MR766, MOI=5). In contrast to other screening approaches that 
expanded surviving cells following viral infection (Marceau et al. 2016; Zhang et al. 
2016), we harvested genomic DNA from unamplified surviving cells to identify host 
factors that may be lost through expansion as a consequence of altered cell 
proliferation. sgRNAs sequences from surviving cells were PCR amplified and 
sequenced (Illumina NextSeq) and analysed using the CaRpools package (Fig. 1B) 
(Winter et al. 2016). We identified several genes which were statistically enriched 
using DESeq2 and/or MAGeCK, some of which were previously identified as playing 
a role in viral replication. These include the ER membrane protein complex proteins 
(EMC) (EMC1, MMGT1 (EMC5) and EMC6) as well as BAX. (Fig. 1B). However, our 
most significant hit identified was sgRNAs targeting GNB2L1, otherwise known as 
RACK1. Interestingly, RACK1 has previously been shown to be an important host 
factor in virus infections including HCV (Majzoub et al. 2014; Lee et al. 2019). In 
addition, a proteomics screen involving DENV NS1 also identified RACK1 as an 
interacting partner and thus was pursued further (Hafirassou et al. 2018). To confirm 
our screen results, we generated independent EMC1, EMC6 and RACK1 CRISPR 
polyclonal knockouts in Huh7.5 cells and infected with ZIKV (MR766) and assessed 
viral replication by qRT-PCR and plaque assay (Fig. 1C & D). As expected, both ZIKV 
RNA accumulation and the production of infectious viral particles were significantly 
reduced in cells depleted for EMC1 and EMC6 expression, and similar replication 
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defects were observed in the absence of RACK1. The identification of EMC1 and 
EMC6 validate our screening approach and thereby identify RACK1 as a potential host 
factor involved in ZIKV replication.  
Confirmation of RACK1 as a critical host factor for ZIKV infection 
To confirm if RACK1 is an important host factor for ZIKV replication, siRNA targeting 
RACK1 was utilised as a complementary method of abrogating RACK1 expression. 
Time-course knockdown experiments with siRNA targeting RACK1 showed that 
mRNA (Fig. 2A) and subsequently protein levels (Fig. 2B) are reduced significantly 
after 24 hours siRNA transfection and remain low for at least 72 hours post transfection. 
Since the genome-wide CRISPR KO screen was performed with the liver derived 
Huh7.5 cell-line, we also thought it imperative to determine whether perturbation of 
ZIKV replication was evident in cells of non-hepatic origin. siRNA knockdown in both 
HeLa and the placental cell line HTR8 followed by infection with ZIKV (MR766) 
revealed a reduction in RACK1 mRNA expression that was associated with a 
significant decrease in ZIKV RNA (Fig. 2C). Our original genome-wide CRISPR KO 
screen utilised the MR766 ZIKV strain of African lineage, which through continued 
passage in mouse brains may have resulted in adaptations and changes in host factor 
reliance (Shao et al. 2017). Thus, HeLa cells with RACK1 siRNA knockdown were 
infected with ZIKV MR766 or PRVABC59, the latter of Asian lineage that revealed a 
similar impact on ZIKV replication, indicating that RACK1 is important for replication 
of both African and Asian ZIKV lineages (Fig. 2D). Rescue experiments were 
performed where transfection of plasmid encoding siRNA resistant RACK1 into cells 
which have depleted RACK1 expression and infected with ZIKV (PRVABC59) showed 
restoration of ZIKV RNA levels (Fig. 2E). To ensure the loss of ZIKV RNA by RACK1 
knockdown resulted in perturbation in active viral replication and NS protein formation, 
immunoblot detection revealed a significant decrease in ZIKV NS5 protein levels in 
the absence of RACK1 expression (Fig. 2F). In a complementary approach, 
immunofluorescence microscopy was employed that revealed a reduction in ZIKV 
envelope protein staining post siRNA knockdown of RACK1 (Fig. 2G). Together, these 
findings indicate RACK1 is an important proviral host factor for different ZIKV strains 
and in multiple cell types.  
RACK1 is required for flavivirus replication  
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To determine whether RACK1 is also a proviral host factor for other flaviviruses, we 
explored whether other mosquito or tick-borne flavivirus species require RACK1 for 
virus replication. Compared to siRNA non-targeting control (NTC) cells, knockdown of 
RACK1 had a significant impact of at least a 1 log10 decrease in infectious virus release 
of the mosquito-borne flaviviruses including ZIKV (strain 2013 French Polynesia), 
WNV (strain NY99) and DENV (strain NGC, serotype 2). Interestingly, there was no 
effect on YFV (strain 17D) replication in the absence of RACK1 expression (Fig. 3A). 
Demonstrating that this effect is not specific to mosquito-borne flaviruses, we also 
noted that the tick-borne flaviviruses, Langat virus (LGTV; an attenuated member of 
the TBEV serocomplex) and Powassan virus (POWV; strain LB) also had a 
dependency for expression of RACK1. In fact, of all the flaviviruses investigated, 
POWV revealed the greatest dependency on RACK1 with a consistent 2 log10 
decrease in viral RNA following RACK1 depletion (Fig. 3A). We next investigated if 
other RNA viruses required a dependency for RACK1. Using an EBOV luciferase 
reporter virus, we noted no significant impact of RACK1 on viral replication in 
comparison to the NTC siRNA (Fig 3B).  Interestingly, RACK1 was required for SARS-
CoV-2 replication, as shown by reduced infectious virus release (approx 1 log10) and 
intracellular spike protein expression (Fig. 3B and 3C). No requirement for RACK1 
was observed for either VSV (negative strand RNA virus) or HSV (DNA virus) 
replication. Collectively, this suggests that positive strand RNA viruses of the flavivirus 
genus exhibit dependency for RACK1 expression. 
RACK1 is important prior to establishment of replication 
To gain insight into the mechanism of action of RACK1, we next determined at which 
stage of the viral lifecycle RACK1 was functioning. To achieve this, we used a sub-
genomic reporter DENV expressing Renilla Luciferase (Rluc). Following transfection 
of in vitro transcribed DENV sub-genomic (SGR) replicon RNA, replication is 
established that recapitulates the complete RNA replication cycle, although infectious 
virions are not produced due to the lack of structural proteins required for virion 
morphogenesis. Using this approach, Rluc is expressed at low levels as a function to 
translation of the input RNA and increases thereafter during genome amplification. 
Huh7 cells were pre-treated with NTC or RACK1 siRNA prior to transfection with RNA 
representing DENV SGR or DENV SGR containing a GND mutation in the NS5 protein 
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encoding the viral RNA-dependent RNA polymerase to control for input RNA mediated 
luciferase expression (Fig. 4A). In addition, we also infected siRNA treated cells with 
DENV (16681). In the absence of RACK1, DENV SGR replication was supressed at 
late but not early time points following transfection of RNA suggesting that primary 
viral translation was not impacted (Fig. 4B). Furthermore, the pattern of Rluc 
expression in the absence of RACK1 from DENV SGR GND was similar to DENV 
SGR confirming no impact on viral translation. As expected, DENV RNA levels were 
significantly reduced when RACK1 expression is decreased prior to infection with 
DENV (16681) infectious virus (Fig. 4C). We also investigated the impact of RACK1 
depletion post establishment of viral replication (Fig. 4D). siRNA treatment of cells with 
NTC or RACK1 post infection with DENV or transfection of the DENV SGR revealed 
no impact on viral replication as determined by qRT-PCR or luciferase assay 
respectively (Fig 4E and 4F). Collectively, these results suggest that entry and 
translation of viral RNA are not impacted, whereas RACK1 is important for viral RNA 
genome replication.    
RACK1 is instrumental to the formation of the flavivirus replication complex 
Following translation and processing of the viral polyprotein, a hallmark of flavivirus 
replication is rearrangement of ER membranes to form single membrane vesicle 
packets (VPs) that house sites of viral RNA replication in a replication complex (RC) 
(Paul and Bartenschlager 2015). However, the requirement of RACK1 for viral 
replication will inevitably impact RC formation and thus uncoupling polyprotein 
synthesis from viral replication is necessary to determine the role of RACK1 on 
flavivirus RNA replication. To achieve this, we used a replication independent 
expression system, termed pIRO (plasmid induced replication organelle formation) 
that induces DENV and ZIKV vesicle packets that are morphologically 
indistinguishable from infected cells (Cerikan et al. 2020). Huh7/Lunet-T7 cells were 
reverse transfected with either NTC or RACK1 siRNA, following which cells were 
transfected with either ZIKV or DENV pIRO constructs and 20 hrs later cells were fixed 
and processed for immunofluorescence and TEM (Fig. 5A). Transfection efficiencies 
determined for both ZIKV NS4B and DENV NS3 were comparable between siRNA 
treatments (Fig 5E and 5F). Cells transfected with siRNA targeting RACK1 revealed a 
significant decrease in RACK1 expression at 48 and 68 hrs post treatment that 
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correlated with significant impairment of VP formation for both DENV and ZIKV pIRO 
systems (Fig. 5B and 5C). In cells treated with NTC siRNA and expressing pIRO-
DENV or -ZIKV constructs, distinct ER membrane alterations were visible representing 
VPs, however this was not the case for cells lacking RACK1 expression (Fig. 5C). 
Furthermore, VP quantification by TEM were classified into three categories; cells with 
no VPs, cells with 2-5 VPs and cells > 5 VPs. For cells transfected with either pIRO-
DENV or -ZIKV, there was a significant increase in the numbers of cells lacking VPs 
when RACK1 expression is depleted (Fig. 5D). Conversely, under the same conditions, 
we also noted a decrease in the number of cells harbouring VPs.  Collectively, our 
results show that RACK1 is an essential host factor for mediating the biogenesis of 
convoluted ER membrane structures and VPs essential for RNA viral replication. 
RACK1 is required for the positioning of flavivirus molecular components 
during virus replication 
The NS1 protein across the flaviviruses has a major role in the virus lifecycle, 
particularly in VP formation [reviewed in (Rastogi et al. 2016)]. Given our results above 
and based on a previous study identifying NS1 interaction with RACK1 (Hafirassou et 
al. 2018), we next investigated the impact of RACK1 deletion on the subcellular 
localisation of NS1 and dsRNA as a marker of replication complex formation following 
either DENV or ZIKV infection. Under normal infection conditions, confocal microscopy 
assumed NS1 localisation to a punctate and reticular subcellular localisation with 
significant colocalization to dsRNA, representing replication complexes and the ER 
respectively as previously demonstrated (Fig. 6). However, following RACK1 depletion, 
there was a significant decrease in NS1 expression as expected and altered NS1 
localisation to a predominantly peri-nuclear localisation juxtaposed to dsRNA punctate 
VPs. This altered NS1 and dsRNA localisation is consistent with our EM studies in 
which we showed a decrease in VPs with altered morphology (Fig. 5D).  
RACK1 interacts with multiple flavivirus NS1 within the ER lumen 
Re-modelling of ER membranes is required for flavivirus replication complex formation, 
driven by interactions between viral and ER-associated host factors (Rothan and 
Kumar 2019). One of the viral proteins critical for VP biogenesis is NS1, which 
localizes to the ER lumen (Ci et al. 2020). In addition, a recent DENV NS1 interactome 
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map has identified RACK1 as an interaction partner (Hafirassou et al. 2018). Therefore, 
to investigate whether RACK1 was associated with the ER and in a position to 
potentially interact with NS1, HeLa cells were infected with DENV, WNVKun or ZIKV 
following RACK1 knockdown. Immunoblotting was utilised to determine levels of both 
flavivirus NS1 and RACK1 within fractional whole cell lysates (WCL) containing 
cytosolic (digitonin-sensitive) and membranous organelles (NP-40-sensitive) which 
include the ER (Holden and Horton 2009). Flavivirus NS1 was only present within the 
NP-40 fraction, indicating its predominant localisation within the membranous 
organelles, such as the ER lumen as expected (Fig. 7A). However, RACK1 was 
present in both the digitonin and NP-40 fraction, indicating RACK1 localisation within 
the cytosol and membranous organelles and thus potentially capable of interacting 
spatially with RACK1 within the replication complex.  
 
Given that both NS1 and RACK1 are integral to flavivirus VP formation and reside in 
the same cellular compartment, we next assessed if they interact. This was achieved 
by transfection of Huh7 cells with flavivirus NS1 expression constructs bearing an N-
terminal FLAG-tag and RACK1 bearing an N-terminal HA-tag. Indeed, the co-
expression of NS1 (DENV, WNVKun, YFV17D and ZIKV) and RACK1 revealed a 
reticular cytoplasmic staining pattern consistent with co-localisation and robust 
interaction between NS1 and RACK1 also observed using proximity ligation assays 
(Fig. 7B and 7C). As overexpression can result in mis-localised proteins, we next 
sought to investigate the interaction of NS1 with endogenous RACK1 in HeLa cells 
infected with DENV, WNVKUN, YFV17D or ZIKV. Co-immunoprecipitation experiments 
were conducted to pull down NS1 (humanized NS1 4G4 antibody) from virus-infected 
HeLa cells, followed by immunoblotting to detect endogenous RACK1. Comparative 
analysis of NS1 expression revealed a strong interaction for DENV and ZIKV NS1 with 
endogenous RACK1 which was not as pronounced for WNVKun and YFD17D (Fig. 7D).  
Discussion 
Host factors play critical roles in all facets of the flavivirus lifecycle and identification of 
such factors is essential to not only our understanding of viral replication but also to 
exploit these host-virus interactions in the development of novel antiviral therapeutics. 
Although numerous host factors important for ZIKV and other flaviviruses have been 
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identified, it is likely that additional host factors remain to be discovered. Therefore, to 
expand our understanding of virus-host interactions, we used a genome-scale 
CRISPR KO approach to screen for single guide RNAs (sgRNAs) that upon gene 
knockout conferred cell survival following infection with ZIKV. Similar approaches 
using genome-wide CRISPR KO screens have identified novel host factors essential 
for a range of viruses including the flaviviruses and include the OST, EMC and TRAP 
complexes [reviewed in (McDougall et al. 2018)]. Although CRISPR technology has 
significant advantages to siRNA mediated screens in the form of improved consistency 
as a result of a reduction in false positives, differences in experimental parameters 
can result in bias during the recovery of sgRNAs and therefore influence novel host 
factors identified. In contrast to previous CRISPR screens in which cells are expanded 
(allowing for sgRNA enrichment) following viral induced CPE, we harvested cells 
immediately following viral induced cell death in the control cells to allow for 
identification of sgRNAs that may target genes that confer inherent defects in cell 
proliferation and that would otherwise be missed during the expansion process. 
Interestingly, using this approach we identified a limited number of sgRNAs compared 
to previous screens, indicating the expansion stage is critical for the augmentation of 
the number of gRNAs required to surpass the threshold of significance utilising the 
DESeq2 or MAGeCK algorithims. Nevertheless, among our top hits, in addition to 
RACK1 (GNBL21), our screen identified sgRNAs targeting the EMC complex (EMC1, 
MMGT1 (EMC5) and EMC6) that have been previously identified in supporting 
biogenesis of flaviviral NS4A and NS4B and thus confirms the validity and 
reproducibility of our approach (Fig. 1) (Savidis et al. 2016a; Li et al. 2019; Lin et al. 
2019a). In addition, we identified sgRNAs targeting BAX, a member of the BCL2 family 
regulating apoptosis. This is not surprising, given that DENV and ZIKV both rely on 
BCLx to suppress activation of BAX to prolong cell survival (Suzuki et al. 2018). 
However, sgRNAs targeting RACK1 were the most significantly enriched in the current 
screen and thus we focused on the role of RACK1 in flavivirus biology. 
 
Previous studies have identified a role for RACK1 in the lifecycle of a number of 
unrelated viruses, the mechanism of which falls into two main categories; (i) RACK1 
support of IRES mediated translation by virtue of RACK1 being localised to the 40s 
ribosomal subunit for viruses such as HCV, polio virus, cricket paralysis virus (CrPV) 
and picorna-like Drosophila C Virus (DCV), and (ii) RACK1 mediated intracellular 
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signalling or as a scaffolding protein which assists the virus lifecycle of viruses such 
as porcine reproductive and respiratory syndrome virus (PRRSV), IAV and HIV 
(Gallina et al. 2001; Demirov et al. 2012; Majzoub et al. 2014; Bi et al. 2018; 
LaFontaine et al. 2020). Our results indicate that the flaviviruses can now be added to 
the list of viruses for which RACK1 is a host dependency factor. Using an siRNA 
depletion approach, we report that RACK1 is an essential host factor for multiple 
strains of ZIKV in different cell types and as expected given the similarities in their viral 
lifecycles, RACK1 was important for other mosquito (DENV, WNV) and tick-borne 
flaviviruses (LGTV and POWV). Interestingly, the vaccine strain YFV17D used in this 
study is evolutionally distinct from other flaviviruses such as DENV and ZIKV was not 
affected by RACK1 knockdown. While DENV and ZIKV have likely streamlined their 
lifecycles to require minimal host factors to improve efficiency, YFV exhibits slower 
evolutionary dynamics and therefore may utilise multiple redundant proteins to fulfil 
the same role as RACK1 (Sall et al. 2010). Another factor to consider is that although 
the vaccine strain of YFV results in active viral replication, this strain is both 
evolutionarily and replication divergent from circulating YFV, which may behave 
differently when RACK1 expression is lost (Beck et al. 2014; Fernandez-Garcia et al. 
2016). It will be interesting to determine in future studies if WT strains of YFV are 
dependent on RACK1.  We extended our RACK1 studies to determine if viruses 
outside the flavivirus genus also had a dependency for RACK1. Depletion of RACK1 
had no impact on VSV or Ebola (negative strand RNA genome), MERS-CoV (positive 
stand RNA) or the DNA virus HSV. While the list of viruses we included was not 
exhaustive, our results suggest selective dependency of the flavivirus lifecycle for 
RACK1.   
 
From our initial studies it was not apparent at what stage of the flavivirus lifecycle 
RACK1 was playing a role. To investigate this further, we utilised a DENV SGR 
expressing Rluc to separate viral entry from viral RNA replication. Following 
transfection of in vitro transcribed DENV SGR RNA in cells devoid of RACK1, we noted 
a significant reduction of DENV replication suggesting viral genome replication was 
inhibited. Given that RACK1 is a constituent protein of the eukaryotic ribosome and 
has been reported to play a role in HCV and CrPV IRES-dependent translation, it is 
possible that RACK1 may effect DENV 5’UTR cap dependent translation (Majzoub et 
al. 2014). This was improbable as input in vitro transcribed DENV SGR RNA (including 
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the GND replication mutant) was translated with equal efficiency at early time points 
following transfection, ruling out RACK1 as playing a role at the level of translation. 
Moreover, the depletion of RACK1 post initiation of viral replication has no apparent 
impact on flavivirus replication. This indicates that RACK1 is a proviral host factor that 
must be present prior to the establishment of replication and supports the finding that 
it may target virus-induced ER membrane alteration and generation of vesicle packets 
and the virus replication complex.  
 
Following flavivirus infection expression of the viral NS proteins results in the 
reorganisation of host ER membranes to generate viral replication organelles (ROs). 
These ROs are comprised of arrays of vesicle-like invaginations into rough ER 
membranes that have been designated as vesicle packets (VPs) (Chatel-Chaix and 
Bartenschlager 2014). Evidence that the VPs is the site of viral RNA replication stems 
from the detection of dsRNA (a flavivirus RNA genome replication intermediate) and 
viral replication components including viral NS proteins and essential host factors 
(Gillespie et al. 2010). However, while we have a good understanding of the 
architecture of flavivirus VPs, the host factors and mechanisms of biogenesis are not 
well understood.  Evidence to suggest that RACK1 may play a role in flavivirus VP 
formation comes from the recent observation that it plays a role in the biogenesis of 
HCV ROs through an interaction with the HCV NS5A protein and ATG14L to induce 
autophagasome formation (Lee et al. 2019). However, the mechanism of RO 
formation and the double-membrane vesicle morphology following HCV infection are 
fundamentally different to that of ROs generated following either DENV or ZIKV 
infection suggesting specific mechanisms are a play (Chatel-Chaix and 
Bartenschlager 2014; Lee et al. 2019). For example, the HCV protein NS5A recruits 
and interacts with phosphatidylinositol 4-kinase-α (PI4Kα) resulting in increased local 
levels of PI4P that induces high amounts of localised phosphatidylinositol-4-
phosphate that is required to modulate membrane lipid composition and drive the 
formation of double membrane vesicles and generation of HCV replication ROs. 
However, PI4P is dispensable for DENV RO formation (Reiss et al. 2011). Moreover, 
the significant perturbation of NS1 and dsRNA localisation following depletion of 
RACK1, and the requirement of RACK1 prior to infection combined with its interaction 
with NS1 (a key NS protein involved in VP formation) suggests that RACK1 may 
significantly influence VP formation.   
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A number of viral proteins and host factors have been implicated in flavivirus VP 
biogenesis, however evaluation of their role in this process has been problematic as 
deletion of these factors can impact replication in the context of virus infection or using 
autonomous SGR based cell lines (Aktepe et al. 2017; Richardson et al. 2018; 
Neufeldt et al. 2019). To overcome this limitation, we adopted the recently described 
pIRO transcription-translation system that relies on T7 RNA polymerase and a 
heterologous IRES to achieve robust production and cleavage of DENV and ZIKV 
polyproteins with subsequent VP formation that is indistinguishable to VPs in infected 
cells (Cerikan et al. 2020). Thus, the production of VPs in this system is independent 
of replication and allows the study of host cells factors involved in RO production. 
Using this system coupled with siRNA knockdown of RACK1, we determined that 
RACK1 is important in the formation of VPs for both DENV and ZIKV. TEM revealed 
that in the absence of RACK1, the morphology of VPs for both DENV and ZIKV was 
significantly altered while quantification of VPs revealed that the percentage of cells 
with 2-5 or >5 VPs was also decreased with reduced RACK1 expression. These 
results are consistent with our immunofluorescence data in which we revealed 
significant alteration of NS1 and dsRNA positive DENV and ZIKV ROs in the absence 
of RACK1 expression. Collectively these results indicate that RACK1 is crucial for the 
biogenesis of both DENV and ZIKV (and most likely other flavivirus VPs) VPs to 
support robust viral replication. This raises the question as to how RACK1 drives VP 
formation. In the case of HCV, even though the VPs are morphologically distinct to 
DENV and ZIKV, the HCV NS5A protein induces autophagy and DMV formation 
through its interaction with RACK1 and ATG14L. Like HCV, we revealed that RACK1 
resides interacts with a flavivirus NS protein namely NS1 using a number of 
experimental approaches. Interestingly, as for HCV NS5A protein, the flavivirus NS1 
protein has recently been shown to be required for the biogenesis of DENV ROs 
independent of RNA genome replication. It is not inconceivable to envisage that 
RACK1 helps stabilise NS1 at the ER membrane to facilitate VP formation or 
alternatively it provides a scaffold for the autophagy nucleation complex and formation 
of altered membrane vesicles as with HCV. Autophagy, the mechanism proposed for 
RACK1 assisted HCV DMV construction is also proposed to be induced during DENV 
and ZIKV infection [reviewed in (Chiramel and Best 2018)] and it is possible that even 
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though the ROs are morphologically different, similar mechanisms may be at play for 
flavivirus RO biogenesis and warrants further investigation. 
 
The dependency for RACK1 with regards to the flavivirus replication cycle most likely 
relates to its role in the biogenesis of ROs. Interestingly, the coronaviruses also initiate 
an extensive remodelling of intracellular ER membranes forming a three-dimensional 
structure referred to as the replication membranous web containing multiple 
interconnected vesicles with single or double membrane vesicles (DMVs) [reviewed 
in (Hopfer et al. 2020)]. DMV formation is not completely understood, however, non-
structural viral proteins are critical for this process and hence it is not inconceivable to 
assume that RACK1 may also play a role in coronavirus DMV formation. While not a 
complete surprise, RACK1 depletion had a significant impact on SARS-CoV-2 
genome replication, suggesting coronavirus cellular membrane rearrangements are 
RACK1 dependent and highlights the possibility of a shared mechanism by which 
positive stranded viruses remodel ROs. Given that both HCV and coronaviruses 
induce DMVs which are principle sites of virus replication (reviewed in (Wolff et al. 
2020)), future experiments should investigate the role of RACK1 and autophagy as a 
common mechanism in the biogenesis of viral replication complex formation.    
 
In conclusion, we have successfully used a genome-wide CRISPR KO screening 
approach to identify RACK1 as a host factor important for flavivirus infection. We have 
demonstrated that RACK1 interacts with the flavivirus NS1 protein and colocalised to 
replication organelles containing dsRNA. Furthermore, depletion of RACK1 
significantly impacts flavivirus replication and the formation of replication organelles 
highlighting the role of RACK1 as a key host factor essential for RO biogenesis. This 
study not only enhances our knowledge in the intricacies of the flavivirus lifecycle and 
RO biogenesis, but also may guide novel approaches toward the design of pan-
flavivirus antiviral strategies that are currently lacking. 
Materials and Methods 
Cell and culture conditions 
All mammalian cell lines were maintained at 37°C in a 5% CO2 air atmosphere. Huh7 
and Huh7.5 human hepatoma cells, HeLa human epithelial cells, HTR8/SVneo human 
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trophoblast cells, HEK293T human embryonic kidney cells and Vero monkey kidney 
epithelial cells were maintained in DMEM (Gibco) containing 10% (v/v) FCS and 1% 
(v/v) penicillin and streptomycin. Huh7/Lunet-T7 cells stably expressing the 
bacteriophage T7 RNA polymerase have been described previously (Appel et al. 
2005). C6/36 Aedes albopictus cells were maintained in Basal Medium Eagle (BME) 
supplemented with L-glutamine, MEM non-essential amino acids, sodium pyruvate, 
10% FBS and P/S and cultured at 28 °C with 5% CO2. 
 
Antibodies and Chemicals 
Mouse anti-envelope glycoprotein 4G2 (D1-4G2-4-15) was prepared from hybridoma 
cells purchased from ATCC. Mouse anti-dsRNA 3G1, mouse anti-flavivirus NS1 4G4 
and human anti-flavivirus NS1 4G4 was a generous gift from Roy Hall (University of 
Queensland). Mouse anti-RACK1 was purchased from Santa Cruz Biotechnology 
(SC-17754) and mouse anti-FLAG and anti-HA was purchased from Sigma Aldrich. 
Mouse anti-myc and Rabbit anti-FLAG was purchased from Cell Signalling 
Technologies. Mouse anti-SARS-CoV-2 spike antibody (1A9-GTX632604) was 
purchased from GeneTex. All secondary antibodies were purchased from Thermo 
Fisher Scientific. 
 
Viruses and Plasmids 
 
The ZIKV strains MR766 (Uganda, 1947) and PRVABC59 (Puerto Rico, 2015) were 
propagated in C6/36 cells by infection at a multiplicity of infection (MOI) of 0.01 and 
supernatants harvested at 5-6 dpi. PRVABC59 is a contemporary strain that was 
isolated by CDC from the serum of a ZIKV infected patient who travelled to Puerto 
Rico in 2015. The complete genome sequence is published (Ref. Gene bank 
accession # KU501215). DENV infections utilised Mon601, a derivative of the New 
Guinea C strain that was produced from in vitro transcribed RNA, transfected into 
BHK-21 baby hamster kidney cells, amplified in C6/36 insect cells and titered in Vero 
cells. DENV 16681 infectious virus was generated as previously described (Eyre et al. 
2017b). Other flaviviruses (Chiramel et al. 2019) and EBOV (Kondoh et al. 2018) have 
been described previously. SARS-CoV2 nCoV-WA1-2020 (MN985325.1) was 
provided by the Centers of Disease Control and Prevention (CDC) and propagated in 
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Vero E6 cells in DMEM, supplemented with 2% (v/v) FCS, 1mM L-glutamine and 1% 
(v/v) penicillin and streptomycin.  
 
 
Plasmids were transfected with Lipofectamine 3000 (Thermo Fisher Scientific) 
following manufacturer’s recommendations. RACK1 tagged plasmids were cloned via 
PCR of cDNA from Huh7 cells and Gibson Assembly performed with restriction 
enzyme digested pcDNA6.2. N-EmGFP-DEST. pEGFP-N1-RACK1 was a gift from 
Anna Huttenlocher (Addgene plasmid # 41088). ZIKV NS tagged proteins were 
individually cloned via PCR of pZIKV-ICD (strain Paraiba_01/2015) and Gibson 
Assembly performed with restriction enzyme digested pcDNA6.2. N-EmGFP-DEST. 
LentiCRISPRv2 was a gift from Feng Zhang (Addgene plasmid# 52961). Plasmid 
encoding for RACK1 which was resistant to RACK1 siRNA (described below) was 
constructed by Gibson Assembly of restriction enzyme digested pcDNA6.2. N-
EmGFP-DEST and a gBlock with silent mutations within RACK1 where the siRNA 
bound.  
 
In vitro transcription of viral RNA 
Plasmid pFK-DVs containing the full-length DENV-2 genome (strain 16681), pFK-
sgDVs-R2A and pFK-sgDVs-R2A-GND which are the sub-genomic DENV replicon 
and GND mutant based on the DENV-2 genome (strain 16681) respectively was 
provided by Ralf Bartenschlager (Fischl and Bartenschlager 2013). To initiate virus 
replication, all DENV plasmid constructs were linearized with XbaI prior to in vitro RNA 
transcription with the mMessage Machine SP6 transcription kit (Thermo Fisher 
Scientific) and transfection of viral RNA into Huh7.5 cells by transfection with 
Lipofectamine 3000 (Thermo Fisher Scientific) following manufacturer’s 
recommendations.  
 
CRISPR/Cas9 Genome-wide KO Screen  
The Human GeCKOv2 CRISPR knockout pooled library was a gift from Feng Zhang 
(Addgene #1000000048). Generation of the lentiviral CRISPR knockout pooled library 
and subsequent screening has been described previously (Shalem et al. 2014; Joung 
et al. 2017). Briefly, the library was amplified with the supplied protocol and lentivirus 
generated via transfection of 293T cells with Lipofectamine 2000 (Thermo Fisher 
 175 
Scientific) and psPAX2 and PMD2.G lentiviral packaging plasmids. Following 
determination of the lentiviral titre, 300 million Huh7 cells were transduced with the 
lentiviral pooled library at a MOI of 0.3. One week post transduction, puromycin 
(3µg/ml) was added for a week to select for cells with successful transduction. ZIKV 
(MR766) was added to the 300 million puromycin resistant transduced cells at a 
MOI=5 and the screen terminated when the control un-transduced cells had died 
following ZIKV induced CPE. Surviving lentiCRISPRv2 transduced cells were 
harvested and genomic DNA isolated using a Blood and Cell Culture DNA Midi Kit 
(Qiagen). Genomic DNA from LentiCRISPRv2 transduced cells in the absence of ZIKV 
infection was also harvested to determine the representation of the library prior to ZIKV 
infection. Two rounds of PCR (Q5 - NEB) was performed on the genomic DNA to first 
amplify the guide region of both control and ZIKV-infected samples and secondly, 
introduce the Illumina primers to enable the samples to be run on next-generation 
sequencing. The NextSeq 2x75 bp kit (Illumina) was utilised and the data run through 
caRpools with the assistance of the Adelaide Bioinformatics Hub to identify enriched 
genes and therefore novel host factors required for ZIKV infection. 
 
Generation of EMC1/EMC6/RACK1 CRISPR KO polyclonal cell lines 
Benchling was utilised to generate 20nt guide sequences targeting EMC1, EMC6 and 
RACK1. 20nt oligos were synthesized and annealed prior to insertion into BsmBI 
digested LentiCRISPRv2. Sanger sequencing was employed to confirm insertion of 
the appropriate guide into LentiCRISPRv2. Following the generation of lentiviruses 
encoding LentiCRISPRv2 with EMC1, EMC6 or RACK1, Huh7.5 were transduced and 
puromycin selected 5 days post transduction for 1 week. Surviving cells were infected 
with ZIKV (PRVABC59) and qRT-PCR performed to quantify mRNA levels of EMC1, 
EMC6 or RACK1 and ZIKV RNA levels. sgRNA sequences are listed below: EMC1= 
TCCTGGGAGACTAACATCGG, EMC6=CCGGCAATAATCCAGGACGG and 
RACK1=CGCCATTTTGCATGGTCGAG.  
 
RACK1 knockdown and pIRO plasmid transfection 
RACK1 knockdown for use in infection, immunofluorescence and pIRO assays was 
achieved using a RACK1 siRNA pool (Dharmacon: L-006876-00-0005, 5 nmol). 
Concentrations of reagents were modified dependent on vessel size. For a well of a 
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6-well plate, 3 µl of either RACK1 or non-targeting control (NTC) (Dharmacon: D-
001810-10) siRNA pool from a stock solution of 20µM was added to 100µl of Opti-
MEM (ThermoFisher: 31985070) and 5 µl of Lipofectamine RNAi-MAX was added to 
another tube containing 100 µl of OPTI-MEM. After 5 mins incubation at RT, Opti-
MEM solutions containing the siRNA and transfection reagent were mixed and 
incubated for 15 mins at RT. siRNA transfection mix was added to Huh-7 cells (seeded 
24hrs prior) and 24hrs post transfection cells were either infected with virus or 
transfected with plasmids/RNA. Studies using the pIRO system are described 
eleswhere (Cerikan et al. 2020). In brief, Huh7/Lunet T7 cells (3×105) were seeded 
per well of a 6-well plate well, together with either RACK1 or NTC siRNA transfection 
mixture (reverse transfection). After 24 hrs cells, were trypsinized and 5×104 cells were 
seeded per well of a 24-well plate containing a glass coverslip. For expression of viral 
proteins (ZIKV or DENV) in these cells, either plasmid DNA (500 ng) pIRO-Z:D 5’SLAB 
or pIRO-D:D 5’SLAB was added to 100 µl of Opti-MEM media, mixed briefly and 1.5 
µl of Trans-IT-LT1 transfection reagent (Mirus: MIR2304) was added to the DNA - 
Opti-MEM mixture and mixed briefly. After 20 mins incubation at RT, the transfection 
mixture was added onto the cells. Following a 4hr incubation period, medium was 
changed, and cells were fixed 16 to 20 hrs after transfection for transmission electron 
microscopy (EM) or immunofluorescence (IF) analysis. TEM was performed as has 
been recently described (Cerikan et al. 2020). 
 
Immunofluorescence microscopy, Immunoprecipitation and Immunoblot 
Immunofluorescent labelling was performed as described previously (Van der Hoek et 
al. 2017). Cells were examined using either a Nikon Eclipse Ti microscope or an 
Olympus FV3000 confocal microscope. To perform immunoprecipitation, cell lysates 
were harvested from cells using a lysis buffer containing 1% Triton X-100, 50mM Tris 
pH 8, 150mM NaCl and 1x Protease Inhibitor cocktail (Sigma) and centrifuged at 
21,000xg to remove cell debris. Following overnight incubation of the antibody of 
interest (0,5ug/sample at 4oC), Protein A MagBeads (Genscript) was added to each 
sample and the manufacturers recommended protocol followed. To isolate bound 
protein from the beads during elution, 2x sample buffer (Bio-Rad) was added to each 
sample and boiled at 100oC for 10 minutes. After separation from the MagBeads, the 
boiled lysate was utilised for western blotting. Western blotting was performed as 
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described elsewhere (Van der Hoek et al. 2017). Chicken anti-NS5 and mouse and 
human anti-flavivirus NS1 4G4 ab were used to detect expression of infection-based 
NS5  and NS1 respectively. Mouse anti-SARS-CoV-2 spike ab was used to detect 
SARS-CoV-2 spike protein expression following infection. Mouse anti-RACK1, mouse 
anti-Vinculin and mouse anti-b-actin were used to detect endogenous expression of 
RACK1, Vinculin and b-action respectively. Membrane-bound protein was detected by 
chemiluminescence using SuperSignal West Femto (Thermo Fisher Scientific) and 
imaged using a ChemiDoc MP imaging system (Bio-Rad). 
 
Nano Luciferase Assays 
Luciferase assays to quantify nano-luciferase (NLuc) were performed as described 
previously (Eyre et al. 2017a). Briefly, Huh7.5 cells were seeded into 48 well plates 
prior to transfection with NTC/RACK1 siRNA or infection with DENV2-NS1-Nluc at the 
indicated MOI. Samples were harvested with 1x passive lysis buffer before 
measurement of NLuc activity using the Nano-Glo luciferase assay system (Promega) 
with the GloMax 20/20 luminometer (Promega).  
 
Proximity Ligation Assay 
Proximity ligation assay kits (Duolink PLA) were purchased from Sigma Aldrich and 
the manufacturer’s protocol was followed. Briefly, cells were fixed with 
acetone/methanol, blocked with 5% BSA and incubated with primary antibodies of 
interest raised in divergent species. Cells were then incubated with mouse PLA probe 
PLUS and rabbit PLA probe MINUS for 1 hour in a humidity chamber at 37oC. The 
ligation mix containing the ligase enzyme was incubated with the cells for 30 minutes 
in the humidity chamber at 37oC, followed by the amplification mix (90 minutes in the 
humidity chamber at 37oC) containing the polymerase which facilitates rolling circle 
amplification if the PLA probes are sufficient proximity in the cells. Cells were then 
incubated with DAPI for 5 minutes at room temperature and visualised under the 
immunofluorescence microscope as outlined above. 
 
Plaque Assay 
Virus infectivity was determined by plaque assay as described previously (Van der 
Hoek et al. 2017). Briefly, Vero cells in 24-well plates were infected with 200 µl of 
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serially-diluted virus-containing supernatants (ZIKV, DENV, WNV, YFV, LGTV, POWV, 
SARS-CoV-2, VSV and HSV) for 1 hr at 37 °C before the addition of 1ml overlay of 
complete media containing 1.5% (w/v) carboxymethylcellulose (CMC) (Sigma) and 
cells returned to culture for various days dependent on the virus. Following fixation 
with 10% formation for 1 hour, the CMC overlay was removed and plaques visualised 
via crystal violet stain. Plaques were counted and virus infectivity expressed as 
plaque-forming units (PFU) per ml. 
 
Quantitative Real-Time PCR 
Cells were seeded in 24 well plates for 24 hours prior to transfection or infection. Total 
RNA was extracted from cells using NucleoZOL (Macherey Nagel) per manufacturers 
recommendation. Both cDNA synthesis and qRT-PCR were performed simultaneously 
with the Luna Universal One-Step RT-qPCR Kit (NEB) with the Quantstudio 7 Flex 
(Life Technologies) to quantitate relative levels of ZIKV RNA, RACK1 mRNA and 
house-keeping gene ribosomal protein lateral stalk subunit PO (RPLPO) (36B4). All 
primer sequences used are outlined below: EMC1 FP: 
5’CGGCCTGAGCGGCTGTATATC3’, EMC1 RP: 5’CTCCACAGCACCACCTTCCC3’, 
EMC6 FP: 5’TTCTACCTGCTCGCCTCCGT3’, EMC6 RP: 5’ 
CCCGATGAGGCCTCCTGTAA3’, RACK1 FP: 5’ TAACCGCTACTGGCTGTGTG3’ 
and RACK1 RP: 5’ GCCTTGCTGCTGGTACTGAT3’.  
 
Statistics 
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Figure legends 
Figure 1: Identification of RACK1 as a critical host factor for the ZIKV lifecycle. 
(A) Schematics of the genome-wide CRISPR/Cas9 screen with ZIKV strategy. (B) 
Enriched genes after CaRpools analysis isolated several genes of interest including 
proteins from the EMC complex (EMC1, MMGT1, EMC6), BAX2 and GNB2L1 
(RACK1). (C) Independent polyclonal CRISPR knockouts were performed for EMC1, 
EMC6 and RACK1, infected with ZIKV (MOI=2) and qRT-PCR utilised to determine 
levels of both the respective knockout gene transcripts as well as ZIKV RNA. NTC = 
non-targeting control (n=3, *p<0.05, error bars=SD). (D) Plaque assays were also 
performed concurrently with EMC1, EMC6 and RACK1 knockout cell lines to 
determine levels of ZIKV virions within the supernatant. NTC = non-targeting control 
(n=3, *p<0.05, error bars=SD). 
 
Figure 2: RACK1 is a critical host factor for ZIKV infection.  
Huh7 cells were transfected with either NTC or RACK1 siRNA and cells harvested for 
RNA extraction and qRT-PCR (A) or western blot (B) at indicated time points (n=3 
*p<0.05). HeLa (C) and HTR8 (D) cells were transfected with either NTC or RACK1 
siRNA prior to infection with ZIKV (PRVABC59, MOI=2). 48hpi, RNA was harvested 
and qRT-PCR performed (n=3 *p<0.05). (E) HeLa cells were infected with either ZIKV 
MR766 or PRVABC59 (MOI=2) 24 hrs post NTC/RACK1 siRNA transfection and RNA 
harvested for qRT-PCR 48 hours post infection (n=3 *p<0.05). (F) 
Immunofluorescence was performed on endogenous RACK1 and ZIKV envelope by 
transfecting NTC/RACK1 siRNA into HeLa cells and infection with ZIKV (PRVABC59, 
MOI=1) 24 hrs post transfection. Cells were fixed 48hpi and stained as indicated. (n=3, 
*p<0.05, scale bar: 250µm) 
 
Figure 3: RACK1 is required for flavivirus replication. 
Huh7 cells were transfected with either NTC/RACK1 siRNA and infected with the 
following viruses 24 hrs post transfection: (A) ZIKV (MOI=0.5), DENV (MOI=0.5), WNV 
(MOI=0.5), YFV (MOI=0.5), LGTV (MOI=0.5), POWV (MOI=0.5), (B) VSV (MOI=0.5), 
MERS-CoV/EMC12, EBOV/MAY (103 TCID50) and HSV (MOI=0.05). Plaque assays 
were performed to determine viral titers within the supernatant (n=3, *p<0.05). (C) 
A549 cells stably expressing the ACE2 receptor was transfected with NTC/RACK1 
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siRNA prior to infection with SARS-CoV-2 (MOI=0.1). WCL was harvested and 
immunoblot analysis performed with primary (anti-vinculin, anti-SARS-CoV-2 spike 
and anti-RACK1) and secondary (anti-mouse conjugated HRP) antibodies. Vinculin 
served as sample loading control (n=3). 
 
Figure 4: RACK1 is important prior to flavivirus replication complex formation. 
(A) Huh7.5 cells were transfected with NTC/RACK1 siRNA for 24 hrs prior to (B) 
transfection of DENV2 SGR/SGR GND RNA or (C) infection with DENV2. (B) Cells 
transfected with DENV-SGR RNA were lysed at the appropriate time points and 
luciferase assay performed to determine Renilla Luciferase levels. (C) RNA was 
harvested and extracted from DENV-infected cells 24hpi and qRT-PCR performed. (D) 
In contrast, Huh7.5 cells were transfected with DENV2 SGR/SGR GND RNA (E) or 
infected with DENV2 (F) for 24 hrs prior to transfection of NTC/RACK1 siRNA for 24 
hrs. (E) Cells transfected with the DENV SGR RNA were lysed at the appropriate time 
points and luciferase assay performed immediately to determine Renilla Luciferase 
levels . (F) RNA from DENV infected cells was extracted and qRT-PCR performed 
(n=3, *p<0.05). 
 
Figure 5: RACK1 is critical for the formation of the flavivirus replication complex.  
(A) Huh7/Lunet-T7 cells were reverse transfected with NTC/RACK1 siRNA for 24 hrs 
prior to re-seeding onto glass coverslips. Cells were transfected with pIRO-DENV or -
ZIKV constructs for 20 hrs before fixation and electron microscopy. (B) Immunoblot 
analysis performed to evaluate RACK1 levels 48 and 72 hrs post transfection of siRNA. 
ß-actin served as sample loading control. (C) Thin-section TEM images of altered 
morphology of VPs upon transfection of pIRO-DENV or -ZIKV constructs when 
RACK1 expression is reduced. Upper panel scale bar: 500nm. Lower panels are 
magnifications of yellow squared areas in the upper panel images. Lower panel scale 
bar: 100nm. (C) For each condition, VPs present within whole-cell sections from 100 
cells were counted (n=3, *p<0.05). (E&F) Transfection efficiency of pIRO-DENV and -
ZIKV constructs were analysed via immunofluorescence with anti-NS3 and NS4B 
primary antibodies and appropriate secondary antibodies and multiple fields of view 
quantified by counting positive staining cells and normalization to total number of cells 
(n=3, *p<0.05).  
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Figure 6: RACK1 is required for the positioning of flavivirus molecular 
components during virus replication. 
Huh7 cells were transfected with NTC/RACK1 siRNA for 24 hours prior to infection of 
DENV2 or ZIKV PRVABC59 (MOI=1). Cells were subjected to indirect 
immunofluorescence labelling with primary (anti-NS1 and anti-dsRNA) and secondary 
(mouse anti-IgG 488 and anti-IgM-555) antibodies. DAPI was used to stain nuclear 
DNA in the merged images (scale bar: 5µm, inset scale bar: 2µm, images 
representative of 3 biological triplicates where 5 cells were imaged for each replicate) 
 
Figure 7: RACK1 interacts with multiple flavivirus NS1 proteins within the ER 
lumen.  
(A) HeLa cells were infected with DENV, WNVKUN, YFV17D or ZIKV (MOI=2) and 48hpi, 
WCL were harvested and incubated with human flavivirus NS1 4G4 antibody overnight. 
Immunoblot analysis was performed with mouse flavivirus NS1 4G4 and RACK1 
antibodies. Vinculin served as sample loading control (n=3). (B) Huh7.5 cells were 
transfected with DENV, WNVKUN, YFV17D or ZIKV NS1-FLAG and RACK1-HA tagged 
constructs. 24 hours post transfection, cells were fixed and stained with primary 
antibodies - anti-mouse FLAG/anti-rabbit HA, secondary antibodies – anti-mouse 
488/anti rabbit 555. DAPI was used to stain for nuclear DNA (scale bar: 70µm, images 
representative of n=3). (C) HeLa cells were transfected with DENV, WNVKUN, YFV17D 
or ZIKV NS1-FLAG and RACK1-HA tagged constructs. 24 hrs post transfection, cells 
were fixed and proximity ligation assay performed. DAPI was used to stain for nuclear 
DNA (scale bar: 15µm, images representative of n=3). (D) HeLa cells were infected 
with DENV2, WNVKUN or ZIKV (MOI=1) for 24 hours and WCL extracted for 
immunoblot analysis with primary (anti-vinculin, anti-NS1 and anti-RACK1) and 
secondary (anti-mouse conjugated HRP) antibodies. Vinculin served as sample 
loading control. Lysates were also used for immunoprecipitation using human anti-
NS1 4G4 antibody and subjected to immunoblot analysis with primary (mouse anti-
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Data in addition to the manuscript 
4.1  RACK1 interacts with multiple ZIKV NS proteins 
The exploitation of host factors to support the viral lifecycle is often mediated by direct 
interactions with one or more viral proteins. Proteins within the EMC complex (EMC1 
and EMC6) are required for the biogenesis of both flavivirus NS4A and NS4B (Lin et 
al. 2019a). This is also true for viral induced antagonism of the innate immune 
response, where NS1 and NS4B both interact with TBK1 to inhibit RLR signalling and 
the production of the type I IFNs (Wu et al. 2017). Given that each flavivirus NS protein 
has specific main roles within the virus lifecycle, association of RACK1 with a particular 
flaviviral NS protein may assist in the characterisation of RACK1’s role within flavivirus 
replication. Cells transfected with RACK1 in combination with each ZIKV NS protein 
were subjected to Proximity Ligation Assay (PLA), an antibody-based interaction 
assay. RACK1 was able to interact with all ZIKV NS proteins with the exception of 
ZIKV NS5, as observed by punctate red fluorescence (Fig. 4.1). Previous reports have 
shown that most but not all flavivirus NS5 accumulates within the nuclei of both 
transfected and infected cells 396-398. In addition, although RACK1 is a cytoplasmic 
adapter protein, it can also enter the nucleus after stimuli from the cAMP signalling 
pathway (Neasta et al. 2012). Thus, lack of interaction of RACK1 with ZIKV NS5 
suggests that the former’s role in the flavivirus lifecycle is not confined to the nucleus. 
It is probable that RACK1 has a specific role with each ZIKV NS protein (except NS5) 
given its role as a cytoplasmic chaperone protein, possibly in complex with other host 
factors. However, it is more likely that RACK1 plays a key role within the virus lifecycle 
where all ZIKV NS proteins share common roles within close proximity, one of which 
is the construction and maintenance of the replication complex. 
4.2  The WD2 domain of RACK1 is important for flavivirus NS1 binding 
RACK1 is an evolutionary conserved chaperone protein and a key mediator of various 
signalling pathways [reviewed in (Adams et al. 2011)]. Interactions between RACK1 
and host proteins is facilitated by the 7 WD40 repeat domains present within the β-
propeller structure, where miniscule structural differences between each WD40 repeat 
domain dictates binding specificity. Multiple interacting proteins are often bound to the 
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Figure 4.1: Interaction of ZIKV NS proteins with RACK1. 
ZIKV NS FLAG tagged constructs were transfected in combination with the RACK-HA 
plasmid construct and subjected to proximity ligation assay (PLA) to determine 
interaction. Mouse-FLAG and Rabbit-HA antibodies were utilised and after DAPI 










same WD domain of RACK1 to facilitate signal transduction. Isolation of the binding 
site of NS1 to RACK1 relative to other binding partners may identify the potential 
signalling pathways mediated by RACK1 with regards to replication complex formation. 
Expression of highly truncated RACK1 resulted in poor protein stability in contrast to 
other studies (Chang et al. 2002). Thus, RACK1 mutants, where each lack one WD40 
repeat domain were constructed to determine the binding location of NS1 as outlined 
in Figure 4.2. Co-immunoprecipitation was performed on both DENV NS1 and ZIKV 
NS1 with each RACK1 ΔWD mutant was performed and interaction was lost with both 
flaviviral NS1 when the WD2 domain of RACK1 was absent (Fig. 4.3A, 4.3B). 
Interestingly, interaction between NS1 and RACK1 was increased when the WD7 
domain of RACK1 was absent for both flaviviruses.  
4.3  ZIKV NS1 interacts with ATG14 in a complex with RACK1 
It has been reported during the development of this manuscript that HCV NS5A 
interacts with RACK1 in a complex with ATG14L-Beclin1-Vps34-Vps15, all of which 
are major components of autophagy regulation (Lee et al. 2019). In addition, Lee et al. 
show that RACK1 is critical for the induction of autophagy by HCV NS5A, and that 
both RACK1 and ATG14L are required for NS5A mediated DMV formation. ATG5 has 
also been shown to be an interacting partner with RACK1 to induce autophagy (Erbil 
et al. 2016). Since flaviviruses also induce autophagy during virus replication 
[reviewed in (Ke 2018)], we assessed whether flavivirus NS1 can also interact with 
either ATG5 and/or ATG14L to determine a potential mechanism by which RACK1 
supports the biogenesis of VPs. Co-immunoprecipitation experiments were performed 
on cells transfected with ZIKV NS1-FLAG in combination with ATG5-myc or ATG14-
myc constructs. Pull down of ZIKV NS1 showed that both endogenous RACK1 and 
ectopically expressed ATG14L were interacting partners (Fig. 4.4). Since ZIKV NS1, 
like HCV NS5A are critical for the formation of VPs and DMVs respectively, the 
interaction of flavivirus NS1 with RACK1 may recruit members of autophagy regulation 





Figure 4.2: Schematic of RACK1 ΔWD mutants. 
To construct all seven RACK1 ΔWD mutants, primers containing KpnI restriction sites 
were designed flanking each domain in the opposite direction. PCR amplification was 
performed, digested with KpnI and self-ligated. Sanger sequencing confirmed the loss 













Figure 4.3: The WD2 domain of RACK1 is important for interaction with DENV 
and ZIKV NS1.  
293T cells were transfected with wildtype (WT) or RACK1ΔWD mutants alongside (A) 
DENV NS1-FLAG or (B) ZIKV NS1-FLAG plasmid constructs for 24 hours prior to 
whole cell lysate extraction. Rabbit anti-FLAG antibody was incubated with lysates 
overnight prior to immunoprecipitation. Western blotting was performed with mouse 
anti-FLAG or anti-HA primary and anti-mouse HRP secondary antibodies. 
CTL=Control (mock transfection), WT=wildtype, WCL=whole cell lysate, 
IP=immunoprecipitation. Vinculin was included as a protein loading control. Image 








Figure 4.4: ZIKV NS1 interacts with both RACK1 in complex with ATG14 but not 
ATG5. 
293T cells were transfected with the only ZIKV NS1-FLAG or in combination with 
ATG5-myc or ATG14-myc plasmid constructs for 24 hours prior to whole cell lysate 
extraction. Rabbit anti-FLAG antibody was incubated with lysates overnight prior to 
immunoprecipitation. Western blotting was performed with mouse anti-FLAG or anti-
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Viperin is an important host 
restriction factor in control of Zika 
virus infection
Kylie H. Van der Hoek1,3, Nicholas S. Eyre1,3, Byron Shue1,3, Onruedee Khantisitthiporn1,3, 
Kittirat Glab-Ampi1,3, Jillian M. Carr4, Matthew J. Gartner1,3, Lachlan A. Jolly2, Paul Q. 
Thomas1, Fatwa Adikusuma1, Tanja Jankovic-Karasoulos2, Claire T. Roberts2, Karla J. Helbig5 
& Michael R. Beard  1,3
Zika virus (ZIKV) infection has emerged as a global health threat and infection of pregnant women 
causes intrauterine growth restriction, spontaneous abortion and microcephaly in newborns. Here 
we show using biologically relevant cells of neural and placental origin that following ZIKV infection, 
there is attenuation of the cellular innate response characterised by reduced expression of IFN-β 
and associated interferon stimulated genes (ISGs). One such ISG is viperin that has well documented 
antiviral activity against a wide range of viruses. Expression of viperin in cultured cells resulted in 
significant impairment of ZIKV replication, while MEFs derived from CRISPR/Cas9 derived viperin−/− 
mice replicated ZIKV to higher titers compared to their WT counterparts. These results suggest that 
ZIKV can attenuate ISG expression to avoid the cellular antiviral innate response, thus allowing the 
virus to replicate unchecked. Moreover, we have identified that the ISG viperin has significant anti-ZIKV 
activity. Further understanding of how ZIKV perturbs the ISG response and the molecular mechanisms 
utilised by viperin to suppress ZIKV replication will aid in our understanding of ZIKV biology, 
pathogenesis and possible design of novel antiviral strategies.
Zika virus (ZIKV) is an arbovirus and a member of the Flaviviridae family that is a significant health threat on a 
global scale1. ZIKV gained global attention in 2007 when the first major outbreak was reported in Micronesia fol-
lowed by smaller outbreaks in other pacific islands thereafter2. However, the largest outbreak to date was reported 
in 2015 in Brazil and was followed by widespread dissemination in Central and South America. While the major-
ity of infections in humans are either asymptomatic or associated with fever, rash and conjunctivitis, the 2015 
outbreak was associated with an alarming number of neurological and birth defects including microcephaly3. 
Evidence linking ZIKV to the above mentioned pathologies include ZIKV RNA present in the amniotic fluid and 
fetal and newborn brain tissue4. It is now well accepted that ZIKV can cross the placenta and subsequently infect 
neural progenitor cells of the fetus leading to significantly impaired brain development. ZIKV antigen has been 
identified in the placental chorionic villi from an infected mother who gave birth to a microcephalic infant and 
can also infect human placental trophoblasts and macrophages in vitro5, 6. Moreover, recent mouse models have 
revealed that ZIKV infection can result in placental insufficiency, alterations in neural progenitor proliferation 
and fetal demise7–10. In addition to the classical mosquito transmission, ZIKV can be sexually transmitted via 
infected seminal fluid11–13. The growing association of ZIKV infection during pregnancy with serious neurologi-
cal defects in newborns has resulted in ZIKV being declared as a public health emergency by the WHO.
The innate immune response to virus infection plays a crucial role in controlling viral infection in addition to 
shaping the adaptive immune response. This innate response is initiated by the recognition of genetic components 
expressed during viral replication, collectively termed pattern associated molecular patterns (PAMPs), by cellular 
sensors termed Pattern Recognition Receptors (PRRs)14. In the case of RNA viral infection, the best-characterized 
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PRRs are the membrane bound toll-like receptors (TLRs) and the cytoplasmic RNA sensors RIG-I and MDA515. 
Engagement of PRRs by viral PAMPs results in the activation of NF-κB, IRF-3 and IRF-7 and production of the 
type I interferons. Further amplification of the interferon (IFN) system occurs when IFN binds to the interferon 
receptor (IFNAR) and activates the Jak/Stat signaling cascade to ultimately drive expression of hundreds of inter-
feron stimulated genes (ISGs). These ISGs inhibit viral replication and drive the inflammatory process in an 
attempt to limit viral replication. The importance of this system is exemplified by the fact that most viruses have 
evolved mechanisms to evade or inactivate the innate response16. As an example the Flaviridae members West 
Nile Virus (WNV) and dengue virus (DENV) target multiple sites following PRR activation and IFN signaling 
and most recently ZIKV has been shown to degrade STAT2 to inhibit ISG expression17–19. Furthermore the obser-
vation that mice deficient in the type I IFN receptor are more susceptible to ZIKV infection in comparison to WT 
mice highlights the importance of the innate response and ISG expression in controlling ZIKV infection20–22.
Although it is firmly established that the interferon response is an important determinant of host resistance, 
the antiviral mechanisms responsible for direct suppression of virus replication are less well understood. This, 
together with the observations that placental cells can resist ZIKV infection due to the actions of the type III 
IFN-λ and susceptibility of Ifnar−/− mice to ZIKV infection suggests a role for specific ISGs in control of ZIKV 
infection21. With this in mind we investigated the innate response to ZIKV infection and revealed that ZIKV 
infected cells of neural and placental origin fail to induce a robust ISG response. In particular we noted significant 
abrogation of expression of the ISG viperin that prompted us to investigate the antiviral role of viperin against 
ZIKV. We and others have demonstrated that the evolutionary conserved ISG viperin can inhibit the replication 
of a wide range of viruses that are responsible for significant disease in humans23. These include the Flaviviridae 
family members, DENV, TBEV, WNV and HCV24–28. Interestingly viperin exerts its antiviral effect by diverse 
mechanisms; for example viperin interacts with the HCV NS5A protein and the proviral host factor VAP-A, 
both of which are important in HCV replication, while in TBEV infection viperin restricts viral RNA replication 
dependent on the radical S-adenosyl-l-methionine (SAM) domain25, 28, 29. As for other flaviviruses we observed 
that expression of viperin in Huh-7 cells limited ZIKV replication, whereas viperin−/− MEFs displayed height-
ened permissiveness to ZIKV infection. Taken together, this work suggests that the ability of ZIKV to impair 
innate immune recognition and specific ISG expression may be fundamental in enabling virus replication to 
proceed unchecked in specific cell types. Thus, viperin is a key ISG in controlling ZIKV infection. Understanding 
the ISGs that control ZIKV and other emerging viral infections is essential for defining mechanisms of viral 
pathogenesis and possible novel therapeutic strategies.
Results
The antiviral response is attenuated in placental and neural progenitor derived cell lines fol-
lowing ZIKV infection. The cellular innate immune response to viral infection results in expression of the 
interferons and ISG expression that is critical to the establishment of an antiviral state. However, viruses can 
block this innate response and ZIKV is no exception with recent work showing that the ZIKV NS5 protein can 
degrade STAT2, a key transcription factor in the IFN signaling pathway18, 19. Host innate responses are often 
cell type specific and with this in mind, we investigated ISG expression in a range of cell types following ZIKV 
infection. Initially, we infected the liver derived cell line Huh-7 with ZIKV (MOI of 0.1 and 1.0) and assessed ISG 
mRNA expression by qRT-PCR and ZIKV infectivity using an antibody (4G2) that detects pan-flavivirus enve-
lope including ZIKV. As previously described, Huh-7 cells were readily infected by ZIKV resulting in spreading 
infection that ultimately resulted in significant cytopathic effect (CPE) at 72 hr post-infection (h.p.i)30. We pre-
viously reported that infection of Huh-7 cells with the closely related flavivirus DENV results in significant ISG 
expression; however, this was not the case with ZIKV infection24. We quantitated the induction of IFIT1, viperin, 
IFN-β, IFITM1, ISG15, OAS1 and Mx1 mRNA by qRT-PCR at 24 and 48 h.p.i. Early in infection (24 h.p.i) cells 
were particularly unresponsive to ZIKV infection even though a significant proportion of the culture was infected 
(Fig. 1A,B). Even after establishment of infection (48 h.p.i) there was minimal expression of ISGs. In contrast, 
stimulation of these cells with the double-stranded RNA (dsRNA) mimic poly(I:C) resulted in robust induction 
of ISG expression (Supplementary Fig. S1), indicating that the weak response observed in ZIKV-infected cells 
cannot be attributed to defects in dsRNA sensing or signaling pathways in these cells.
Next we investigated ISG expression in a number of more physiologically relevant cell lines, namely the first 
trimester immortalised extravillious trophoblast line HTR8/SVNeo and JEG3 a trophoblast derived choriocar-
cinoma line31. Following ZIKV infection at MOI of 0.1 and 1.0, HTR8/SVNeo cells harbored productive viral 
replication as determined by immunolabeling of both E protein and dsRNA (Fig. 1D). Even in the face of sig-
nificant viral replication at 24 and 48 h.p.i there was minimal or no induction of mRNA expression of our ISG 
panel and only a moderate increase in IFN-β mRNA at 48 h.p.i. (Fig. 1C). A similar pattern of ISG expression was 
seen following infection of cultures with ZIKV strain PRVABC59 confirming that this observation is not strain 
dependent (Supplementary Fig. S2). In contrast, JEG3 choriocarcinoma cells were more responsive to infection 
with increases, albeit moderate, in mRNA expression for IFIT1 and IFN-β at 24 and 48 h.p.i, however viperin 
expression was attenuated at both time points post ZIKV infection (Fig. 1E). As above, this attenuation of ISG 
mRNA expression was not a result of a defect in innate immune sensing or signaling as significant increases in 
ISG induction could be seen following stimulation with poly (I:C) in all cell-lines tested (Supplementary Fig. S1).
Our results suggest that while ZIKV may induce a cellular innate response, the early response may be actively 
attenuated. To investigate this further we quantified viperin, IFIT1 and IFN-β mRNA following polyI:C stim-
ulation of Huh-7 cells in the presence or absence of ZIKV infection. As expected, mRNA for viperin, IFIT1 
and IFN-β significantly increased following polyI:C stimulation, however this was significantly attenuated in 
the presence of ZIKV infection (Fig. 2A). Consistent with the notion that ZIKV can actively suppress early ISG 
expression we also demonstrate that ZIKV can attenuate the IFN-β promoter in response to both polyI:C and 
expression of constitutively active RIG-I (RIG-N) (Fig. 2B,C). RIG-I PAMP recognition ultimately induces IRF3 
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phosphorylation and nuclear translocation and collectively these results suggest that ZIKV can actively reduce 
RIG-I sensing of ZIKV RNA and downstream ISG expression.
ZIKV has been shown to infect both human and mouse neural progenitor cells (mNPCs) resulting in cell-cycle 
arrest and apoptosis thus providing a direct potential link between ZIKV infection and microcephaly8, 9, 30, 32. We 
therefore investigated innate responses to ZIKV (MR766 strain) infection, in NPCs derived from mouse E14-18 
cortices. To investigate which cells were infected by ZIKV, cultures were immunostained using Sox2 and Pax6 as 
markers of apical progenitor cells and radial glial cells respectively, GFAP to identify astrocytes, βIII-Tubulin to 
identify neurons and histone H3 to identify mitotic cells. ZIKV infection was noted as early as 12 h.p.i with a sig-
nificant number of cells in the culture positive for ZIKV E antigen at 48 h.p.i (Fig. 3A). Consistent with previous 
Figure 1. ZIKV infection results in an attenuated interferon-stimulated gene (ISG) response. (A,C and E) 
Huh-7, HTR8/SVNeo and Jeg3 cells, respectively were infected with ZIKV (MR766) at indicated multiplicity of 
infection (MOI). At 24 and 48 h.p.i total RNA was extracted and qRT-PCR was used to detect mRNA for IFN-β 
and the ISGs IFIT1, viperin, IFITM1, ISG15, OAS1 and Mx1. Data are normalised to the RPLPO housekeeping 
gene and expressed as a fold-change relative to mock-infected control (data are means + SD, n = 3). (B,D and 
F) Indirect immunofluorescence of corresponding ZIKV infection in Huh-7, HTR8/SVNeo and Jeg3 cells 
respectively. Cells were stained with the 4G2 antibody to detect ZIKV E antigen or 3G1 antibody to detect 
dsRNA (red) and DAPI DNA stain (blue). Scale bars represent 20 µm.
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reports in vitro and in vivo, ZIKV-infected cells were positive for Sox2, Pax6 and GFAP suggesting the potential 
for ZIKV to infect NPCs and, to a lesser extent, astrocytes in the developing brain (Fig. 3A)9, 30, 33, 34. Next we 
investigated IFN-β and ISG expression at various time points post ZIKV infection. Consistent with our obser-
vations above there was a delayed and attenuated response to ZIKV infection with IFN-β and ISG responses not 
seen until 48 h.p.i (Fig. 3B). Given that this culture is a mixed population of cells, it is unclear at this stage if the 
ISG response is derived from ZIKV infected cells or from uninfected bystander cells that may be responding to 
low levels of IFN-β produced from infected cells. We also infected mNPC cultures with ZIKV strain PRVABC59 
and observed similar innate immune responses to infection with MR766, suggesting that the innate response 
noted above is not strain dependent (Supplementary Fig. S3). Further experiments are required to determine the 
cell types responsible for ISG expression in NPC cultures. Nevertheless, these results suggest that primary neural 
progenitor cells also have a delayed innate response to ZIKV infection.
ZIKV infects and induces an antiviral response in monocyte-derived macrophages. ZIKV has 
been shown to infect human placental macrophages (Hofbauer cells [HCs])5 and given that the closely related 
flavivirus, DENV targets primary monocyte-derived macrophages (MDM) in vivo, we also investigated if MDMs 
Figure 2. Poly I:C stimulated ISG expression and IFN-β promoter activity is attenuated in the presence of 
ZIKV infection. (A) Huh-7 cells were infected with ZIKV (MR766) at indicated MOIs and 16 h.p.i cells were 
transfected with polyI:C (1 µg). 24 hr later total RNA was extracted and qRT-PCR was used to detect mRNA for 
IFN-β and the ISGs IFIT1 and viperin. Data are normalised to the RPLPO housekeeping gene and expressed 
as a fold-change relative to mock-infected control (data are means + SD, n = 3, *P = 0.0003, Students t-test). 
(B) Huh-7 cells were transfected with a luciferase reporter plasmid driven by the IFN-β promoter followed by 
infection with ZIKV (MR766, MOI 5). 16 h.p.i cells were transfected with polyI:C and 24 hr post transfection 
cell lysates were harvested for luciferase assay. Data are normalised to transfection with TK-Renilla plasmid 
and expressed as a relative light units compared to mock-infected control (data are means + SEM, n = 3, 
*P = 0.003, Students t-test). (C) Huh-7 cells were transfected with either a plasmid expressing WT RIG-I or a 
constitutively active RIG-I (RIG-N), together with a luciferase reporter plasmid driven by the IFN-β promoter 
followed by infection with ZIKV (MR766, MOI 5). 24 h.p.i cell lysates were harvested for luciferase assay. Data 
are normalised to transfection with TK-Renilla plasmid and expressed as a relative light units compared to 
uninfected cells (data are means + SEM, n = 3, *P = 0.002, Students t-test).
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Figure 3. Mouse neural progenitor cells (NPCs) are susceptible to ZIKV infection and display delayed 
interferon-stimulated gene (ISG) expression responses. (A) Immunofluorescence analysis of ZIKV infection 
in neural cell subpopulations within NPC cultures. NPCs were infected with ZIKV (MR766, MOI: 0.1) for 48 h 
prior to fixation and staining of the ZIKV E protein (red) in combination with βIII tubulin (neurons), GFAP 
(astrocytes), phospho-Histone H3 (mitotic cells), Sox2 (apical progenitor cells) or Pax6 (radial glia) markers 
of neural cell sub-populations (green). Nuclei were counterstained with DAPI (blue). Scale bars are 100 µm for 
main images and 10 µm for ‘zoom insets’. (B) Mouse neural progenitor cells were infected with ZIKV (MR766) 
at the indicated MOI before extraction of total cell RNA at 12–48 h.p.i and analysis of ISG expression by qRT-
PCR. Data are normalised to the RPLPO housekeeping gene and expressed as a fold-change relative to mock-
infected control (data are means + SD, n = 3).
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were also permissive to ZIKV infection and the associated antiviral response. In this instance we used a low 
cell culture passaged ZIKV strain PRVABC59, isolated from the sera of an infected patient in Puerto Rico in 
2015 that is closely related to the epidemic strains circulating in the Americas that have been linked to in utero 
ZIKV infection. We demonstrate that MDMs are permissive to productive ZIKV infection as determined by both 
qRT-PCR and immunoblot for detection of NS4B (Fig. 4A,B,C,D). We also evaluated the antiviral potential of 
MDMs infected with ZIKV. MDMs were infected with ZIKV (MOI 1.0) and 48 h.p.i mRNA for viperin, IFIT1, 
IFN-β, MxA and OAS were quantified (Fig. 4E). For comparison we also infected MDMs with DENV (MOI 
1.0), given that these cells are a well-validated target cell in vivo. We observed increased expression of transcripts 
for viperin, IFIT1, IFN-β, MxA and OAS at 48 h.p.i for both ZIKV and DENV. However, transcript levels were 
significantly more elevated in DENV infection (Fig. 4E), although this may be a result of more efficient DENV 
replication as evident by qRT-PCR and immunoblot analysis (complete unprocessed immunoblots can be seen 
in Supplementary Fig. S4) of DENV RNA and NS4B expression respectively (Fig. 4A,B). Most notable was the 
significantly elevated expression of IFN-β in DENV, compared to ZIKV infected MDMs that may in turn drive 
higher viperin and IFIT1 mRNA and viperin protein expression. Collectively these results show that MDMs are 
susceptible to ZIKV infection and respond through activation of antiviral signaling pathways.
The antiviral ISG viperin modulates ZIKV replication. Our results above revealing attenuated viperin 
mRNA induction following ZIKV infection prompted us to investigate the antiviral nature of viperin against 
ZIKV. We and others have shown that viperin restricts replication of the related flaviviridae family members, 
HCV, DENV TBEV and WNV24, 25, 27–29. To investigate the antiviral potential of viperin against ZIKV we trans-
fected a plasmid that drives viperin expression into Huh-7 cells and 16 hr post transfection cells were infected 
with ZIKV strain MR766 at an MOI of 0.1 and 1.0 and analysis of viral replication was assessed at 24 and 48 h.p.i. 
Consistent with previous observations with other flaviviruses, viperin restricted replication of ZIKV MR766. In 
Huh-7 cells expressing viperin, compared to control cells there was a significant decrease in the proportion of 
Figure 4. Human monocyte-derived macrophages are moderately susceptible and responsive to ZIKV 
infection. Human monocyte-derived macrophages were infected with ZIKV (PRVABC59) or DENV-2 
(Mon601) for 48 h (MOI = 1) prior to analysis of viral replication and ISG expression by qRT-PCR and Western 
blotting in parallel. (A) ZIKV and DENV-2 RNA levels were determined by qRT-PCR using plasmid DNA 
standard curves. Data are expressed as viral RNA copy numbers per µg of total cell RNA (means + SD, n = 3). 
(B) Parallel cultures were subjected to immunoblotting analysis of viperin and NS4B expression, with β-actin 
serving as a loading control. (C,D) Quantitation of Viperin and NS4B protein levels, normalized to β-actin 
(means + SD, n = 3). (E) ISG mRNA levels were determined by qRT-PCR. Data are normalised to the RPLPO 
housekeeping gene and expressed as a fold-change relative to mock-infected controls (means + SD, n = 3).
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ZIKV positive cells at both 24 and 48 h.p.i as determined by immunofluorescence microscopy to detect the ZIKV 
E protein (Fig. 5A). Even though approximately 30–40% of cells expressed viperin we could rarely detect cells 
positive for both viperin and ZIKV (Fig. 5B). Quantitative analysis of ZIKV RNA and release of infectious virus 
by qRT-PCR and plaque assay concurred with the microscopy analysis showing that compared to mock transfec-
tion, Huh-7 cells expressing viperin displayed a significant decrease in ZIKV RNA and production of infectious 
ZIKV 24 and 48 h.p.i. (Fig. 5C,D,E). Collectively these results indicate that the ISG viperin has significant antiviral 
activity against ZIKV.
Figure 5. Viperin expression inhibits ZIKV infection in Huh7 cells. (A,B) Huh7 cells were mock transfected 
or transfected with a plasmid expressing viperin-FLAG. 16 hr post transfection, cells were infected with ZIKV 
(MR766) at the indicated MOI. Cells were fixed at the indicated time points and stained for ZIKV E antigen 
(green) in combination with viperin-FLAG (red). Nuclei were counterstained with DAPI (blue). Panel A 4x 
magnification. Scale bar on high-power images in (B) represents 50 µm. (C) RNA was extracted from ZIKV 
(MR766) infected Huh7 cells and ZIKV RNA levels analysed by qRT-PCR. Data is normalised to the RPLPO 
housekeeping gene and expressed as a fold-change relative to mock-infected controls (data are means + SD, 
n = 3, *p ≤ 0.0001, Two-Way Anova). (D,E) Supernatants from ZIKV (MR766) infected Huh7 cells were 
collected and plaque assay performed using Vero cells. Plaques were counted and averaged to deduce plaque 
forming units and subsequently ZIKV infectivity load. A representative plaque assay at 24 and 48 h.p.i is 
presented. (*p ≤ 0.03, Two-Way Anova).
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Next we investigated the anti-viral potential of viperin against ZIKV using a panel of viperin mutants that have 
previously been used to investigate viperin’s antiviral activity against the closely related flavivirus, DENV24. Huh-7 
cells were transfected with the WT and mutant viperin constructs after which cells were infected with ZIKV 
and ZIKV RNA quantified by qRT-PCR (Fig. 6). Consistent with our previous results with DENV, the radical 
SAM domain mutant (SAM1) and the amino-terminal deletion mutant (5′∆50) retain antiviral activity while the 
carboxy-terminal deletion mutant (3′∆4) abolished viperin’s anti-ZIKV activity (Fig. 6). These results highlight 
the importance of the carboxy-terminal domain of viperin for anti-viral activity against ZIKV.
CRISPR/Cas9-derived Viperin null MEFs result in increased ZIKV infection. Murine viperin has 
been shown to limit replication of a number of viruses in vivo27, 35. To assess the impact of viperin deletion on 
ZIKV infection, we generated viperin null mice using CRISPR/Cas9 genome editing. Our approach used a gRNA 
to create indels in the ORF of exon I, thus generating frameshift null alleles. All 16-founder mice generated from 
CRISPR/Cas9 injection contained indels (mostly deletions) around the expected position within the viperin cod-
ing sequence as shown by Sanger sequencing, suggesting highly efficient editing of CRISPR/Cas9 system in our 
experiment. A 32 bp deletion derived from founder #67 and a 113 bp deletion derived from founder #72 were 
selected for further analysis (referred to hereafter as Vip−/−del32 and Vip−/−del113 respectively). In both lines 
of mutant mice, these deletions are predicted to generate a premature stop codon within the first viperin exon. 
Viperin immunoblot analysis of the isolated MEFs from both lines of mice following IFN-α stimulation revealed 
an absence of viperin expression (results not shown), indicating successful disruption of the viperin locus in the 
viperin KO lines.
Next we investigated the role of viperin in controlling ZIKV replication in Vip−/−del32 mouse embryonic 
fibroblasts (MEFs) following ZIKV infection. Infection of WT and Vip−/−del32 MEFs with either ZIKV strains 
MR766 or PRVABC59 revealed that at 48 h.p.i viperin expression was induced in the WT MEFs but not the 
Vip−/−del32 MEFs indicating that the innate cellular response to ZIKV infection is activated and results in viperin 
expression (Fig. 7A). Moreover, in the Vip−/−del32 MEFs there was a significant increase in ZIKV NS4B protein 
compared to WT MEFs suggesting that endogenous viperin can restrict ZIKV replication (complete unprocessed 
immunoblots can be seen in Supplementary Fig. S5). This was further confirmed by immunofluorescence analysis 
of infected cultures that revealed an increased proportion of ZIKV positive cells in Vip−/−del32 MEFs compared 
to WT MEFs (Fig. 7B,D). Furthermore quantification of ZIKV RNA by qRT-PCR analysis from infected cultures 
of WT and Vip−/−del32 MEFs revealed a significant increase in ZIKV RNA in the Vip−/−del32 MEFs at 48 h.p.i. 
(Fig. 7C). It should be noted that this represents experiments using MEFs derived from Vip−/−del32, however 
similar results were also obtained with the independent Vip−/− del113 line. These results reveal that endogenously 
expressed viperin can limit ZIKV infection of MEFs and together with our transfection studies above indicate that 
viperin is a host innate restriction factor for ZIKV infection.
Discussion
The host innate response to viral infection is critical in controlling viral replication through the induction of a 
type I interferon response and ISG expression which serves to limit viral replication and accelerate the inflam-
matory process36. Recent studies using mice with a defect in the type I interferon signaling axis such as Ifnar or 
Irf3/5/7 knockout mice develop neurological disease and increased viral replication in the brain, spinal cord and 
testes following ZIKV infection7. Moreover, in utero infection of Ifnar knock out mice early in pregnancy resulted 
in ZIKV infection of the placenta, and brain causing intrauterine growth restriction and spontaneous abortion37. 
Further evidence for the importance of the type-I response comes from recent work showing that like DENV, the 
NS5 protein of ZIKV abrogates IFN signaling through NS5 protein binding to STAT2 inducing its proteosomal 
Figure 6. The C-terminal region of viperin is responsible for anti-ZIKV activity. (A) Schematic of Viperin WT 
and associated mutants used to transfect Huh-7 cells to assess the domains responsible for viperin’s anti-ZIKV 
activity. (B) Huh-7 cells were transfected to express WT or viperin mutants and at 24 hr infected with ZIKV 
(MR766, MOI = 1). RNA was extracted and ZIKV RNA quantitated by qRT-PCR. Results were normalised 
against control RPLPO mRNA levels and expressed as fold change (data are means + SD, n = 3, *p ≤ 0.025, 
Students t-test).
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degradation18, 19. These results highlight the importance of the type I interferon response in controlling ZIKV 
replication and pathogenesis, but the molecular mechanisms that underpin this restriction are not well under-
stood. However, as for other viral infections, host control is most likely a combination of antiviral ISG expression, 
initiation and exacerbation of an inflammatory response and maturation of the adaptive antiviral response.
With this in mind we investigated the role that ZIKV infection has in induction of antiviral gene expression 
by measuring the induction of IFN-β and a panel of ISGs (viperin, IFIT1, IFITM1, ISG15, OAS and Mx1) at var-
ious time points following infection using physiologically relevant cell lines of placental and neurological origin. 
Consistent with other flavivirus infections we expected to see an early response to infection that is mediated inde-
pendently of the synthesis of IFN-β. However, even at 24 h.p.i significant induction of IFN-β or ISGs in Huh-7 
cells, HTR8/SVNeo (first trimester trophoblastic line) or murine neural progenitor cell cultures was not detected 
even though there was significant ZIKV replication. This attenuation of ISG expression seems to be an active 
process as polyI:C stimulation of ZIKV infected Huh-7 cells resulted in a significant reduction in ISG expression 
(Fig. 2A). Interestingly the JEG3 choriocarcinoma cell line, displayed a robust ISG response to infection suggest-
ing that the ISG response may be determined by a combination of viral suppression of the innate response and 
cell intrinsic factors. While it has been reported that ZIKV can inhibit innate signaling post engagement of the 
Figure 7. Viperin knockout mouse embryonic fibroblasts (MEF) are more susceptible to ZIKV infection. 
(A) MEFs derived from either WT or CRISPR/Cas9 viperin Ko (Vip−/−del32) mice were infected with ZIKV 
(MR766 or PRVABC59 at MOI ~1) for 48 hours prior to immunoblot analysis of Viperin and ZIKV-NS4B 
expression, with β-actin serving as a loading control. (B) MEFs from WT and viperin KO (Vip−/−del32) were 
infected with ZIKV (MR766) at an MOI of 1.0 and at 48 h.p.i the number of ZIKV positive cells (E antigen) was 
counted using Nikon ImageQuant software. (*p ≤ 0.0001, Students t-test). (C) RNA was extracted from ZIKV 
(MR766) infected WT and Vip−/−del32 MEFs 48 h.p.i and ZIKV RNA levels analysed by qRT-PCR. Data is 
normalised to the RPLPO housekeeping gene and expressed as a fold-change relative to mock-infected control 
(data are means + SD, n = 3). (*p ≤ 0.02, Two-Way Anova). (D) Indirect immunofluorescence of corresponding 
ZIKV infection of WT and Vip−/−del32 MEFs. Cells were stained with the 4G2 antibody to detect ZIKV E 
antigen (green) and DAPI DNA stain (blue). Scale bar represents 100 µm.
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type I IFN receptor, as discussed above, the lack of an early response is likely indicative of interferon independent 
suppression18, 19. IFN-β transcription is coordinately regulated by IRF3/7 and NF-κB and numerous ISGs such as 
IFIT1 and viperin can also be regulated independently of IFN by IRF338, 39. Accordingly, the lack of expression of 
IFN-β and ISGs suggests that ZIKV may impact innate immune signaling upstream of IFN signaling. This is not 
inconceivable as DENV NS2B/3 can block the kinase activity of IKKε and cleave human STING while NS2A and 
NS4B can inhibit the autophosphorylation of TBK1 thereby inhibiting IRF3 phosphorylation40–42. Moreover, it 
was recently reported that ZIKV can suppress reporter expression from the IFN-β, IRF3 and NF-κB promoters19. 
With this in mind we confirmed that ZIKV can suppress IFN-β promoter activity in response to polyI:C and 
expression of constitutively active RIG-I (RIG-N) indicating that the blockade occurs post engagement of RIG-I 
(Fig. 2B,C). Clearly more work is required to determine the molecular mechanisms that underpin ZIKV mediated 
suppression of the early innate immune response upstream of IFN signaling.
We also investigated ZIKV infection and its ability to induce IFN-β and ISGs in primary MDMs a defined tar-
get cell type for the related DENV. ZIKV has been previously shown to infect and replicate in primary human pla-
cental macrophages (HC: Hofbauer cells) resulting in production of IFN-α and associated cytokines and ISGs5. 
Similarily, in MDMs we demonstrate significant expression of IFN-β, IFIT1, viperin, MxA and OAS mRNA 
and viperin protein expression at 48 hpi. Interestingly, even though both DENV and ZIKV infection of MDMs 
resulted in a similar number of infected cells, as determined by qRT-PCR, DENV infection resulted in greater 
levels of DENV NS4B protein and significantly higher viperin expression, suggesting that DENV RNA may be a 
more potent inducer of the innate response or that ZIKV can suppress innate immune activation. However, this 
is complicated by the possibility that DENV infection of MDMs may be more efficient than that of ZIKV and fur-
ther experiments are required to dissect this difference. Interestingly, it should be noted that the observed innate 
response is the result of a relatively small proportion of MDMs directly infected with ZIKV (and for DENV), 
an observation that was also reported in the infection of HC cells (0.6–6.3% infection rate) suggesting that ISG 
expression may be largely derived and amplified from uninfected bystander cells in response to type I IFN pro-
duction that would contribute to making bystander cells refractory to infection.
Activation of the innate immune response following RNA viral infection results in the production of type I 
interferons and the production of hundreds of IGS. While antiviral properties have been assigned to a number 
of these ISGs, the role of many of these ISGs remain undefined36. Given the growing list of ISGs with antiviral 
action against RNA viruses, it is likely that multiple ISGs act in a coordinated response in an attempt to limit viral 
infection. As an example it has recently been reported that the IFITM family of ISGs can limit ZIKV as it also 
does for a number of other RNA viruses including HCV43, 44. Interestingly, we noted during our investigations 
that the antiviral ISG viperin was only weakly induced following ZIKV infection of cells of placental and neural 
origin, and prompted us to investigate the antiviral potential of viperin against ZIKV. Viperin is strongly induced 
following a number of viral infections and has been shown by many laboratories including ours to be antiviral 
against HCV, DENV, WNV, TBEV, HIV, CHIV and HCMV (reviewed in ref. 23). We now show in this study that 
ZIKV can also be added to the list of viruses that can be restricted by viperin. Using a similar based approach to 
our previous studies in which we transiently expressed viperin and coupled with MEFs isolated from CRISPR/
Cas9 derived viperin null mice we clearly demonstrate that viperin can limit ZIKV infection. Together these data 
clearly demonstrate that viperin is a potent host restriction factor of ZIKV replication.
The molecular mechanism(s) that underpins viperin-mediated viral restriction varies between viruses and 
even between viruses of the same family. Viperin restriction of HIV and influenza A seems to be mediated at the 
stage of viral egress in which viperin can disrupt lipid raft formation and membrane fluidity via dysregulation 
of cholesterol biosynthesis by inhibition of farnesyl diphosphate synthase a key enzyme in cholesterol and sterol 
biosynthesis45, 46. In contrast restriction of HCV and DENV (both Flaviviridae family members) is at the level 
of viral RNA replication. Here, viperin demonstrates antiviral restriction against a HCV replicon and interacts 
with both HCV NS5A and with the cellular pro-viral host factor VAP-A that are both viral replication complex 
components essential to HCV replication25, 29. Furthermore viperin co-localized and co-precipitated with dsRNA 
in DENV-2-infected cells and interacted with the DENV-2 NS3 (protease/helicase) protein, suggesting a possible 
interaction of viperin at sites of DENV-2 replication24. In addition, viperin can also restrict TBEV RNA replica-
tion and it would be logical to assume that common molecular mechanisms are at play. However this is not the 
case as restriction of TBEV is dependent on a radical S-adenosyl-L-methionine (SAM) domain within viperin 
while this domain is dispensable for DENV and HCV restriction28. Interestingly, the carboxy-terminus of viperin 
is important for restriction of DENV while for HCV restriction the carboxy-terminus and the amino-terminal 
amphipathic helix are important with the latter crucial for viperin’s interaction with NS5A and VAP-A24, 25. To 
this end we show using a panel of viperin mutants that the antiviral activity of viperin is similar to that of DENV 
in that the carboxy-terminus of viperin is essential while the amino–terminus and the SAM domain are dispen-
sable. This is not surprising given the similarity between DENV and ZIKV and suggests that like DENV viperin 
interferes with ZIKV RNA replication and future studies are required to determine if viperin interacts with ZIKV 
replication complex proteins and/or essential pro-viral host factors. Understanding how viperin restricts ZIKV is 
not only important to our understanding of the innate host response to infection but also in our understanding 
of the ZIKV life cycle. Ultimately this knowledge may be used to develop therapeutic options to combat emerging 
viral infections.
Materials and Methods
Cells and Culture Conditions. All mammalian cell lines were maintained at 37 °C in a 5% CO2 air atmos-
phere. The human hepatoma cell line Huh-7 was maintained as previously described25. The placental lines, HTR8/
SVneo cells (from Professor Charles Graham, Queen’s University, Kingston, Ontario) and JEG3 cells (purchased 
from ATCC) were maintained in RPMI-1640 media supplemented with 10% FBS, penicillin and streptomycin 
(P/S). Vero cells were cultured in DMEM supplemented with 10% FBS and P/S. Murine Embryonic Fibroblasts 
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(MEFs) were prepared from day 13.5–14.5 embryos. Isolated MEFs were maintained in DMEM supplemented 
with 10% FBS and P/S. Neural progenitor cells (NPCs) were isolated from E14-18 embryonic cortices and grown 
as neurospheres as previously described47. Cells were grown in the presence of growth factors Epidermal Growth 
Factor (rhEGF, 20 ng/ml; STEMCELL Technologies) and Fibroblast Growth Factor (bFGF2, 10 ng/ml; GIBCO). 
NPCs from dissociated neurospheres (at first or second passage) were plated onto poly-l-lysine coated covers-
lips and culture surfaces at a density of 50,000 cells/cm2, and cultured overnight prior to infection with ZIKV, 
as indicated. C6/36 Aedes albopictus cells were maintained in Basal Medium Eagle (BME) supplemented with 
L-glutamine, MEM non-essential amino acids, sodium pyruvate, 10% FBS and P/S and cultured at 28 °C with 
5% CO2. Human monocyte-derived macrophages (MDM) were prepared by adherence of PBMC isolated from 
blood from healthy donors provided by the Australian Red Cross Blood Service and were cultured for 5 days in 
the presence of 7.5% (v/v) human serum, as described previously48.
Viruses. The ZIKV strains MR766 (Uganda, 1947) and PRVABC59 (Puerto Rico, 2015) were propagated 
in C6/36 cells by infection at a multiplicity of infection (MOI) of 0.01 and supernatants harvested at 5–6 days 
post-infection. PRVABC59 is a contemporary strain that was isolated by CDC from the serum of a ZIKV infected 
patient who travelled to Puerto Rico in 2015. The complete genome sequence is published (Ref. Gene bank acces-
sion # KU501215). DENV infections utilised, Mon601, a derivative of the New Guinea C strain that was produced 
from in vitro transcribed RNA, transfected into BHK-21 baby hamster kidney cells, amplified in C6/36 insect cells 
and titered in Vero cells.
Plaque Assay. Virus infectivity was determined by plaque assay. Briefly, Vero cells in 6-well trays at approx-
imately 90% confluency were infected with 800 µl of serially-diluted virus-containing supernatants for 1 hour 
at 37 °C. Supernatants were then replaced with a 2ml overlay of complete media containing 1.5% (w/v) carbox-
ymethylcellulose (CMC) (Sigma) and cells returned to culture for 5–6 days. Cell monolayers were then fixed by 
addition of 2 ml of 10% formalin and incubation for 1 h. The CMC overlay was then removed and plaques were 
visualised via crystal violet stain. Plaques were counted and virus infectivity expressed as plaque-forming units 
(PFU) per ml.
Plasmids and transfections. The human viperin cDNA expression plasmid with an N-terminal FLAG tag 
in the pLenti6/V5-D-TOPO plasmid was previously described24. Transfection of plasmids and PolyI:C (Sigma) 
was performed using Lipofectamine 3000 (Thermo Fisher Scientific) according to the manufacturer’s recommen-
dations. Plasmids expressing a constitutively active RIG-I (RIG-N), the IFN-β promoter driving luciferase and 
viperin WT and mutant plasmids have been described elsewhere24, 49.
Real-time PCR. Extraction of total cellular RNA, first-strand cDNA synthesis and real-time qRT-PCR was 
performed as described previously26. All primer sequences used are outlined in Supplementary Table 1. Primer 
sequences for ZIKV RNA have been described previously50. Generation of a ZIKV RT-PCR standard curve used 
plasmids pFK-DVs (DENV-2, strain 16681)51 and pZIKV-ICD (strain Paraiba_01/2015)52.
Antibodies. Mouse anti-envelope glycoprotein 4G2 (D1-4G2-4-15) was prepared from hybridoma cells pur-
chased from ATCC. Mouse anti-dsRNA 3G1 was a generous gift from Roy Hall (University of Queensland)53. 
Mouse anti-viperin (ab107359), rabbit anti-PAX6 (ab2237) and rabbit anti-phospho(S10) Histone H3 (ab5176) 
were obtained from Abcam. Rabbit anti-SOX2 (ab5603) was obtained from Merck Millipore. Rabbit anti-GFAP 
(G9269), rabbit anti-β-tubulin isotype III (T2200) and mouse anti-β-actin (AC15) was purchased from 
Sigma-Aldrich. Mouse anti-NS4B mAb 44-4-7 was generously provided by Qing Yin Wang (Novartis Institute for 
Tropical Diseases, Singapore). All secondary antibodies were purchased from Thermo Fisher Scientific.
Immunofluorescence Microscopy. Immunofluorescent labelling and wide-field fluorescence microscopy 
was performed essentially as described54. Briefly, cells growing in cell culture plates or on glass coverslips coated 
with poly-L-lysine (0.1% [w/v]) were washed with PBS, fixed with 4% paraformaldehyde in PBS for 15 min at 
room temperature and permeabilised with 0.1% Triton X-100 in PBS for 15 min at 4 °C. Alternatively, cells were 
fixed with ice-cold acetone:methanol (1:1) for 5 minutes at 4 °C. Samples were then blocked with 5% BSA in PBS 
for 30 min at room temperature and incubated with primary antibody diluted in PBS/1% BSA for 1 h at room 
temperature. After washing twice with PBS, cells were incubated with Alexa Fluor-conjugated secondary antibody 
diluted 1:200 in PBS/1%BSA for 1 h at 4 °C in the dark. Samples were then washed with PBS and incubated with 
DAPI (Sigma-Aldrich, 1 µg/ml) for 15 min at room temperature. Samples were then washed with PBS and, for 
cells grown on coverslips, mounted with Vectashield Antifade Mounting Medium (Vector Laboratories). Images 
were then acquired using a Nikon TiE inverted fluorescent microscope equipped with Plan Apochromat 60× NA 
1.4 oil immersion, Super Plan Fluor 40× NA 0.4, Super Plan Fluor 20× NA 0.4 and Plan Fluor 10× NA 0.3 objec-
tives (Nikon). Illumination was provide by an Intensilight C-HGFIE Precentered Fiber Illuminator mercury light 
source (Nikon), while BrightLine single-band filter sets (DAPI-5060C-NTE-ZERO, FITC-3540C-NTE-ZERO 
and TxRed-4040C-NTE-ZERO) were from Semrock and emitted light was collected with a monochrome 12-bit 
cooled charge-coupled device (CCD) camera with a maximum resolution of 1,280 × 1,024 (DS-Qi1; Nikon). 
Unless otherwise indicated images were processed using NIS Elements AR v.3.22. (Nikon) and Photoshop 
6.0 (Adobe) software. In most instances contrast stretching was applied using the ‘Autoscale’ function of NIS 
Elements v.3.22.
Immunoblotting. Western blotting was performed essentially as described elsewhere55. Membrane 
bound protein was detected by chemiluminescence using SuperSignal West Femto (Pierce) and imaged using a 
ChemiDoc MP imaging system (Bio-Rad).
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Generation of Viperin null mice. A CRISPR gRNA was designed to target exon 1 of murine Viperin 
(5′-agggtggctagatcccggga-3′) using CRISPR Design tool (crispr.mit.edu) and then generated according to the 
protocol as previously described56. gRNA IVT was performed using HiScribe™ T7 Quick High Yield RNA 
Synthesis Kit. Cas9 mRNA was generated by IVT using mMESSAGE mMACHINE® T7 ULTRA Transcription 
Kit (Ambion) from pCMV/T7-hCas9 (Toolgen) digested with XhoI. gRNAs and Cas9 mRNA were purified using 
MEGAclear™ Transcription Clean-Up Kit (Ambion). CRISPR gRNA (50ng/mL) and gRNA pairs (100 ng/mL 
each) were injected into C57BL/6N zygotes, transferred to psuedopregnant recipients and allowed to develop to 
term as previously described57. Founder pups were screened for exon deletion by PCR amplification across the 
targeted region (F-5′gtgtttgcctggaatataccagtcttgagtcct -3′, R-5′ - gacaatctgcaaggattgaatgcta -3′). PCR products 
from founders with deletions were Sanger sequenced to identify specific mutations. Routine genotyping was 
performed by PCR with the above primers spanning the target region and separated on 1% agarose gels. The 
University of Adelaide animal ethics committee approved generation and experiments involving viperin null 
mice.
Statistics. Data were graphed and analysed within the Prism 7 software (Graphpad Software Inc CA) using 
either T tests or Ordinary One or Two way Anova, all tests were corrected for multiple comparison using the 
Holm-Sidak method.
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Chapter 6 - Final Discussion 
 
Viruses within the Flaviviridae family are a major contributor of morbidity and mortality 
worldwide and inflict significant burden on healthcare systems. Effective vaccines are 
currently not available for the majority of viruses within this family including HCV, 
DENV and ZIKV. Furthermore, there are many facets of flavivirus biology that remain 
to be characterised. Therefore, in order to expedite vaccine development, further 
research is required to gain a better understanding of the virus lifecycle and the 
complex interplay between the host cell and infecting virus as a major regulator of the 
virus lifecycle. Proviral host factors are essential in supporting all facets of the virus 
lifecycle. Conversely, antiviral host factors induced upon viral recognition are able to 
potently subvert virus replication prior to the activation of adaptive immunity. The main 
objectives of this thesis were to not only uncover novel host factors required for both 
HCV and ZIKV replication but also to gain further understanding of the innate immune 
response in restricting ZIKV replication. 
6.1  CRISPR Genome-wide KO Screens 
At the commencement of this project, a number of proviral host factors had been 
identified utilising RNAi technology, however this technology is beset with multiple 
limitations stemming from poor and unpredictable knockdown efficiency ultimately 
resulting in false positives (see section 1.91). The discovery and adaption of the 
CRISPR/Cas9 system for molecular editing has revolutionised gene editing 
technology with its simplicity, enabling screening for host factors following virus 
infection at the whole genome level (Puschnik et al. 2017a). Despite the identification 
and characterisation of a number of host factors important for HCV replication prior to 
the introduction of CRISPR, we decided to utilise HCV in our studies, firstly as a proof 
of concept for use in CRISPR genome-wide screens, and secondly to further research 
into HCV replication cycle and molecular virology. In addition, the relative low priority 
of an HCV vaccine (from a pharmaceutical perspective) due to the high efficacy of 
DAAs, has transitioned research in HCV in the past five years from basic molecular 
studies to predominantly clinical investigations. Thus, many host factors required for 
HCV replication remain uncharacterised. We also chose to investigate ZIKV using 
genome-wide CRISPR screens given the explosive number of infections that emerged 
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in South America and the lack of understanding of the ZIKV lifecycle compared to 
other flaviviruses at the time (WHO). 
 
CRISPR/Cas9 technology and especially genome-wide KO screens was in its infancy 
when this project was conceived in 2015, where it enabled targeted genetic 
manipulation in a simplistic manner, relative to other nucleases, including zinc finger 
proteins and TALENs [reviewed extensively in (Gaj et al. 2013)]. Its efficiency in 
knockout of host factors in the context of the viral lifecycle was relatively unknown. 
Therefore, we performed proof of concept experiments to evaluate the efficiency of 
CRISPR (and specifically the LentiCRISPRv2 system which forms the backbone of 
our chosen library) knockout of host factors against HCV infection. In short, we were 
able to efficiently knockout CD81 expression in Huh7.5 cells that resulted in cells which 
were no longer permissive to HCV infection (Fig. 3.6 - 3.10). These experiments gave 
us the confidence that efficient knockout could be achieved in Huh7.5 cells using the 
LentiCRISPRv2 system and provided scientific evidence for us to move onto genome-
wide CRISPR screening.  
 
When designing a genome-wide screen using either RNAi or CRISPR technology to 
identify novel host factors, a crucial aspect that needs to be carefully considered is the 
establishment of a clear phenotypic endpoint to allow separation of cells which are 
resistant to infection. Virus-based systems that generate high titres of virus, ultimately 
leading to CPE are the simplest to work with. Flaviviruses including DENV and ZIKV 
fit these criteria, where cells which remain permissive to infection after the introduction 
of genome-wide siRNA/CRISPR libraries undergo rapid viral induced CPE and allow 
separation of surviving cells that have knockdown/knockout of a proviral host factor. 
This enabled us to identify RACK1 in addition to other host factors critical for ZIKV 
infection within our genome-wide CRISPR screen and will be discussed further. 
 
However, for viruses like HCV that don’t propagate to high titres in vitro, producing the 
extreme quantity of virus and associated cytopathic effect is both problematic and 
untenable in the context of genome-wide CRISPR screens as outlined above. Despite 
these limitations, a genome-wide CRISPR screen has been reported with infectious 
HCV, resulting in the identification of multiple host factors required for virus entry 
(CD81, CLDN1 and OCLN) and replication (miR-122) phases of the viral lifecycle 
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(Marceau et al. 2016). In this genome-wide screen using the GeCKO LentiGuide 
library, Huh7.5.1 cells were infected with HCV JFH-1 at a MOI of 0.3 and CPE was 
visible after 5 days. This observation is intriguing in that we and others do not 
encounter mass HCV induced CPE. The differences in our experience compared to 
that of Marceau et al. is not immediately apparent, but may be due to differences in 
both the Huh7.5 cells used and experimental design. It is possible that Huh7 cells from 
one laboratory can support not only higher levels of HCV replication but also viral 
induced CPE (Sainz et al. 2009). We could have chosen to import the Huh7.5 cell line 
used by Marceau et al. to perform our genome-wide CRISPR screen, however we 
decided to utilise the SGR system to not only ensure homogenous HCV replication 
within our entire cell population but also specifically target the replication phase of the 
lifecycle which may help identify elusive novel host factors which may be obscured by 
more dominant host factors (such as entry receptors) in an infectious virus based 
system (Marceau et al. 2016). 
 
The HCV SGR model does not induce CPE as a phenotypic endpoint for our genome-
wide CRISPR screen and thus we needed to incorporate suitable reporter proteins to 
enable separation of HCV resistant cells due to knockout of a proviral host factor. 
Renilla luciferase has been used as a reporter protein for a HCV genome-wide siRNA 
screen (Tai et al. 2009). However, this experimental setup is not amendable for the 
genome-wide CRISPR screens used in this thesis. We therefore employed the 
reporter proteins mCherry, GFP or thymidine kinase, which their expression is directly 
coupled to active viral replication, to allow screening within a pooled setting. However, 
a key factor that we encountered during screening which ultimately made use of the 
HCV SGR for genome-wide CRISPR screens untenable, was that prior to 
commencement of our genome-wide CRISPR screen with either mCherry, GFP or 
thymidine kinase reporter proteins, required the removal of the eukaryotic selection 
reagent BSD from the culture medium. The BSD resistance gene expressed by the 
HCV SGR provides positive selection to establish and retain HCV replication, and 
while Huh7.5 cells can retain the HCV-SGR in the absence of selection within the 
culture media, the combination of lentivirus transduction of the GeCKO 
LentiCRISPRv2 library with the duration needed to complete the screen resulted in 
complete loss of HCV replication and thymidine kinase protein expression (Fig. 3.20 
& 3.21). This was not an issue with the previous genome-wide siRNA HCV-SGR 
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screens since the screen was terminated 72 hours post transfection (Tai et al. 2009). 
Moreover, most genome-wide CRISPR screens to date have been performed where 
gene knockout is initiated prior to virus infection, collectively suggesting the possibility 
that introduction of CRISPR/Cas9 or lentiviral transduction may indirectly interfere with 
HCV replication (McDougall et al. 2018). Thus, in future experiments, a modified 
screening protocol would have to be adapted, where a reporter system such as NIrD 
would have to utilised to counteract the absence of HCV induced CPE within our 
Huh7.5 cells (Fig. 3.22). 
 
The problems encountered with using the HCV SGR system and genome-wide 
CRISPR screening meant that we needed to refocus our efforts and we decided to 
investigate host factors important for the ZIKV lifecycle. During the course of this thesis, 
a number of similar screens have been undertaken. However, the ability of ZIKV to 
infect multiple cell types may indicate diverse exploitation of proviral host factors. Thus, 
multiple genome-wide CRISPR screens using different cell types may be useful to 
further our understanding of the viral-host interactome. Another factor to be 
considered in genome-wide CRISPR screens is the use of either immortalised or 
primary cells, as key genes involved in the viral lifecycle may differ between the two. 
To illustrate this point, a CRISPR screen for ZIKV host factors in human pluripotent 
derived neural progenitors (hNPC) identified top hits present in not only previously 
published CRISPR screens with flaviviruses but also ours (Li et al. 2019). These hits 
include proteins within the EMC complex (EMC1, EMC6, MMTG1), indicating that 
these host factors are commonly exploited during flavivirus replication, and thus could 
be targeted as a potential antiviral to combat infection within multiple cell types. 
Furthermore, the hNPC screen with ZIKV also identified additional pathways including 
heparan sulfation, active suppression of IFN activity, and the endosome lysosome 
pathway. The absence of these additional host factors in previous CRISPR screens 
performed in immortalised cells suggest that primary cells may respond and modulate 
virus infection somewhat differently to immortalised cells. Thus, in future experiments, 
it may be useful to perform genome-wide CRISPR screens on HCV infection with 
primary hepatocytes to identify elusive host factors which may not be expressed within 
immortalised Huh7.5 cells. However, the use of primary cells in a pooled genome-wide 
screening setting remains challenging due to a number of factors which include, (i) the 
high quantity of cells required coupled with limited life spans to enable completion of 
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a screen and, (ii) poor lentiviral transduction efficiency in primary cells to maintain 
library complexity and (iii) ensuring Cas9 expression is present to induce DSBs and 
subsequently knockout of target genes during screening. In addition, challenges of 
utilising primary cells for HCV include variable permissibility in stem cell-derived 
hepatocytes and further research is required to determine suitability of organoids 
containing liver-derived LGR5 positive stem cells for HCV infection (Dutta and Clevers 
2017; Schöbel et al. 2018; Carpentier et al. 2020). 
6.2  Identification and characterisation of host factors including RACK1 for 
flavivirus infection 
Viruses are grouped according to similarities in their genome structure and replication 
strategies despite inflicting distinct pathologies during infection. Therefore, it is not 
inconceivable that viruses within the same family would exploit similar host factors to 
establish infection and replication. Host factors within the mosquito-borne flaviviruses 
are often shared for example the entry factors for both DENV and ZIKV include DC-
SIGN and the TIM (T-cell Ig mucin) and TAM (TYRO3, AXL and MERTK) family 
members, resulting in infection of multiple cell types (Laureti et al. 2018). However, 
selectivity of cell types is influenced by the efficiency in binding to these receptors, 
where ZIKV, WNV and DENV can bind DC-SIGN with similar proficiency (Richard et 
al. 2017). However, ZIKV can bind the receptor AXL with a higher efficiency, which 
may lead to increased infection in cells with higher levels of AXL expression (Richard 
et al. 2017). During the replication phase of the virus lifecycle, multiple genome-wide 
CRISPR screens including ours have uncovered numerous novel host factors such as 
the OST and EMC complexes (Savidis et al. 2016a; Marceau et al. 2016; Zhang et al. 
2016). The EMC proteins act as chaperones and promote the biogenesis of both 
DENV and ZIKV NS proteins, whereas the OST complex proteins likely play a 
structural role within the formation of the replication complex (Puschnik et al. 2017b; 
Lin et al. 2019a). Interestingly, the role of the OST complex, which is composed of 2 
subunits STT3A and STT3B, differs between flaviviruses, where DENV is reliant on 
both subunits while ZIKV, WNV and YFV only utilise SST3A, highlighting similar but 
distinct requirements in host factor driven virus replication within the flavivirus family 
(Marceau et al. 2016). Our genome-wide CRISPR screen has identified RACK1 as a 
critical host factor for successful ZIKV infection and like the OST/EMC complex, it is 
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also important for replication of other flaviviruses (DENV and WNV), demonstrating 
that RACK1 is another host factor that is shared between flaviviruses. However, unlike 
the OST complex, RACK1 was not important for YFV infection. Since our study and 
that of Marceau et al. utilised the same YFV 17D vaccine strain, it is likely that YFV 
utilises an alternative host factor to fulfil the role RACK1 plays when it is absent from 
an evolutionary point of view, relative to other flaviviruses which have likely evolved 
streamlined replication strategies which rely heavily on RACK1. In addition, the YFV 
strain utilised is both replication and evolutionally divergent from circulating YFV 
strains and thus confirmation studies for RACK1 dependency will need to be 
performed with the latter strain (Beck et al. 2014; Fernandez-Garcia et al. 2016).  
 
RACK1 is an evolutionary conserved intracellular member of the tryptophan-aspartate 
repeat (WD) family and is highly expressed in most tissues. RACK1 is also a 
dispensable subunit within the 40S ribosomal complex, allowing for efficient translation 
of capped mRNAs (Gallo et al. 2018). RACK1 consists of seven 40 amino acid repeats 
(WD40), which facilitate interactions with a large number of proteins to act as a 
signalling hub for the transduction of multiple signalling pathways including Protein 
Kinase C (PKC) and thus critical for cell homeostasis and proliferation [reviewed 
extensively in (Adams et al. 2011)]. The role RACK1 plays to maintain cellular 
homeostasis is likely a major factor of why we failed to generate a RACK1 monoclonal 
CRISPR knockout cell line and thus had to use siRNA as a complementary method to 
perform further experiments. It is also an explanation of why in comparison with other 
genome-wide CRISPR screens, our strategy identified RACK1 as a novel proviral host 
factor for ZIKV infection. We intentionally modified the recommended screening 
protocol to identify potential genes which when knocked out conferred a disadvantage 
to cell proliferation, a process where RACK1 expression is instrumental. 
 
With regards to virus replication, RACK1 is critical for replication of multiple viral 
families using diverse mechanisms. RACK1 is proposed to be critical for the translation 
of IRES-mediated viral genomes which include HCV and Cricket Paralysis Virus 
(CrPV), likely due to its role with the 40S ribosome (Majzoub et al. 2014). However, its 
role in HCV translation is somewhat contentious as Lee et al. revealed no significant 
impact on IRES-dependent translation upon RACK1 knockdown (Lee et al. 2019). In 
addition, during the course of this project, RACK1 has been demonstrated to interact 
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with HCV NS5A, forming a complex with ATG14L-Beclin1-Vps34-Vps15 to enable 
induction of autophagy and construction of DMVs within the membranous web (Lee et 
al. 2019). It is not surprising that studies performed by us and Lee et al. have 
demonstrated RACK1’s role in the biogenesis of replication organelles of flaviviruses 
and HCV respectively, given that both viruses belong to the flaviviridae family (Fig. 
6.1). In addition, HCV NS5A and flavivirus NS1 play similar roles within their respective 
viral lifecycle, which include remodelling of ER membranes to form replication 
complexes (Romero-Brey et al. 2015; Ci et al. 2020). Since flaviviruses also induce 
autophagy during virus replication, we also investigated whether DENV and ZIKV NS1 
could interact with autophagy proteins ATG5 and ATG14L, which have been shown to 
previously interact with RACK1 (Erbil et al. 2016; Lee et al. 2019). Preliminary co-
immunoprecipitation experiments indicate that ATG14L interact with ZIKV NS1 (Fig. 
4.4). Further experiments would need to be performed to determine if RACK1-NS1 
interactions drive the biogenesis of VPs by an autophagy mediated mechanism (Fig. 
6.1) (Echavarria-Consuegra et al. 2019). 
  
Other viruses which also rely on RACK1 as a proviral host factor include Epstein Barr 
Virus (EBV), Hepatitis E Virus (HEV) and Mumps Virus (MuV). Yeast 2 hybrid assays 
were performed with RACK1 to identify viral interacting partners for EBV, HEV and 
MuV infection. For EBV infection, RACK1 was shown to interact with the EBV activator 
protein BZLF1, which is critical for reactivation of latently infected cells by the PKC 
signalling pathway, a pathway RACK1 is implicated in (Baumann et al. 2000). The 
MuV V and HEV X protein have also been identified by yeast 2 hybrid assays to 
interact with RACK1, where the former is responsible for antagonism of the IFN JAK-
STAT pathway and the latter critical for virus replication (Kubota et al. 2002; 
Subramani et al. 2018). These studies illustrate the importance of RACK1 as a 
scaffolding protein, where protein-protein interactions with RACK1 are critical as its 
role as a proviral host factor. Thus, we decided to perform interaction studies with 
RACK1 with regards to flaviviruses and have demonstrated that RACK1 not only 
interacts with flavivirus NS1, but also all ZIKV NS proteins except NS5 (Fig. 7 in 
manuscript and 4.1). Further studies will need to be performed to not only confirm 
preliminary studies of RACK1-ZIKV NS protein interactions with co-
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Figure 6.1 Proposed mechanism by which RACK1 supports the flavivirus 
lifecycle. 
Upon entry of flaviviruses including DENV and ZIKV and translation and processing 
of the viral NS proteins, NS1 interacts with RACK1 within the ER lumen to drive 




immunoprecipitation and/or immunofluorescence co-localisation studies but also 
determine the consequences of these interactions. Although there may be distinct 
roles for each of these RACK1-ZIKV NS protein interactions within the virus lifecycle, 
it is likely that the RACK1 plays a common role shared by all ZIKV NS proteins in close 
proximity with the replication complex, which is the biogenesis of replication organelles 
(Fig 6.1). 
 
Since RACK1 interacts with a large repertoire of proteins in multiple signalling 
cascades, we believed that pursuing mutant studies of RACK1 would help narrow 
down potential proteins and therefore signalling pathways which could interact with 
the RACK1-NS1 complex to drive the biogenesis of replication organelles. Loss of 
interaction between DENV and ZIKV NS1 and the RACK1 harbouring a ΔWD2 
deletion suggests a putative binding site for NS1 within the RACK1 WD2 domain (Fig 
4.2B, 4.2C). Interestingly, the WD1, WD2 and WD5 domains of ribosome associated 
RACK1 are obscured by rRNA, therefore the WD2 domain is likely more accessible 
for flavivirus NS1 to bind when RACK1 is acting as an adaptor molecule (Rabl et al. 
2011). Proteins which may also bind the WD2 domain include the PKC mediated JNK2 
signalling cascade, a key regulator in cell cycle proliferation and cell survival and 
induced during DENV infection (López-Bergami et al. 2005; Ceballos-Olvera et al. 
2010; Wu et al. 2019a). Post-translational modifications are also present within 
RACK1, where phosphorylation of Tyr-52 at the boundary of WD1 and WD2 domains 
shown to be critical for interaction between c-Abl and FAK (Kiely et al. 2009). However, 
the RACK1 WD2 mutant retains Tyr-52 and thus this mechanism is unlikely 
responsible for flavivirus infection. The mediation of numerous cell responses by 
RACK1 is often dependent on its movement to distinct subcellular locations to facilitate 
signal transduction. In particular, RACK1 is sequestered into cytoplasmic stress 
granules to prevent induction of the MAPK signalling cascade to inhibit apoptosis, a 
process which all flaviviruses modulate during the virus lifecycle (Lee et al. 2005; 
Ceballos-Olvera et al. 2010). Although the majority of punctate dots containing RACK1 
observed when expressed with ZIKV NS1 were localised to the ER, cytoplasmic 
punctate dots were also present and whether the interaction of NS1-RACK1 results in 
the movement and subsequent accumulation of RACK1 within cytoplasmic stress 
granules remain unclear and warrants further investigation (Fig. 7A in manuscript).  
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6.3  The innate immune response to ZIKV infection 
The innate immune response is the first line of defence against invading pathogens of 
bacterial, fungal or viral origin, where the production of IFN and upregulation of ISGs 
is a key component to respond against virus infection (Schoggins 2019). Prior to the 
advent of unbiased identification of mRNA profiles, only a handful of ISGs were 
identified such as PKR, ISG15, OAS and MX-A (Kerr et al. 1977; Haller et al. 1979; 
Blomstrom et al. 1986; Meurs et al. 1990). However, with the development of 
microarray and RNA sequencing to profile mRNAs in multiple cell types stimulated 
with different IFNs, more than 300 ISGs are thought to exist (Schoggins et al. 2011). 
Although the antiviral function of a number of ISGs have been characterised mainly 
through ectopic expression, it is unclear which ISGs are necessary or contribute to 
virus mediated inhibition. Thus, both genome-wide siRNA and CRISPR KO libraries 
have been utilised to give an unbiased perspective on not only which ISGs directly 
inhibit virus infection, but also which non-ISGs host factors support the innate immune 
response. Richardson et al. performed a genome-wide CRISPR screen with flavivirus 
infection and identified IFI6 as the only classical ISG that has direct antiviral activity, 
along with STAT2 and IRF9 which are critical for the IFN JAK-STAT signalling cascade 
(Richardson et al. 2018). The absence of previously identified antiviral ISGs in this 
screen, such as viperin, suggest that CRISPR screens may only reveal genes that 
have an extremely potent phenotype and highlights a limitation of using CRISPR 
screens as a tool to uncover novel ISGs. Furthermore, it is likely that there is significant 
redundancy in antiviral ISGs and an antiviral state may be induced by multiple ISGs 
that can be expressed in specific cell types or a temporal manner.  
 
The explosive number of ZIKV infections in 2016 that emerged in South America and 
associated increase of microcephaly in newborns led us to investigate the cellular ISG 
response upon ZIKV infection in different cell types and moreover the role the ISG 
viperin plays in restricting virus infection. Upon infection, flaviviruses including DENV 
and ZIKV trigger recognition of viral genomic RNA in both the cytoplasm (RIG-I/MDA5) 
and endosome (TLR3) resulting in the production of IFNs and upregulation of ISGs 
(Saito and Gale 2007). However, it is well recognised that the flaviviruses have 
evolved mechanisms to evade the innate immune response (Gack and Diamond 2016; 
Coldbeck-Shackley et al. 2020). This is demonstrated in this thesis by the lack of 
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upregulation of canonical ISGs, including viperin, IFIT1, IFN-b, IFITM1, ISG15, OAS1 
and MX1, following ZIKV infection of Huh7 and the placental cell lines, HTR8 and 
JEG3 (Fig. 1 in manuscript). Furthermore, the addition of poly I:C to optimally stimulate 
the innate immune response in ZIKV infected cells resulted in reduced IFN-b promoter 
activity and ISG mRNA upregulation (Fig. 2 in manuscript). Interestingly, mouse neural 
progenitor cells (NPCs) infected with ZIKV displayed delayed ISG upregulation (Fig. 3 
in manuscript). The delayed responses in ISG upregulation observed can be attributed 
to the numerous ZIKV immune evasion strategies orchestrated by the viral NS proteins 
(see section 1.16.2). However, monocyte-derived macrophages (MDMs) could 
upregulate innate signalling pathways in response to ZIKV infection (Fig. 4 in 
manuscript). Other publications also show that both patient and hPSC-derived 
macrophages are also susceptible to ZIKV infection which are consistent with our 
studies (Lang et al. 2018; Carlin et al. 2018). However, both reports demonstrate that 
low levels of pro-inflammatory cytokines and chemokines are expressed, resulting in 
dampened type I IFN responses and upregulation of ISGs. In addition, Lang et al. 
show that ZIKV but not DENV infection disrupts the NF-kB macrophage migration 
inhibitory factor (MIF) positive feedback loop, resulting in enhanced suppression of 
pro-inflammatory cytokine expression (Lang et al. 2018). This could explain the 
significant increase in IFN-b upregulation in DENV infected MDMs compared to ZIKV 
infected MDMs. Thus, it is highly probable that the high innate immune responses 
observed within MDMs in our study can be attributed to the low infection rate (0.6-
6.3%), where the bulk of ISG regulation is derived from innate immune activation of 
uninfected bystander cells. 
 
Viperin is a potent anti-viral ISG that has received much attention, due to its ability to 
not only directly restrict replication against multiple viruses with diverse mechanisms, 
but also its ability to augment the innate immune signalling pathways creating positive 
feedback loops (see section 1.15 and references therein). Encoded by the gene 
RSAD2, viperin is a part of the superfamily of radical S-adenosyl-L-methionine (SAM) 
domain-containing enzymes that cleaves SAM via utilisation of the 4Fe-4S cluster 
(Duschene and Broderick 2010). Through a SAM-dependent manner, viperin can 
catalyse cytidine triphosphate (CTP) to 3’-deoxy-3’,4’-didehydro-CTP (ddhCTP), a 
novel antiviral ribonucleotide, where incorporation of ddhCTP into newly synthesised 
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viral RNA results in termination of translation via RNA dependent RNA polymerases 
(Gizzi et al. 2018). We show that ectopic expression of viperin inhibits ZIKV infection 
in Huh7 cells, where reduced ZIKV RNA and envelope expression is observed (Fig. 5 
in manuscript). In addition, using MEFs generated from viperin-/- mice, we confirmed 
the importance of viperin in restricting ZIKV infection (Fig. 7 in manuscript). However, 
our viperin mutant studies show that although the SAM domain mutant impaired anti-
ZIKV activity, the 3’ domain mutant of viperin had lost complete antiviral activity relative 
to wildtype, indicating that there are multiple mechanisms by which viperin inhibits 
ZIKV replication (Fig. 6 in manuscript). This is not surprising given that the innate 
immune response is not selective and thus has evolved multiple mechanisms to 
combat virus infection. Vanwalscappel et al. showed that the lysine amino acid residue 
at position 358 in viperin is crucial for antiviral activity against ZIKV infection, which 
supports our findings as the 3’ mutant of viperin we utilised has lost the amino acid 
present in positions 357-361 (Vanwalscappel et al. 2019).  
 
Viperin has been shown previously to inhibit multiple members of the flaviviridae family 
including HCV, DENV, WNV, ZIKV and TBEV (Helbig et al. 2011; Helbig et al. 2013; 
Van der Hoek et al. 2017). Viperin interacts with viral proteins such as HCV NS5A, 
and ZIKV and TBEV NS3, to exert its antiviral activity (Helbig et al. 2005; Panayiotou 
et al. 2018). However, the mode of action in each case is strikingly different. Viperin 
binds to HCV NS5A on the surface of lipid droplets to disrupt interactions with host 
factors such as VAP-A, critical for formation and maintenance of the replication 
complex (Helbig et al. 2005). In contrast, despite viperin’s ability to interact with the 
NS3 protein of JEV, TBEV, YFV and ZIKV, only TBEV and ZIKV NS3 is targeted for 
proteasomal degradation (Panayiotou et al. 2018). In addition, viperin promoted NS3-
dependent degradation of other viral proteins prM, E, NS2A and NS2B, suggesting 
the capability of ISGs to co-opt viral protein enzymatic functions to respond against 
virus infection (Panayiotou et al. 2018). Given that our mutant studies and previous 
publications show that both the SAM domain and C-terminus of viperin is critical for 
ZIKV and TBEV antiviral activity respectively, it would be interesting to determine 
whether targeted interaction and subsequent proteasomal degradation of NS3 is 
linked to the SAM domain and the requirement of viperin’s c-terminus interaction with 
CIAO1 to enable enzymatic activity of the SAM domain, or whether it is a SAM-
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independent mechanism by which viperin restricts flavivirus replication (Upadhyay et 
al. 2014).  
 
Although viperin is able to synthesise the novel ribonucleotide ddhCTP to facilitate 
premature termination of RNA synthesis by flavivirus NS5, it does not explain the 
diverse antiviral activities viperin displays against multiple pathogens. One unifying 
mechanism by which viperin could limit multiple pathogens is through positive 
regulation of the innate immune response. Viperin can enhance both TLR7 and TLR9 
signalling pathways via interactions with IRAK1 and TRAF6, resulting in increased 
production of IFN (Saitoh et al. 2011). In addition, viperin can also interact with STING 
and induce TBK1 K63-linked polyubiquitination, resulting in enhancement of the innate 
immune response against dsDNA viral mimics and HBV infection (Crosse et al. 2020). 
Unpublished data in our laboratory also demonstrated that overexpression of viperin 
enhances the TLR3 signalling pathway via co-localisation with both TBK-1 and TRAF3 
after stimulation with dsRNA mimics. Whether viperin enhances TLR3 and/or TLR7 
signalling in the context of both HCV and ZIKV infection with a similar mechanistic 
nature remains unexplored and warrants further investigation.  
 
Although viperin is primarily known for it’s role to restrict virus replication from multiple 
viral families, Human Cytomegalovirus (HCMV) exploits viperin as a proviral host 
factor where interferon independent induced viperin is transported to the mitochondria, 
resulting in increased lipid synthesis required for progeny virion production (Seo et al. 
2011). Conversely, it may therefore be possible for viruses to utilise pro-viral host 
factors such as RACK1 (as shown in this thesis) to regulate innate immune responses. 
It has been reported that RACK1 plays a role in multiple pathways of the innate 
immune response, where the literature suggests RACK1 acting in the capacity of both 
a positive and negative regulator of immune signalling. It has been postulated that the 
interaction of RACK1 with MAVS results in reduction of IFN-b promoter activity and 
disruption of signalling complexes (RACK1-TRAF6/TRAF3) (Xie et al. 2019a). In 
addition, RACK1 forms a complex with the phosphatase PP2A to dephosphorylate 
IRF3 and hence further strengthens the argument of RACK1 acting as a negative 
regulator within the RIG-I signalling pathway (Long et al. 2014). However, RACK1 
mediates the interaction of the IFNAR and STAT1, resulting in STAT1 tyrosine 
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phosphorylation and activation of STAT2 within the IFN pathway (Usacheva et al. 
2001). Given the prominent role of RACK1 in regulating the innate immune response, 
it is logical that viruses may exploit the former’s ability to bind multiple proteins to 
subvert the innate immune response. Interestingly, the Mumps virus (MuV) V protein 
is able to competitively bind to RACK1 and disrupt binding of the IFNAR with STAT1, 
resulting in downregulation of specific ISGs (IFIT1) (unpublished preliminary data in 
this thesis) (Kubota et al. 2002). Therefore, ZIKV NS proteins may also utilise RACK1 
as an adapter molecule to inhibit the innate immune response. ZIKV NS4A and NS2B3 
have been reported to bind to MAVS and JAK1 respectively, the same proteins RACK1 
interacts with (Fig. 6.2). Our preliminary data suggests that RACK1 also binds ZIKV 
NS4A and NS2B3 (Fig 4.1) and therefore it is possible that ZIKV may exploit RACK1 
to subvert the innate immune response (Fig. 6.2). This could be achieved by 
recruitment of RACK1 by viral proteins to sites of innate signalling to exert a negative 
influence on target proteins such as MAVS and JAK1, ultimately resulting in decreased 
ISG upregulation. In addition, interaction of ZIKV NS1 with RACK1 during the 
biogenesis of the replication complex and subsequent relocation of RACK1 to the ER 
lumen may allow for sequestration of the latter to prevent induction of the IFN JAK-
STAT signalling cascade (Fig. 6.2). Thus, investigations into RACK1 as a major 
contributor to immune evasion by flaviviruses in addition to its role as a proviral host 
factor should be considered in further studies. 
 
6.4  Development of novel therapeutics to target flavivirus infection 
Both proviral and antiviral host factors have a major impact on the virus lifecycle. Thus, 
knowledge of the function of these host factors could lead to further insight into the 
viral lifecycle and aid in the development of novel antiviral therapeutics. Host factors 
identified in genome-wide CRISPR screens are expected to have a particularly potent 
phenotype and could serve as antiviral drug targets. For example, a genome-wide 
CRISPR screen targeting flaviviruses, identified the OST complex as essential for 
virus replication (Marceau et al. 2016). A small cell-permeable compound NGI-1, 
originally developed to target the OST complex for the treatment in lung cancer, was 
then repurposed as a novel antiviral against multiple flaviviruses (Lopez Sambrooks 
et al. 2018). NGI-1 acted as a pan-flavivirus antiviral compound, where multiple 
serotypes of DENV infection were inhibited (Puschnik et al. 2017b). Antiviral activity 
associated with NGI-1 was separate from its main cellular N-glycosylation role 
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Figure 6.2 Potential mechanisms by which RACK1 regulates innate signalling 
pathways. 
ZIKV NS4A may interact with MAVS to allow for virus induced disruption of signalling 
complexes to prevent induction of IFN-β. In addition, ZIKV NS2B3 may inhibit RACK1 
mediated STAT1 tyrosine phosphorylation in the IFN JAK-STAT signalling pathway. 
In addition, ZIKV NS1 may bind to RACK1 to sequester the latter away from the IFN 






of the OST complex, making it a desirable therapeutic to treat flavivirus infection. Novel 
serotypes of DENV infection were inhibited (Puschnik et al. 2017b). Antiviral activity 
associated with NGI-1 was separate from its main cellular N-glycosylation role of the 
OST complex, making it a desirable therapeutic to treat flavivirus infection. Novel 
antiviral therapeutics could also be developed against RACK1, that we have identified 
in this thesis to be important for pan-flavivirus replication. Given that RACK1 
possesses no enzymatic activity yet has multiple cellular roles critical for cell 
homeostasis, therapeutics would likely be targeted to exploit RACK1-protein 
interactions with either additional host factors or viral NS proteins rather than RACK1 
expression itself. Likewise, exploitation of the mechanisms by which antiviral ISGs act 
against virus infection can lead to the development of novel antiviral drugs. For 
example, the discovery of the ddhCTP ribonucleotide that is produced by viperin to 
combat flavivirus infection, has led to the synthetic generation of the ddhCTP 
precursor ddhC, that is able to enter cells and inhibit ZIKV replication in vitro (Gizzi et 
al. 2018).  
 
In summary, we have validated, optimised and performed a genome-wide CRISPR 
screen to identify novel host factors important for ZIKV infection. One enriched novel 
host factor, RACK1 was shown to be critical for replication complex formation via 
interactions with NS1 within the DENV and ZIKV lifecycles. In addition, we also show 
for the first time, the antiviral activity of the ISG viperin against ZIKV infection is 
mediated by the 3’ terminus of the protein. Collectively, the studies conducted in this 
thesis demonstrate the importance of both proviral and antiviral host factors in 
understanding viral replication and highlights the complex interplay between host and 
virus proteins that ultimately determine the outcomes of virus infection. An improved 
understanding of the molecular mechanisms by which RACK1 and viperin influence 












Appendix I: Primer sequences 
Gene name Forward primer ( 5’ to 3’) Reverse primer ( 5’ to 
3’) 














































































































































































































































HSV TK  GAACAAACGACCCAAC
ACCC 
























































































































Appendix II: Solutions 
The following solutions were obtained from the Central Services Unit (CSU) and 
Tissue Culture Services Unit (TSU), School of Biological Sciences, The University of 
Adelaide. 
§ 0.85% saline solution 
§ 10x GTS buffer 
§ 10x TBS buffer 
§ 1x and 20x PBS (phosphate buffered saline) solutions 
§ 20% Glucose solution 
§ 4M NaCl solution 
§ Ampicillin 1 mg/ml 
§ EDTA (different concentration and pH) 
§ Kanamycin 1 mg/ml 
§ L-Agar + ampicillin plates 
§ Luria agar plates 
§ Luria Broth 
§ SDS 
§ SOC media 
§ Tris solutions (different concentration and pH) 
§ G418 
§ Penicillin/streptomycin 
§ Trypan blue 
§ Trypsin-EDTA 
§ FCS (Foetal Calf Serum) 




Cell lysis RIPA Buffer (40 ml) 
 
150mM NaCl (1.5ml of 4M NaCl) 
0.5% deoxych = 0.2g  
0.1% SDS (0.4ml of 10% SDS) 
1% NP-40 (0.4 ml  of NP-40) 
50mM Tris (2 ml of 1M Tris) 
dH2O 35.7 ml 
Cell lysis NP-40 Buffer (40 ml) 
 
50 mM Tris-HCL (2 ml of 1M Tris-
HCL,pH8) 
150mm NaCl (1.5 ml of 4M NaCl) 
1% NP-40 (0.4 ml  of NP-40) 
dH2O 36.1 ml  
5X Laemmli Buffer 5% β-Mercaptoethanol  
0.02% Bromophenol blue  
30% Glycerol  
10% SDS  
0.25 mM Tris-Cl (pH 6.8) 
SDS PAGE Running Buffer 2.9% Trisma Base 
14.14% glycine 
1% SDS 
SDS PAGE Transfer Buffer 0.3% Trisma Base 
1.44% glycine 
20% (v/v) methanol 
TBS-T washing solution 
(Western blot) 
1x TBS buffer in dH2O 
0.1 % Tween® 20 
Acetone:Methanol 50% acetone 
50% methanol 
4% Paraformaldehyde (100 ml)  4g of paraformaldehyde (PFA)  
10ml of 10x PBS  
dH2O up to a final volume of 100 ml 
Redsafe solution 3 μl Redsafe  
100 ml of melted-agarose gel  
1% Agarose 1g Agarose  
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100ml 1xTAE buffer 
1% BSA 1 g of Bovine serum albumin (BSA) 
100 ml of 1X PBS 
5% BSA 5 g of BSA 
100 ml of 1X PBS 
2x Freezing medium (10 ml) 
 
50% complete DMEM medium (5 ml) 
30% FCS (3 ml) 
20% DMSO (2 ml) 
 
Competent Cells: 
The E.coli α-Select Chemically Competent Cells used for bacterial transformation was: 
deoR endA1 recA1 relA1 gyrA96 hsdR17(rk-mk+) supE44 thi-1 Δ(lacZYA-argFV169) 
Φ80δlacZΔM15 F- γ-. 
 
The Endura™ Electrocompetent cells used for bacterial transformation of the GeCKO 
LentiCRISPRv2 library was:  recA13 supE44 ara-14 galK2 lacY1 proA2 rpsL20(StrR) 
xyl-5 λ– leu mtl-1 F– mcrB mrr hsdS20(rB–, mB–). 
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Appendix III: Antibodies 
Antibody dilution for Western blot analysis 
 
Primary antibody  Dilution  Incubation  Supplier 
Mouse anti-FLAG (M2) 1:1,000 O/N, 4°C Sigma Aldrich 
Rabbit anti-FLAG (D6W5B) 1:1,000  O/N, 4°C Cell Signaling 
Technology 
Mouse anti-b-actin (AC-74) 1:10,000  O/N, 4°C Sigma Aldrich  
Rabbit anti-viperin (AT131) 1:1,000  O/N, 4°C Enzo life sciences 
Mouse anti-HA (HA-7) 1:1,000 O/N, 4°C Sigma Aldrich 
Rabbit anti-HA (polyclonal) 1:1,000 O/N, 4°C Sigma Aldrich 
Mouse anti-myc (9B11) 1:1,000  O/N, 4°C Cell Signaling 
Technology 
Anti-EGFP 1:1,000  O/N, 4°C N/A 
Mouse anti-flavivirus NS1 
4G2 
1:1,000  O/N, 4°C UQ 
Chicken anti-flavivirus NS5 1:1000 O/N, 4°C NIH 
Mouse anti-vinculin (hVIN-1) 1:1000 O/N, 4°C Sigma Aldrich 
Mouse anti-RACK1 (B-3) 1:1,000 O/N, 4°C Santa Cruz 
Biotechnology 
Secondary Antibody    
Goat anti-mouse IgG (H+L), 
peroxidase conjugated 
1:10,000  1 hr, RT Thermo Fisher Scientific 
Goat anti-rabbit IgG (H+L), 
peroxidase conjugated 




Rabbit anti-chicken IgY 
(H+L), peroxidase 
conjugated 
1:10,000  1 hr, RT Millipore 
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Antibody dilution for Immunofluorescence labelling 
 
Primary antibody  Dilution Incubation Supplier 
Mouse anti-FLAG (M2) 1:200 1 hr, RT Sigma Aldrich 
Rabbit anti-FLAG (D6W5B) 1:200 1 hr, RT Cell Signaling 
Technology 
Mouse anti-HA (HA-7) 1:200 1 hr, RT Sigma Aldrich 
Rabbit anti-HA (polyclonal) 1:200 1 hr, RT Sigma Aldrich 
Mouse anti-myc (9B11) 1:200 1 hr, RT Cell Signaling 
Technology 
Mouse anti-RACK1 (B-3) 1:200 1 hr, RT Santa Cruz 
Biotechnology 
Mouse anti-CD81 (JS-81) 1:100 1 hr, RT BD Biosciences 
Mouse anti-HCV NS5A 1:5 1 hr, RT Hybridoma S/N 
Mouse anti-flavivirus NS1 
4G4 
1:5 1 hr, RT Hybridoma S/N 
Mouse anti-flavivirus 
Envelope 
1:5 1hr, RT Hybridoma S/N 
Mouse anti-dsRNA 3G2 1:5 1 hr, RT Hybridoma S/N 
Secondary Antibody    
Anti-mouse/Alexa 488 IgG 1:200 1 hr, RT Invitrogen 
Anti-mouse/Alexa 555 IgG 1:200 1 hr, RT Invitrogen 
Anti-mouse/Alexa 555 IgM 1:200 1 hr, RT Invitrogen 
Anti-rabbit/Alexa 488 IgG 1:200 1 hr, RT Invitrogen 
Anti-rabbit/Alexa 555 IgG 1:200 1 hr, RT Invitrogen 
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Appendix IV: Target sequences of siRNA RACK1 
A SMARTpool of ON-TARGETplus RACK1 siRNA (5 nmol) containing a mixture of four 
siRNA targets to human RACK1 (accessions NM_006098) was obtained as dry pellet 
from Dharmacon (part of GE Healthcare, USA, catalogue number L-006876-00-0005). 
The target gene sequences are listed below: 






ON-TARGETplus Non-targeting pool (5 nmol, catalogue number D-001810-10-05) 


















Appendix V: Plasmid Maps 






























































The pcDNA6.2 N-EmGFP-DEST plasmid was digested with XbaI and PmeI and 
Gibson assembly performed for insertion to construct the following plasmids:  
• RACK1-2xHA 
• ZIKV NS1-FLAG 
• ZIKV NS2A-FLAG 
• ZIKV NS2B3-FLAG 
• ZIKV NS4A-FLAG 
• ZIKV 2K-NS4B-FLAG 
• ZIKV NS5-FLAG 
• DENV NS1-2xFLAG 
• WNVKUN NS1-2xFLAG 









To construct the RACK1 mutant plasmids, each WD domain was removed via PCR 
amplification of pcDNA6.2 RACK1-2xHA with the appropriate primers (see Appendix 
I), digested with KpnI and re-ligated.  
 



















The LentiCRISPRv2 plasmid was digested with BsmBI and annealed oligonucleotides 
with complementary overhangs targeting EGFP, CD81, PI4KA, RACK1, EMC1 and 
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